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Abstract 
This series of studies includes both methodological analyses, aimed at furthering our understanding of, 
and improving the tools used in molecular epidemiology, and investigative projects which have used 
these tools to add to our knowledge of the M. tuberculosis epidemic. 
Using serial isolates from tuberculosis patients, we have investigated the evolutionary rate of the 
IS6110 RFLP pattern. In accordance with other studies, we determined a ½-life for this 
epidemiological marker of 10.69 years, confirming its appropriateness for this purpose. We also 
identified an initial, much higher apparent rate which we proposed was the result of pre-diagnostic 
evolution. In support of this, our investigations in the context of household transmission of M. 
tuberculosis revealed that IS6110-based evolution is closely associated with transmission of the 
organism, resulting in a strain population rate of change of 2.9% per annum. 
To accommodate evolution within estimates of transmission, we proposed that calculations 
incorporate the concept of Nearest Genetic Distance (cases most similar in RFLP pattern and most 
closely associated in time). We used this to create transmission chains which allowed for limited 
evolution of the IS6110 marker. As a result, in our study community, the estimated level of disease 
attributable to ongoing transmission was increased to between 73 and 88% depending on the Genetic 
Distance allowed. 
We identified the duration of a study as a further source of under-estimation of transmission. This 
results from the artefactual abridgement of transmission chains caused by the loss of cases at the 
temporal boundaries of a study. Using both real and simulated data, we showed that viewing a 12-
year study through shorter window periods dramatically lowered estimates of transmission. This effect 
was negatively correlated with the size of a cluster. 
Various combinations of MIRU-VNTR loci have been proposed as an alternative epidemiological 
marker. Our investigations showed that, while this method yielded estimates of transmission similar to 
those of IS6110, there was discordance between the two markers in the epidemiological linking of 
cases as a result of their independent evolution. Attempting to compensate for this by allowing for 
evolution during transmission improved the performance of IS6110, but generally had a deleterious 
effect of that of MIRU-VNTR. However, this marker remains a valuable tool for higher phylogenetic 
analysis and we used it to demonstrate a correlation between sublineages of the Beijing clade and the 
regions in which they are found. We proposed that, either the host population had selected for a 
particular sublineage, or that specific sublineages had adapted to be more successful in particular 
human populations. 
We further explored the dynamics of the epidemic over a 12-year period in terms of the five 
predominant M. tuberculosis clades. We found that, while four of these clades remained relatively 
stable, the incidence of cases from the Beijing clade increased exponentially. This growth was 
attributed to drug-sensitive cases although drug-resistant Beijing cases also appeared to be more 
successful than their non-Beijing counterparts. Possible factors contributing to this clade’s success 
were a greater proportion of positive sputum smears and a lower rate of successful treatment. 
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Oorsig 
Hierdie reeks studies bevat beide metodologiese analises, gerig op die uitbreiding van ons kennis van 
die metodes in gebruik in molekulêre epidemiologie en die verbetering daarvan, en ondersoekende 
projekte wat hierdie metodes gebruik om by te dra tot ons verstaan van die M. tuberculosis epidemie. 
Ons het die evolusionêre tempo van die IS6110 RFLP patroon ondersoek deur gebruik te maak van 
opeenvolgende isolate vanaf tuberkulose pasiënte. In ooreenstemming met ander studies, het ons die 
½-leeftyd van hierdie epidemiologiese merker bepaal as 10.69 jaar, wat die geskiktheid daarvan vir 
hierdie doel bevestig het. Ons het ook `n aanvanklike, veel groter klaarblyklike tempo geïdentifiseer, 
wat ons voorgestel het afkomstig was van pre-diagnostiese evolusie. Ter ondersteuning hiervan, het 
ons ondersoeke in die konteks van huishoudelike oordrag van M. tuberculosis getoon dat IS6110-
gebaseerde evolusie sterk geassosieer is met die oordrag van die organisme, wat lei tot `n raspopulasie 
tempo van verandering van 2.9% per jaar.  
Om evolusie binne die berekening van oordrag in te sluit, het ons voorgestel dat berekeninge die 
konsep van Naaste Genetiese Afstand (gevalle wat die mees soortgelyk is in RFLP patroon en naaste 
geassosieer is in tyd) moet inkorporeer. Ons het dit gebruik om oordragkettings te skep wat beperkte 
evolusie van die IS6110 merker toelaat. Die resultaat daarvan, in ons studie gemeenskap, is dat die 
beraamde vlak van siekte wat toegeskryf kan word aan deurlopende oordrag, verhoog is na tussen 73 
en 88%, afhangende van die Genetiese Afstand wat toegelaat is. 
Ons het die lengte van `n studie as `n verdere bron van onderberaming van die hoeveelheid oordrag 
geïdentifiseer. Dit is die resultaat van die artefaktuele verkorting van oordragkettings wat veroorsaak 
is deur die verlies van gevalle by die temporale grense van `n studie. Deur gebruik te maak van beide 
werklike en nagebootsde data, kon ons aantoon dat berekeninge van oordrag dramaties verlaag is deur 
`n 12-jaar studie in korter vensterperiodes te besigtig. Hierdie effek is negatief gekorreleer met die 
grootte van `n stam-groep.  
Verskeie kombinasies van MIRU-VNTR lokusse is voorgestel as `n alternatiewe epidemiologiese 
merker. Ons ondersoeke het getoon dat, alhoewel hierdie metode beramings van oordrag soortgelyk 
aan die van IS6110 gelewer het, daar tog onenigheid tussen die twee merkers in die epidemiologiese 
verbinding van gevalle was as gevolg van hul onafhanklike evolusie.  
In `n poging om hiervoor te kompenseer, is daar vir evolusie gedurende oordrag voorsiening gemaak. 
Alhoewel die prestasie van IS6110 hierdeur verbeter is, het dit oor die algemeen `n nadelige effek op 
die prestasie van die MIRU-VNTR gehad. Ondanks dit, bly hierdie merker `n waardevolle metode vir 
hoër filogenetiese analises en het ons daarvan gebruik gemaak om `n korrelasie tussen sublyne van die 
Beijing groep en die areas waarin dit voorkom, te maak. Ons stel twee moontlike verklaarings voor: 
dat die gasheerpopulasie het vir `n spesifieke sublyn geselekteer, óf dat spesifieke sublyne aangepas 
het om meer suksesvol in die onderskeie menspopulasies te wees. 
Ons het die dinamika van die epidemie verder oor `n 12-jaar periode ondersoek in terme van die vyf 
oorheersende M. tuberculosis groepe. Ons het gevind dat, terwyl vier van hierdie groepe relatief stabiel 
gebly het, die voorkoms van gevalle van die Beijing groep eksponensieël vermeerder het. Hierdie groei 
v 
was te wyte aan geneesmiddel-sensitiewe gevalle, alhoewel middelweerstandige Beijing-gevalle ook 
geblyk het om meer suksesvol te wees as die nie-Bejing groepe. `n Groter aandeel van positiewe 
sputum smere en `n laer koers van suksesvolle behandeling is as moontlike faktore wat bydra tot 
hierdie groep se sukses geïdentifiseer.  
vi 
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Preface 
It is estimated by the WHO that roughly 1/3 of the world’s population is infected with Mycobacterium 
tuberculosis and that, currently, 2 million people die annually as a result of this disease. Evidence for the 
existence of tuberculosis as a human pathogen dates back as far as 4000 BC, tubercular decay having 
been detected in skeletal remains and in the spines of Egyptian mummies. Despite its long history, it 
was only with the discovery of M. tuberculosis as the causative agent of tuberculosis in 1882 by Robert 
Koch, made possible by advances in bacteriological techniques, that progress began to be made in 
understanding the disease. However, it was only with the development of molecular epidemiological 
tools, subsequent to the ‘molecular biology revolution’, that a clearer picture began to emerge as to 
the dynamics of the tuberculosis within its host population. 
Chapter 1 gives an overview of the various molecular markers currently used in tuberculosis 
epidemiology in different contexts, as well as a number that have been previously used and some 
prospective future markers which have recently been proposed. 
The subsequent seven chapters describe methodological and analytical studies using the tools 
currently available to molecular epidemiology as it applies to tuberculosis. The community from 
which the data used in this series of studies is derived, comprises a population of approximately 
36 300 according to census data provided by Statistics South Africa. There is a high incidence of 
tuberculosis, with an average of 320 new, bacteriologically-confirmed, adult cases per 100 000 
population reported per annum. 
As a thorough and accurate understanding of any scientific tool is essential, the first four studies 
presented in this thesis comprise a number of investigations into the nature of the most commonly 
used epidemiological marker in tuberculosis: the insertion element, IS6110. The first two (Chapters 2 
and 3) examine the stability of this marker in the context of individual patients and during 
transmission respectively. Having established an evolutionary rate for IS6110, Chapter 4 proposes a 
method whereby minor changes in the marker, in the context of recently transmitted disease, might 
be incorporated into the concept of a chain of transmission for the purposes of epidemiological 
calculations. 
A number of logistical issues beset any epidemiological investigation. One of these is the difficulty in 
describing an epidemic of a complex disease like tuberculosis, which has a lengthy incubation interval 
and may remain dormant for long periods, from data derived from a study of finite duration. Chapter 
5 examines the effect of study duration on the standard calculations of ongoing or recent transmission 
of tuberculosis and the identification of cases having unique strain-types. 
With the nature and use of the IS6110 marker established by the preceding studies and those of other 
investigators in this field, Chapter 6 examines the structure and dynamics of the epidemic in the afore-
mentioned study community in terms of the prevalent strain-clades. The Beijing clade is noted as 
being particularly successful and possible reasons for this are presented. 
The origins of tuberculosis in South Africa are various, however, the Beijing clade is generally accepted 
to have arrived with the importation of slave labour from the Far-East. As noted in the preceding 
xiii 
chapter, this clade has been particularly successful the study community, which consists largely of 
people of the Cape Coloured ethnic group. Chapter 7 addresses this observation using the more recent 
Mycobacterial Interspersed Repetitive Unit (MIRU) marker to show an association between the 
frequency of occurrence of strains from defined Beijing clade sublineages and the human host 
population. 
Use of the MIRU marker is increasing and, while comparative studies between it and IS6110 have 
been done, these have focused on communities with a low-incidence of tuberculosis or those having a 
high proportion immigrant population. Chapter 8, therefore, compares the molecular epidemiological 
analyses using IS6110 and various combinations of MIRU marker sets in data from a high-incidence 
community to evaluate the usefulness of the latter in this context. 
This series of studies has substantially enhanced our understanding of tuberculosis, successfully 
challenged pre-existing dogma and helped to define some of the tools used in the field of molecular 
epidemiology and, as such, has laid the foundation for future studies in this arena. 
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Introduction 
In order to control the epidemic it is essential to understand the epidemic. 
Classical epidemiology, “the branch of medicine that deals with the study of the causes, distribution, and control 
of disease in populations” has, and continues to provide insights into the disease dynamics and the factors 
driving the TB epidemic. For the first 80 years following the discovery of the causative agent, 
epidemiologists had no tools to study the genetics of Mycobacterium tuberculosis and therefore, with the 
exception of phenotypic characteristics such as colony morphology, growth rates and drug resistance 
patterns, investigations largely ignored the bacterial component of the epidemic. 
In the absence of genetic information, numerous assumptions were made in order to facilitate 
epidemiological analysis. Foremost among these was the concept that TB is caused by a single, 
primary infection. Any recurrence of disease after cure was regarded as a relapse of the same infection 
[1]. Furthermore, it was understood that the transmission of M. tuberculosis occurred under conditions 
of close contact, pointing to the household as a primary focal point for the spread of the disease [2]. It 
was also accepted that most cases of drug resistant TB arose as a result of the acquisition of resistance 
due to non-compliance with the treatment regimen [3]. Many of these assumptions have become 
entrenched as dogma and have formed the basis of our understanding and management of the disease. 
It was only with the discovery of phage typing methods [4] that proof of pathogen diversity was 
obtained and it was recognised that the epidemic was probably not caused by a single genetic entity. 
Despite the limited resolution of phage typing, in that it only allows for the differentiation of M. 
tuberculosis into three groups, the method immediately challenged certain dogma and was the first 
method used to investigate the mechanism leading to recurrent disease. It revealed that the epidemic 
was a composite of different groups of M. tuberculosis and that an individual TB patient could harbour 
more than one strain. 
It took a further 30 years and the development of molecular biological tools before the true extent of 
genetic heterogeneity was discovered in the species M. tuberculosis. This culminated in the birth of 
molecular epidemiology: “the application of molecular biology to the answering of epidemiological questions”. 
Essentially, molecular epidemiology is a comparative science which aims to identify epidemiological 
relationships between patients with diagnosed TB through comparison of the genotypes of the disease-
causing bacteria. 
The Purpose of Molecular Epidemiology 
From the onset, molecular epidemiological studies have challenged classical dogma, thereby providing 
new insights into the true nature of the disease. Such knowledge has been used to inform and develop 
policy in many countries thereby resulting in the implementation of infrastructure to ensure more 
effective TB control strategies. 
The objective of molecular epidemiology is to complement classical epidemiology by the use of 
molecular tools, tracking the movement of strains through space and time, thereby enhancing the 
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accuracy and resolution of the epidemiological picture. To a large degree, this is achieved by 
distinguishing bacterial strains on the basis of genetic differences. The ideal approach would be by 
whole genome sequence comparison. However, despite major advances in DNA sequencing 
technology, which may well make this feasible in future, this is currently not a practical solution. 
Thus, we are compelled to use genetic fingerprinting methods that rely on observing a small subset of 
Mycobacterial genome dynamics. These techniques therefore act as surrogates for the underlying 
genetic evolution of the bacterial strains. To the extent that they are able to accurately reflect changes 
within the entire genome, the methods discussed below serve as useful tools to define clonality. 
Requirements for the Successful Application of Molecular Epidemiology 
The Marker 
The inferences drawn from molecular epidemiological data are only as valid as the inherent limitations 
of the biological and analytical tools used to inform them. These molecular tools present an indirect 
window onto selected aspects of genomic dynamics and are thus markers of evolutionary change at the 
DNA level. There is a great deal of diversity between the different molecular markers, which affects 
their suitability for various applications. The features required of a marker used for the phylogenetic 
reconstruction of ancient lineages, for example, will differ from those required for the purposes of 
characterisation and geo-temporal tracking of an ongoing epidemic. In addition, studies attempting to 
answer specific questions or focussing on particular bacterial sub-populations may make different 
demands of a molecular marker. 
An epidemiological molecular marker should have attributes which permit the discrimination, and 
thus the tracking, of distinct bacterial sub-populations or strains. This requires that it should evolve at 
a rate which is reliably predictable and sufficiently rapid so as to distinguish between epidemiologically 
unrelated cases. At the same time, the rate of change should be slow enough that the marker patterns 
of bacteria isolated from patients forming part of a chain of transmission will appear identical (or at 
least, highly similar). This ideal rate will naturally vary between pathogens, but in the case of M. 
tuberculosis, for which the definition of recent transmission allows for a latency interval of up to two 
years between infection and disease onset, would be slightly longer than this period. A further 
requirement is that the mechanism of marker evolution should not favour convergence and the 
number of permutations possible should be great enough to make this unlikely. 
The Analytical Tools 
To facilitate the meaningful comparison of molecular epidemiological data from different regions, 
genotype data must be compatible. This requires, firstly, that the laboratory techniques for producing 
the data be standardised as has been done for a number of currently used markers [5-7]. Secondly, the 
ability to share data necessitates a standardised classification scheme and, preferably, compatible 
analytical software tools. International repositories of easily accessible, shared data do much to foster 
collaboration, facilitate regional or global studies and encourage the implementation and maintenance 
of standards. 
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Genotyping Methods 
Repetitive Sequences 
The earliest methods for genotyping M. tuberculosis were based on short, repetitive DNA sequences 
found scattered throughout the genome. The attribute that makes these elements useful as markers 
derives from their ability to alter the number of tandem repeats of which they are comprised, causing 
each element to vary in length. Five types of variable number tandem repetitive elements have been 
thus far identified and used for M. tuberculosis genotyping. Of these, the polymorphic GC-rich 
repetitive sequence (PGRS) [8], the GTG triplet repeat [9] and the major polymorphic tandem repeat 
(MPTR) [10] are found in multiple genomic clusters and exist as imperfectly repeated units. Further 
genomic loci have been identified containing tandem repeats of identical DNA sequence comprising 
the exact tandem repeat (ETR) elements [11,12]. The last repetitive sequence is a series of 36 bp 
directly repeated elements which are found at a single locus and are interspersed by unique 35 to 
41 bp spacer sequences [7,13]. 
Polymorphic GC-rich Repetitive Sequence Typing 
The PGRS sequences were first identified by de Wit et al. in 1990 [14]. These elements are 
characterised by a 96 bp consensus repeat sequence which is found at a variable number of loci within 
the M. tuberculosis genome (61 loci in H37Rv) associated with the PE gene family [15]. In the PGRS 
Restriction Fragment Length Polymorphism (RFLP) genotyping method, developed by Ross et al. 
[16], a cloned chromosomal domain containing a PGRS repeat sequence is Southern Hybridized to 
AluI restricted chromosomal DNA isolated from clinical isolates of M. tuberculosis. This method 
produces a highly complex banding pattern which has been found to be identical (or very similar) in 
epidemiologically related cases and varies between unrelated cases. Application of this method as a 
secondary typing tool has shown that the method can be more discriminatory than IS6110 DNA 
fingerprinting. This is particularly true for M. tuberculosis isolates harbouring less than six IS6110 
elements (low copy-number strains). However, the PGRS typing method has not found favour with 
molecular epidemiologists, primarily because it has not been standardised. Furthermore, the method is 
time consuming and labour intensive, requiring culture and DNA extraction. The banding patterns 
are also extremely complex, with variation in intensity, making reproducible scoring difficult and thus 
militating against computerised comparison. 
Variable Number Tandem Repeats (VNTR) 
Frothingham and Meeker-O’Connell originally described the polymerase chain reaction (PCR)-based 
VNTR typing technique in which unique ETR sequences from five different chromosomal loci are 
amplified using locus-specific primer sets complementary to the chromosomal domains flanking the 
respective repeat sequences [12] (see Figure 1). The ETR sequences range in length from 53 to 79 bp. 
The genotype of M. tuberculosis isolates is represented by a five-digit allele profile specifying the 
number of repeats at each locus, determined from the size of the respective amplification products. 
The advantage of this method is that crude DNA from M. tuberculosis cultures can be rapidly amplified 
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thereby allowing for prospective, high-throughput genotyping. This method has the potential to allow 
molecular epidemiology to direct TB control in real time. However, it must be acknowledged that the 
five ETR loci show only limited variability in clinical isolates thereby restricting their use as markers in 
molecular epidemiological studies. 
MIRU-VNTR 
Following the release of the whole genome sequence of the M. tuberculosis H37Rv strain [17], Supply 
et al. identified 41 variable tandem repeat sequences (consisting of ETR and MPTR elements) which 
they termed Mycobacterial Interspersed Repetitive Units (MIRU’s) for use as possible markers for 
genotyping [6]. These repeat sequences range in length from 40 to 100 bp and bear many similarities 
to eukaryotic minisatellites. Initial studies identified twelve MIRU loci, containing between two and 
eight repeat elements, which were shown to be polymorphic in clinical isolates. Extensive analysis of 
the allelic diversity of these twelve MIRU loci has been done in many different settings and the results 
have been compared to the “gold standard” IS6110 genotyping method. It is generally accepted that 
the discriminatory power of MIRU typing, using the twelve-allele format, is lower than that of IS6110 
genotyping. This may in part be explained by the slow evolutionary rate of the different loci in 
comparison to IS6110 transposition. This is particularly true for strains with more than six IS6110 
insertions, however, MIRU typing shows greater differentiation of strains with six or fewer IS6110 
insertions. To date, the epidemiological significance of strain genotypes defined by MIRU typing 
remains largely unknown. Furthermore, concern has been raised about possible convergence, and thus 
the usefulness of these markers in phylogenetic studies [18]. 
More recently, investigators have included additional VNTR sequences and have shown that the 
discriminatory power is proportional to the number of alleles analysed. However, the different 
nomenclatures used to describe the various VNTR loci has lead to a certain amount of confusion. 
Current recommendations suggest the use of 15 MIRU-VNTR loci for molecular epidemiological 
studies and two loci for phylogenetic analysis [19]. Before these recommendations can be adopted it 
will be necessary to fully evaluate their performance in different settings, including high and low 
incidence communities. The large number of alleles recommended make the genotyping method 
rather cumbersome and time consuming. To streamline the method a multiplex PCR system using 
fluorescently labelled primers in combination with capillary fractionation has been described [20]. 
Spoligotyping 
Hermans et al. [13] first described the Direct Repeat (DR) region based on genetic analysis of M. bovis 
BCG and it was later suggested that this locus may be informative for epidemiological studies of the 
M. tuberculosis complex [7]. The DR region consists of multiple conserved 36 bp directly-repeated 
sequences (DRs) interspersed by non-repetitive, unique spacer sequences ranging from 35 to 41 bp in 
length. One DR and its neighbouring spacer sequence are termed a direct variable repeat (DVR). 
Polymorphisms in this region arise from homologous recombination between neighbouring or distant 
DRs or adjacent IS6110 elements, IS6110 insertions and single nucleotide polymorphisms (SNPs) in 
the DR’s spacer sequences [21,22]. 
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The internationally standardised method for the analysis of the DR region has been termed 
Spoligotyping [7]. This is a PCR-based technique designed to determine the presence or absence of a 
set of 43 spacer sequences. The primers (of which one is biotinylated) are complementary to the DR 
sequence and allow the amplification of the spacers between the target DRs. The amplification 
products are hybridised to a set of immobilised, complementary oligonucleotides and the presence of 
each spacer sequence is subsequently detected by chemiluminesence (see Figure 1). Strains can be 
differentiated according to the observed hybridisation pattern which indicates the presence or absence 
of the individual DVRs. An octal coding system has been adopted to facilitate the recording and 
collaborative exchange of strain types [23]. 
Spoligotyping is a simple technique which is highly reproducible. The discriminatory power is, 
however, significantly lower than that of IS6110 RFLP, except when the insertion element is present 
in fewer than six copies. Despite these limitations, this method allows for the rapid genotyping of 
clinical isolates using relatively crude DNA isolated from culture or Ziehl-Neelsen-positive slides. 
Insertion Sequences 
IS6110 Restriction Fragment Length Polymorphism (RFLP) 
The most epidemiologically informative repeated sequence in general use is the transposable element 
IS986 (more commonly known as IS6110). An internationally standardised method using this 
sequence led to the birth of modern molecular epidemiology of TB which has allowed for the analysis 
of the epidemic on both community and global scales [24]. 
IS6110 genotyping relies on the ability of the element both to replicate itself randomly into the 
genome at different positions and to excise itself. These mechanisms allow for a theoretically infinite 
number of combinations of IS6110 elements inserted at different loci around the chromosome. In 
practice, the number of IS6110 elements found in clinical isolates appears to be limited to about 26 
and their informativeness is restricted by the resolution of the RFLP technology. 
The IS6110 element is characterised by an imperfect 28 bp terminal repeat sequence and a single 
PvuII restriction site. On PvuII digestion of the chromosomal DNA, the IS6110 element is split into 
two domains, each attached to their respective adjacent genomic segments. The PvuII restricted DNA 
is then electrophoretically fractionated on an agarose gel, Southern transferred to a nylon membrane 
and hybridised with a labelled probe complementary to the 3’-domain of IS6110 (see Figure 1). The 
resulting banding pattern is visualized by autoradiography and is a measure of the number of IS6110 
elements in the genome and their distance from their adjacent chromosomal 3’ PvuII restriction sites. 
Over a broad range of geographic settings and strains, IS6110 genotyping shows the greatest 
discriminatory power of all the markers currently in general use and is regarded as the “gold standard” 
for M. tuberculosis genotyping. The method is internationally standardised which allows for inter-
laboratory comparisons using specialised software. However, it is a cumbersome and time consuming 
technique, requiring prior culture of clinical isolates and purification of large quantities of good quality 
DNA. The result is that molecular epidemiological data can only be analysed retrospectively. 
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The information contained within the banding pattern, and thus the discriminatory power of the 
technique, is dependent on the number of IS6110 elements present in the genome of the M. 
tuberculosis isolate. Epidemiological relationships can only be confidently inferred when more than six 
IS6110 elements are present and therefore, classification of strains having fewer copies must depend 
on secondary typing methods. 
As with all genotyping markers, evolution may occur during transmission, thereby complicating the 
interpretation of the data. Estimates of stability of the IS6110 banding pattern suggest that it is 
sufficiently stable to infer epidemiological contact [25]. However, the observation of IS6110 banding 
pattern changes over the course of ongoing transmission has led to the suggestion that epidemiological 
calculations based on this marker should account for banding pattern evolution [26]. 
Mixed Linker 
This is a rapid, PCR-based technique which measures the position of IS6110 elements relative to 
adjacent restriction sites [27]. The method entails restricting the bacterial genome with HhaI followed 
by ligating a linker oligonucleotide, in which the thymidine residues have been replaced by uracil in 
one strand, to the ends of the restriction fragments. The DNA is then treated with N-glycosylase to 
eliminate the uracil-containing oligonucleotides. The remaining fragments are PCR-amplified using 
primers complementary to the linker and to IS6110, thereby generating fragments corresponding to 
the size of the adjacent chromosomal domains. The primary advantage of this technique is the ability 
to obtain DNA fingerprints without the requirement of first culturing the organism. In a comparative 
methodological study, mixed-linker PCR was shown to have only slightly less discriminatory power 
than that of IS6110 genotyping. However, the method has not been internationally standardised and 
is seldom used for molecular epidemiological studies. 
Single nucleotide polymorphisms (SNPs) 
Comparative genomics based on whole genome sequencing has demonstrated a remarkable degree of 
conservation between the genome sequences of various strains of M. tuberculosis. This sequencing data 
has identified three groups of single nucleotide polymorphisms (SNPs). Non-synonymous SNPs 
(nsSNP) are often associated with amino acid changes which may be subject to various selection 
pressures. Intergenic SNPs may be subject to selective pressure as they may affect gene expression. 
Synonymous SNPs (sSNP) do not alter the amino acid sequence and are therefore generally considered 
neutral to selective pressure. As such, they provide a powerful tool for general molecular 
epidemiology. A limitation in the use of SNPs is that studies based on this technique suffer from 
ascertainment bias (i.e. analyses based on such a dataset are skewed by the non-random nature of the 
selection of the discriminating features). This problem can only be overcome by using many SNPs 
identified from a wide diversity of strain sequences. However, even with large numbers of sSNPs it is 
uncertain whether the information generated would be sufficient to differentiate closely related strains 
for epidemiological calculations. 
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FAFLP 
Fluorescence Amplified-Length Polymorphism (FAFLP) is an extension of the AFLP technique [28] 
which shows much promise. It was first applied to the question of M. tuberculosis strain typing by 
Goulding et al [29]. Briefly, the technique involves restricting M. tuberculosis genomic DNA, usually 
with two restriction enzymes, ligation of linkers onto the restricted DNA, followed by PCR 
amplification of the fragments with fluorescently labelled primers. Discrimination may be further 
enhanced by the use of four primers which differ by one base in the position adjacent to the restriction 
site, each of which is labelled with a different fluorescent marker. The fluorescently labelled amplified 
fragments are then sized using an automated sequencer. FAFLP is based on the detection of random, 
rather than selected SNPs, as well as a variety of other genomic events, thereby avoiding the problem 
of ascertainment bias associated with SNP typing. This also minimises the adverse affects of the often 
complex behaviour of genomic elements such as insertion sequences and minisatellites. The method 
appears to have discriminatory power at least equal to that of IS6110 RFLP, depending on how it is 
applied and has been successfully used in a number of studies. However, the technique still requires 
further development, characterisation and standardisation before it is more generally accepted. 
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Figure 1. (A) IS6110 genotyping showing, on the left, a schematic representation of the PvuII restriction of the 
genome and subsequent hybridization of the probe to the 30 end of the IS6110 domain. The resulting banding 
patterns, after gel electrophoresis, of four strains are shown on the right with the corresponding labeled DNA 
fragments for oneM. tuberculosis strain (for details see Section 3.4.2.1). (B) MIRU genotyping showing PCR 
products of two repeat units of differing sizes. The right-hand panel shows a MIRU-sizing gel, inwhich each PCR 
product is run in a separate lane. The lanes containing the two MIRUs as illustrated in the cartoon are 
highlighted (for details see Section 3.4.1.3). (C) Spoligotyping showing the DR chromosomal region with an 
expanded view of two DVRs and their PCR products hybridized to their specific labeled probes. The 
corresponding spots on the spoligoblot of six strains, indicating the presence of each of the two DVRs, are 
indicated by the arrows (for details see Section 3.4.1.4).  
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Epidemiological Interpretation 
All molecular epidemiological definitions are based on the understanding that bacterial genomes are in 
a constant state of flux. According to this assumption, patients whose bacterial populations show 
identical (or nearly identical) genotypes (termed clusters) can be inferred to have been in contact. Such 
cases are though to reflect recent transmission, where contact with a source case was followed by 
infection and relatively rapid progression to disease (i.e. within 2 years of infection). The remaining 
group of cases are those whose bacterial populations have genotypes which do not match those of any 
other case. Such cases are though to reflect reactivation of a latent infection, which may have been 
acquired many years prior to the onset of disease. The differences between the genotypes of 
reactivation cases and those currently circulating may be due either to the absence of genetic change 
during the latent phase or, alternatively, to rapid change during this period. 
By measuring the relative proportion of TB cases falling into clusters, it is possible to estimate the 
proportion of either recent or ongoing transmission. The former is calculated using the “n–1” formula 
[(the number of cases in clusters minus the number of clusters)/(the total number of cases in the 
study)] which assumes that the first case in each cluster represents a reactivation event [30]. Ongoing 
transmission is calculated using the “n” formula [(the number of cases in clusters)/(the total number of 
cases in the study)] [31,32]. Both of these calculations are used as public health tools to measure the 
efficacy of TB treatment programs. 
It should be noted that a number of confounding factors could influence estimates of recent 
transmission. Firstly, a major, common source of error in molecular epidemiological studies arises as a 
result of under-sampling the infected population [33]. This has the effect of reducing the apparent 
proportion of strain clustering which gives rise to an underestimate of the degree of recent 
transmission and is particularly relevant in settings where the average number of cases in clusters is 
low. 
Secondly, most studies fail to address the issue of migration of patients into or out of the study 
community. This is particularly relevant to mobile, high incidence communities and will tend to result 
in underestimating the degree of recent transmission. The reason for this is that patients entering the 
community may be infected with strains not present in the community and will therefore appear to be 
reactivation cases. Likewise, patients leaving the community will have a similar effect to that of under-
sampling. 
Thirdly, the accuracy of these epidemiological calculations is also dependent on the duration of the 
study. Because there may be a delay of up to two years between infection and progression to disease, 
all molecular epidemiological studies of TB are subject to “edge effects” where it is difficult to predict 
with any degree of accuracy the events that occurred before the initiation of the study or after the 
study was terminated. Studies conducted over very short intervals are particularly prone to errors 
caused by this phenomenon. In order to overcome this problem, it is advisable to allow two-year lead-
in and lag phases during which, strains already present in the community and newly detected strains 
respectively, are disregarded. 
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Fourthly, not all genotyping methods are appropriate to every situation and the choice of technique 
will depend on the study population, the nature of the epidemic and the particular questions being 
addressed. Cost and turnaround time may play a significant role in this decision. A method with lower 
discriminatory resolution may be appropriate in a low-incidence community where strains are highly 
diversified and a large proportion of cases are due to reactivation or immigration. In a high-incidence 
community, on the other hand, where the epidemic is largely driven by transmission of endemic 
strains, greater discriminatory power will be needed to identify strain sub-populations and 
transmission patterns, which will often be complicated by evolutionary changes. The choice of method 
will also be influenced by the possible need for comparison of data with that of other research teams, 
in which case it would be necessary to choose a standardised technique. 
Lastly, the stability of the genotype defines the accuracy of epidemiological inferences. Given that all 
bacterial genotypes are evolving, strict definitions of clustering based on genotypic identity (inferring 
transmission) may lead to an under-estimate of transmission as closely related variants may be 
excluded. To accommodate evolution, the definition of clustering may be relaxed to encompass closely 
related genotypes. 
Evolution of Genetic Markers and Nearest Genetic Distance 
The feature of genetic markers such as IS6110 that makes them useful as indicators of transmission, 
namely their propensity to evolve at a sufficiently high rate, is, ironically, also a complicating factor in 
the interpretation of data thus derived. The difficulty arises when a mutational event alters the genetic 
fingerprint of a transmitted strain. The standard interpretation of this data would regard the altered 
bacteria as a new strain and thus not a part of the original transmission chain. This has significant 
consequences for calculations of ongoing transmission. Salamon et al. proposed the concept of nearest 
genetic distance as a means to overcome this problem where strains that are most closely related, and 
whose differences fall below a certain threshold, can be said to be derived from one another and 
therefore form part of the same chain of transmission [34]. Application of this modified interpretation 
of molecular fingerprinting data has been shown to dramatically alter the results of calculations of 
recent transmission [26]. This has profound implications for understanding the mechanisms driving an 
epidemic and, consequently, what measures need to be taken to improve control strategies. 
Application of Molecular Epidemiology 
Molecular epidemiology has revealed and clarified a number of phenomena not accurately understood 
by classical interpretation. 
M. tuberculosis Population Structure 
In contrast to classical understanding, molecular based genotyping methods have identified genotypic 
heterogeneity among clinical isolates. Accordingly, it has become possible to quantify the 
epidemiological factors contributing to the incidence of TB in different settings. Initial studies done in 
high incidence settings suggested genotypic homogeneity, thereby questioning the value of molecular 
approaches to investigating epidemiology in these communities. However, many high incidence 
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settings have subsequently shown an unexpectedly high level of genotypic heterogeneity, probably 
reflecting a past history of immigration/colonisation. 
Genotypic comparisons have revealed that M. tuberculosis strains can be grouped according to a 
similarity index. These groupings have been termed strain families, representing clonal expansion from 
a common progenitor. Thus, the epidemic in different settings can not be viewed as a single entity, 
but must rather be seen as a combination of sub-epidemics, each represented by different strains with 
differing characteristics and in various phases of progression. The success of each strain may also be 
determined by host-pathogen compatibility. 
Transmission vs. reactivation 
Comparison of genotypes of clinical isolates using cluster analysis has enabled epidemiologists to 
accurately differentiate cases arising from transmission or reactivation. Contrasting with previous 
assumptions, such studies have also revealed the significant role of recent transmission in low-
incidence communities [30,32]. This knowledge has directed public health policy to implement 
strategies aimed at limiting the spread of disease. While it has long been accepted that recent 
transmission plays a significant role in high-incidence communities, population-based molecular 
studies have shown that the role of transmission may be as high as 70% [35-37]. By relaxing the 
definition of a cluster to account for evolution of the marker, the role of transmission may well be 
considerably higher [26]. This suggests that infectious source cases are not being promptly diagnosed 
and appropriately treated thereby perpetuating the transmission cycle. 
Casual Contact 
An unexpected insight resulting from molecular investigations is that transmission of M. tuberculosis is 
not dependent on repeated, close contact, but may often occur as a result of casual contact. Studies in 
San Francisco, CA and Baltimore, MD were able to identify only 10% and 25% respectively of 
epidemiological contacts between molecularly related cases [30,38]. These, and other studies, have 
shown that the majority of transmission arises from complex, casual social interactions which are 
untraceable by classical methods. 
Where transmission occurs 
Classical epidemiology shows that close contacts of TB patients have a higher risk of infection and 
disease than do casual contacts. However, these conclusions are based primarily on household contact 
studies where the number of casual contacts may be limited. Using genotyping methods it has been 
possible to investigate this question in a high incidence setting. Contrary to popular belief, it has been 
shown that most transmission events occurred outside of the household [39]. Similar results were 
observed for children with TB, raising concern as to where such infections occurred, the role of 
prophylaxis and the validity of contact tracing [40]. 
Mapping of Outbreaks 
Outbreaks of TB were classically identified by observing an usually high incidence of disease in a 
community over a defined period. The mechanisms leading to sudden changes in incidence were 
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revealed only with the introduction of genotyping methods which allowed for the tracking of specific 
strains over space and time. Through these methods it has been possible to document transmission in 
health care facilities, prisons and in communities, thereby highlighting the inadequacies of infection 
control measures [41]. The ability of molecular epidemiology to identify new outbreaks of M. 
tuberculosis strains, even in the context of endemic disease, has proved extremely useful. Amongst other 
things, this has facilitated the identification of possible contributory host- or strain-specific risk factors 
for transmission. Such micro-epidemic strains may be characterised in terms of genotypically-derived 
features such as virulence, transmissibility and tropism [42-44]. 
Risk factors for Transmission 
When combined with patient demographic data, molecular epidemiology provides a powerful tool for 
identifying factors associated with the transmission of M. tuberculosis. These risk-factors may be 
common to all patients or may be specific to communities or geographical areas. Ethnicity, age and 
HIV infection have all been associated with transmission in some, but not all populations, whereas 
belonging to immigrant communities has generally not been associated with clustering [30]. 
Transmission from Smear negative cases 
As a rapid, inexpensive procedure, the Ziehl-Neelsen sputum smear has long been regarded as the 
primary, and in many instances, the conclusive diagnostic test for active TB. Until recently, it has 
been generally accepted that smear-negative patients are less infectious, if at all [45]. In a study of 
culture-confirmed TB patients in San Francisco, CA, Behr et al. [46] found that at least 21% of 
IS6110 strain clusters, for which adequate smear data was available for the presumed index case, were 
initiated by smear-negative patients. While classical epidemiological reports had suggested the 
possibility of smear-negative transmission of M. tuberculosis [47], this could only be confirmed and 
quantified using molecular strain typing techniques and this result has subsequently influenced official 
TB management policy decisions [48]. 
Recurrent tuberculosis 
The mechanism leading to recurrent TB has long been disputed. Until recently, two hypotheses 
coexisted. The unitary concept of pathogenesis, as expounded by Stead in 1967 [1], stated that TB 
always began with a primary infection and that recurrent episodes were due to reactivation of dormant 
bacteria. An alternative hypothesis, proposing exogenous re-infection, first received solid support 
when it was demonstrated by Raleigh in 1975 by means of phage typing [49]. This finding has 
subsequently been repeatedly confirmed using molecular strain typing techniques [50]. In such studies 
re-infection is defined by the isolates from each episode having significantly different genotypes while 
isolates from reactivated infections have the same genotype. These definitions are only valid in settings 
where genotypic diversity is high. Not only is re-infection possible, it has been shown to be common 
in high-incidence communities [51] and a recent study has suggested that patients who have had an 
episode of disease are at a higher risk of having a subsequent episode [52]. This paradigm shift in 
epidemiological understanding has important ramifications for classical epidemiological calculations, 
and for vaccine and drug trials. 
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Mixed infection 
The epidemiological significance of re-infection extends beyond recurrence and may play an important 
role in secondary TB. Patients simultaneously infected with more than one strain of M. tuberculosis 
have been identified in both high and low incidence settings [53,54]. The high prevalence of multiple- 
and re-infection suggests that infection with M. tuberculosis provides little or no immuno-protection 
which has implications both for disease control programs and vaccine development. Most significantly, 
mixed infection has been shown to be a novel mechanism whereby drug resistance may develop in a 
patient [54]. This phenomenon influences the diagnosis of drug resistance which is a new concern to 
the TB control programme. 
Laboratory Error 
Laboratory error resulting in false-positive diagnoses or the misidentification of drug-resistance may 
have considerable implications both for the welfare of the patient and the resources of the health 
system. Such errors may occur due to the mislabelling of clinical samples or the cross-contamination of 
samples during handling and analysis. DNA genotyping methods have both highlighted the extent of 
this problem and helped to identify specific instances, thereby facilitating the implementation of 
appropriate corrective measures [55,56]. Detection of possible laboratory error relies on the 
identification of disparate DNA fingerprints of serial isolates from the same patient or detection of 
identical strains from different patients whose clinical samples were processed within a predefined 
period of one-another. The quality, and thus the interpretation of this information will depend on the 
incidence of disease in the relevant community and the diversity of infecting strains found there. A 
confounding factor is the existence of patients simultaneously infected with more than one strain, one 
or both of which may be detected in any sputum sample [54,57]. 
Drug Resistance 
It has long been assumed that drug resistance in TB cases is largely acquired. While poor adherence, 
and inappropriate treatment regimes are certainly important contributory factors, molecular studies 
have revealed the significant contribution of primary resistance (i.e. transmission of resistant bacteria) 
[58]. The outbreak of the notorious, multi-drug-resistant ‘strain W’ in New York, NY challenged the 
dogma that drug resistance necessarily incurs a fitness cost which lowers transmissibility [59]. From a 
public health perspective, classical and molecular epidemiological surveys may often yield 
diametrically opposed conclusions and the resulting TB control strategy adopted will depend largely 
on the method used. 
Insights into the global TB epidemic at the level of the pathogen 
Collation of genotype data in large international databases promises to provide insight into the global 
epidemic. The largest data set is SpolDB representing, to date, in excess of 39000 spoligotypes of 
clinical isolates cultured from patients in 122 countries [60]. This data has demonstrated the 
prevalence of different strains families in different geographical settings. It has been suggested that the 
global distribution of strain families may reflect host-pathogen compatibility [61]. 
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Genotype – phenotype 
Different strains of M. tuberculosis may have different in vivo growth characteristics and may induce a 
diverse range of host immune responses which may, in turn, lead to variable pathologies and have 
consequences for transmissibility. Strains of the Beijing genotype, in communities where this strain 
family is emergent, are associated with younger age groups and are more likely to be drug-resistant 
than the rest of the strain population [62]. Experiments in mice have shown that the highly 
transmissible strain, CDC1551, is associated with a vigorous cytokine response and longer survival 
times [63]. In contrast, the HN878 strain, which belongs to the Beijing grouping, is associated with a 
reduced cytokine response, high pulmonary bacterial load and shorter host survival times. It appears 
that this strain selectively induces a predominantly TH2-mediated response which is less protective 
against M. tuberculosis [64,65]. Zhang et al. showed that Beijing strain 210 was able to replicate in 
human macrophages four to eight times faster than unrelated strains [66]. The four major global 
strain families have demonstrated a diversity of immunopathologies in a mouse intratracheal infection 
model [67]. As with HN878, the Beijing representative in this study elicited a weak immune response 
and demonstrated the greatest virulence. Using 19 different strains of M. tuberculosis in a murine 
model, Dormans et al. showed a wide range of responses in terms of virulence, lung pathology, 
bacterial load and delayed hypersensitivity responses [68]. The observation that certain strains or 
strain families tend to predominate, either globally or locally, suggests that they may well possess 
characteristics which, at least in particular contexts, enhance their fitness. In the case of locally 
dominant strains, this fitness advantage may be related to aspects of the TB control program, HIV 
prevalence or the host population genetic makeup. To the extent that differences between strains of 
M. tuberculosis affect epidemiological parameters such as transmissibility, progression to active disease, 
and ability to reactivate after latency, they have relevance to molecular epidemiology which may be 
used to identify and track the spread of specific strains having particular characteristics and inform the 
treatment and management of patients infected with them. 
Vaccines and Clinical Trials 
As an intracellular pathogen, host immunity is expected to have provided the most significant 
selection force during the evolutionary history of M. tuberculosis. More recently, introduced 
evolutionary pressures include the BCG vaccine and anti-TB drugs. The response of M. tuberculosis to 
these new selective parameters can be observed by the numerous outbreaks of drug resistant TB and 
the implication that mass BCG vaccination in Eastern Asia may have been a selective force in the 
emergence of the Beijing family phenotype [69]. The recent emergence of HIV has resulted in a new 
selection parameter. The evolutionary consequences of M. tuberculosis infection in the context of HIV 
and the antiretroviral therapy used to treat it remains to be determined. Molecular epidemiological 
studies running concurrently with ant-TB vaccine or drug trials will provide essential insights into 
how the implementation of these novel therapies influence the strain population structure and in 
particular will aid in the identification of “vaccine escape” or drug resistant mutants. 
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Summary 
Since molecular technology was first applied to the epidemiology of TB it has had a significant impact 
on the field. As we have shown, it has repeatedly challenged assumptions, altered perceptions and 
made possible the answering of numerous important questions as well as raising many more. A range 
of molecular tools are now available which continue to be added to and refined. Our clearer 
understanding of the epidemic, in terms of the contribution of transmission, particularly in the case of 
drug-resistant TB, has placed us in a position to devise better-informed control programs. New 
diagnostic technologies as well as better treatments and an effective vaccine are three essential 
elements required for combating the epidemic. However, the demonstration of the prevalence of re-
infection and multiple infections is a cause for concern both for TB control programs and the 
development of anti-TB vaccines and novel drugs. The inference drawn from the findings of molecular 
studies is that M. tuberculosis is highly successful pathogen, skilled at evading the host defence systems. 
The battle to understand, control, and possibly eradicate it will be neither quick nor easy. 
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Abstract 
The interpretation of molecular epidemiologic data of M. tuberculosis infection is dependent on the 
understanding of the stability and evolutionary characteristics of the DNA fingerprinting marker used 
to classify clinical isolates. This study investigated the stability of the IS6110 banding pattern in serial 
tuberculosis isolates collected from patients resident in a high incidence area. Evolutionary changes 
were observed in 4 % of the strains and a half-life of 8.74 years was calculated, assuming a constant 
rate of change over time. This rate may be composed of a fast rate of change seen during the early 
disease phase (t½ = 0.57 years) and a slow rate of change seen in late disease phase  (t½ = 10.69 
years). The early rate probably reflects change occurring during active growth prior to therapy, while 
the slow, late rate may reflect change occurring during or after treatment. We demonstrate that the 
calculation of these rates will be strongly influenced by the time interval between onset of disease and 
sputum sampling. These calculations are further complicated by partial replacement of the original 
strain population resulting in the sporadic appearance of clonal variants in sputum specimens. 
Therefore, the true extent of genetic diversity may be underestimated within each host, thereby 
influencing molecular epidemiological data used to establish transmission chains. 
The stability of the IS6110 banding pattern 29 
 
 
Introduction 
Molecular epidemiology needs to differentiate clinical isolates of pathogenic organisms as the same or 
different. This differentiation relies on the evolutionary process generating genotypic diversity among 
isolates. In general, the observation of a number of isolates sharing identical patterns is used to infer 
infection from a common source. In contrast, isolates with unrelated genotypes are thought to 
represent infection from different organisms, and therefore from independent sources.  
The molecular epidemiology of M. tuberculosis is most frequently based on the RFLP (restriction 
fragment length polymorphism) banding patterns generated by Southern hybridization with the probe 
IS6110 (10,13). In community settings isolates with identical IS6110 genotypes are grouped together 
into clusters and are thought to represent recent epidemiological events (5), while isolates with IS6110 
banding patterns unrelated to any others in the database (isolates with unique banding patterns) are 
thought to reflect reactivation of latent infection (1,9). This methodology has been used in numerous 
settings to quantify the relative proportion of recent epidemiological events and thereby estimate the 
extent of recently transmitted disease (1,9,14). 
In order to estimate the stability of the IS6110 RFLP patterns, studies have examined serial isolates 
collected from patients with persistent disease (3,6,15) and have demonstrated that the IS6110 
banding pattern may change over time in a subset of these patients. When survival analysis was 
applied to the RFLP data collected from patients with persistent disease in The Netherlands, De Boer 
et al. (1999), calculated that the half-life of the IS6110 banding pattern was of the order of 3.2 years. 
A similar rate was calculated for isolates originating from San Francisco, although this was restricted 
to isolates obtained at least 90 days apart, to exclude the possibility of variable patterns representing 
co-infection rather than change over time (3). In both datasets, the estimated rate of IS6110 pattern 
change was felt to be of the right magnitude to allow the use of IS6110 as a marker for molecular 
epidemiological studies (3).  
However, the calculated rate of change may not be uniform in two groups of patients: those with 
multiple isolates at the time of diagnosis and those in whom a new pattern develops during or after 
treatment. In this study we have investigated the stability of IS6110 banding pattern in a group of 
patients for whom more than one isolate of M. tuberculosis was collected during the course of disease or 
during re-treatment. The results are discussed in the context of the applicability of calculating a rate 
of change in these patient groups and how such change may influence molecular epidemiological 
calculations. 
Methods 
Study setting 
Between January 1992 and December 1998 M. tuberculosis isolates were collected from patients 
attending the healthcare clinics within adjacent suburbs in Cape Town, South Africa (2). This 
community is experiencing an extremely high incidence of tuberculosis, with approximately 250 new 
30 Chapter 2 
 
 
bacteriologically confirmed adult cases per 100 000 population, per year (11). Before 1995 the 
National TB Program focused on sputum-cultures for the diagnosis of tuberculosis with follow-up 
sputum samples requested by the attending physician on clinical grounds. Both  Ziehl Neelsen 
positive and negative samples collected during this period were included in the study. After 1995 the 
South African National TB Program has been conducted according to the WHO DOTS strategy with 
sputum taken for Ziehl Neelsen smear at presentation for diagnosis, at 2 months for sputum 
conversion and again at six months after initiation of therapy to monitor response to therapy 
(additional sputum specimens may be requested by the attending physician on clinical grounds). As 
part of the research project, all Ziehl Neelsen positive and negative samples are sent for culture. 
Clinical information for each patient was recorded at the time of diagnosis and this data was stored in 
a Microsoft Access database. The restricted sampling of sputum specimens during the course of disease 
in the different patients may influence rate calculations. 
RFLP generation and Gelcompar Analysis. 
The entire culture representing all the possible clonal variants present in each isolate was used for the 
DNA isolation and this DNA was genotypically classified according to the internationally 
standardized DNA fingerprinting protocol, using the IS-3' probe (10,13). The Southern blot 
autoradiographs were normalized and the IS-3' bands were assigned using GelCompar 4.1 software. 
The assignments were visually checked by two independent persons, and only bands with an intensity 
of > 20 % of the other bands were scored as representing IS6110 mediated evolutionary events (4). 
Replicative transposition was identified when the evolved strain showed an additional IS6110 
hybridizing band, while deletion of an IS6110 was identified when an IS6110 hybridizing band was 
absent from the evolved strain. Variation in the electrophoretic mobility of an IS6110 hybridizing 
band was classified as a band shift representing a mutational event in the chromosomal domain 
flanking the IS6110 element. Banding pattern changes suspected of being the result of partial 
digestion of methylated restriction sites (12) were excluded. 
Study population 
Serial isolates from patients with persistent disease 
Patients from whom DNA fingerprints from more than one isolate were available, were selected from 
the complete data-set. This excluded isolates where laboratory error (11), contamination or loss of 
viability had been noted. Patients who had been assigned as being re-infected with a genotypically 
unrelated strain were treated as two separate cases of disease if serial isolates were available for both 
infections. On average 3 isolates were collected from each case, and this was independent of the 
tuberculosis control program at the time of sample collection. Serial isolates collected from patients 
who presented with a genotypically identical or related strain after therapy were treated as a single 
case. Selected patients were divided into two categories; 1) patients infected with a strain which 
remained genotypically identical during the course of sampling were termed invariant, and 2) patients 
infected with a strain which changed during the course of sampling were termed variant. Change in 
the IS6110 banding pattern was identified by the appearance, disappearance or electrophoretic shift of 
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IS-3' hybridising elements. To avoid a possible bias in the invariant patient group, variant strains with 
more than four changes in the IS6110 banding pattern were considered to reflect reinfection rather 
than evolution and were excluded from all calculations. In addition, if any  variant strain (independent 
of the number of changes in the IS6110 banding pattern) was found to be present in the community 
prior to appearance in the patient, the patient was excluded from the study. In such a case, the patient 
may have been reinfected from a community contact. This stringent inclusion criteria excludes the 
possibility that the IS6110 banding pattern may revert to a previous evolution state or that identical 
banding patterns could have evolved convergently. It is envisaged that the above exclusion criteria will 
lead to an overestimate of the stability of the IS6110 banding pattern. 
The sampling interval (days) for patients infected with invariant strains was calculated from the date 
when the first isolate was collected to the date when the last isolate was collected in each patient. The 
sampling interval (days) for patients infected with variant strains was calculated from the date when 
the first isolate was collected to the date when the first variant isolate was identified (3). The overall 
rate of change was calculated using survival analysis according to the method described by de Boer et 
al. (1999). Similarly, the early rate of change was calculated using cases with inter-isolate intervals of 
≤ 90 days, while the late rate of change was calculated using cases with inter-isolate intervals of > 90 
days. 
Statistical analysis 
Fisher’s exact test was used to test whether changes in the IS6110 banding pattern were associated 
with the number of IS6110 insertions present in the evolving strain. This test was also used to identify 
associations between previous therapy and the appearance of a variant strain. Chi-squared analysis was 
used to identify differences between the study sample set and the sample set from The Netherlands 
(3). 
Results 
Study population 
M. tuberculosis isolates were cultured from 954 patients (representing a recovery of approximately 70 % 
of all culture positive patients) attending the healthcare clinics in adjacent suburbs of Cape Town, 
South Africa (2,14). Fifty of these patients (5.2 %) were excluded from the study as their cultures were 
either contaminated or lost viability. Of the remaining patients, 901 (94.4 %) had an M. tuberculosis 
isolate genotypically classified by IS-3' DNA fingerprinting (10,13).  
Patients with serial isolates of M. tuberculosis 
Three-hundred and forty-six patients had ≥ 2 M. tuberculosis isolates, representing serial isolates from 
351 active cases of tuberculosis. Analysis of the serial isolates by IS-3' DNA fingerprinting identified 
335 cases (95.4 %) where the serial M. tuberculosis isolates remained genotypically constant over the 
sampling period (range 0 to 2203 days), termed invariant strains (Table 1). Serial isolates from 16 
cases showed an IS6110 banding pattern change over the sampling period, termed variant strains 
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(Table 1). Two of the patients infected with a variant strain were excluded, as the variant strain was 
found to have been present in the community prior to appearing in the patient, thereby suggesting 
possible exogenous reinfection from a community source case. The remaining 14 variant cases were 
sampled over a period of 0 to 1141 days (Table 1).  Comparing patients with invariant strains to those 
with variant strains did not reveal any differences in the demographic variables. However, a previous 
history of disease was weakly associated with the appearance of variant strains (Fisher’s exact test, P = 
0.045) (Table 1), which may suggest that the evolution of clonal variants occurred either during the 
latent disease phase after the previous infection or during the reactivation process. 
Table 1. Demographics of patients with serial isolates, where the infecting M. tuberculosis strain 
was either genotypically variant or invariant over time.  
Demographics Variant Invariant 
Total  14 335 
Male 7 (50%) 187 (55.8%) 
Mean Age (years) 35.6 34.1 
Previous episode of TB  9 (64%)* 120 (35.8%) 
Pulmonary TB 
Sampling range (days)  
14 (93.3%) 
0 - 1141 
326 (97.3%) 
0 - 2203 
Low IS6110 copy number strains  0** 61 
High IS6110 copy number strains 14** 274 
*(Fisher’s exact, P = 0.045) 
**(Fisher’s exact, P = 0.142) 
The proportion of variant strains identified n = 14 (4 %) is similar to that reported for isolates 
collected in The Netherlands (4.6 %) (3), although this is lower than reported in Germany (9 %) (6) 
and in the restricted analysis performed in San Francisco (24.5 %) (15). Change in the IS6110 banding 
pattern was specifically associated with strains with > 5 hybridizing elements, however, because of the 
low number of observations, this was not statistically significant at the 95% confidence interval 
(Fisher's exact test, P = 0.142) (Table 1). 
Analysis of the RFLP data of the variant isolates showed that in 10 of 14 cases (71.4 %) the IS6110 
banding patterns changed by replicative transposition, while in 2 of 14 cases (14.3 %) a hybridizing 
band was deleted. In 2 of 14 cases (14.3 %), an electrophoretic shift was observed suggestive of a 
chromosomal mutation. In 4 patients the variant strain disappeared from subsequent serial isolates 
demonstrating incomplete clonal replacement. This suggests that two clonal variant populations may 
be present in the patient and that a single sputum specimen may not reflect the true genetic diversity 
of the bacterial population in the host.  
Survival analysis (3) of this data estimated the overall half-life of the IS6110 banding pattern in our 
serial isolates to be 8.74 years (95 % CI, 7.51 – 10.45) (Figure 1). However, the survival plot suggests 
the presence of two distinct rates of change (Figure 1). In 8 of the 14 patients (57 %) both the initial 
and variant isolate were sampled within the first 20 days (median of 10 days), suggesting that the 
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banding pattern change occurred early in the disease process or during the latent phase of a previous 
infection, or during reactivation. This was followed by only partial clonal replacement at the time of 
diagnosis or shortly thereafter. In the remaining 6 patients (43 %), variant isolates were only sampled 
after > 250 days, suggesting that these isolates evolved late in the disease phase. 
 
Figure 1. Survival analysis of IS6110 fingerprint patterns using Kaplan-Meier estimates. The survival function is 
exp(-K*Time) and the values of K for the early, late and total variant groups are -0.003333,-0.0001776 and -
0.0002173, respectively. 
Since all strains sampled between 20 days and 250 days were invariant, this provides further evidence 
for these late variant strains evolving over the course of time, rather than these being due to under-
sampling at an earlier point. Taking into account these two populations of observations, survival 
analysis estimated a half-life of 0.57 years (95 % CI, 0.45 – 0.77) for the early group and 10.69 years 
(95 % CI, 8.22 – 15.31) for the late group (Figure 1).  
Discussion 
The use of RFLP data to infer epidemiologic associations is dependent on an understanding of the 
marker system, including the sources and frequency of variability in that marker. To date, studies to 
determine the frequency of detection of variant strains have used different inclusion criteria and 
assumptions in order to provide an estimate on the ‘molecular clock’ of RFLP for M. tuberculosis. The 
rate of change needs to be fast enough to ensure that most cases not linked through recent 
transmission have different fingerprints, but slow enough to ensure that most cases linked through 
recent transmission have identical fingerprints. A half-life in the order of 2-5 years, as observed in San 
Francisco and The Netherlands suggests that the IS6110 RFLP pattern changes rapidly enough but 
not too rapidly for studying ongoing transmission (3).  A half-life in the order of 8 years, as observed 
in the present study, suggests that recent transmission may be overestimated by RFLP typing using 
IS6110.  
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In this study, the proportion of IS6110 banding pattern changes identified in serial isolates collected 
from patients with persistent disease was comparable to those reported in The Netherlands (3) but 
lower than reported in Germany (6) and San Francisco (15). The comparable proportion of variant 
isolates seen in this study and The Netherlands study suggests that the rate of change is independent 
of the incidence of disease. However, in keeping with the observations of other groups, the ability to 
observe change appears to depend on the number of IS6110 elements present in the precursor strain 
as strains with less than five IS6110 elements were genotypically invariant.  
On further analysis, the emergence of these variant strains does not appear to be uniform, suggesting 
the presence of two distinct populations. The first type of change would occur early in the disease 
process, prior to anti-tuberculosis treatment.  This change might then represent evolution influenced 
by active growth or adaptation to the new host environment. It is also possible that change was 
induced in certain previously treated patients during either the latent growth phase or during the 
subsequent reactivation process.  The second type of change would occur in the late disease phase or 
after treatment.  This slower rate of change may be a consequence of a slower growth rate of the 
bacilli. Similar results were seen in data from the Netherlands (3). Although we have calculated an 
early rate, it is highly probable that this rate will be an under-estimate of the stability of the banding 
pattern, as most of the IS6110 band changes will have occurred prior to the sampling of the first 
isolate. This is supported by the slow in vivo growth rate of M. tuberculosis, requiring extended periods 
before strain population replacement would be observed. Furthermore, if there are long delays in the 
period between onset of early active disease and the first collection of sputa, then it is possible that 
newly evolved strains may have been missed and thereby excluded from the rate calculations.  
Due to the uncertainty of when the early evolutionary events occurred, we attempted to calculate a 
rate of change for variant isolates appearing after 90 days (15). The rate estimate of 10.69 years for 
variant isolates appearing after 90 days was significantly slower than the 2 years calculated from the 
San Francisco data (3). Review of the different rate calculation methods (3,8) shows that these 
methods assume that the rate of appearance of variant strains is constant over time. If this assumption 
is incorrect, as is suggested by this study, then the rate calculated by these methods (3,8) will be 
sensitive to the proportion of (invariant) cases with extended inter-isolate time intervals arising due to 
either non-compliance treatment failure or treatment interruption. Comparison of our data with that 
from The Netherlands shows that there is a significant difference in the proportion of patients with 
invariant isolates after 210 days (this study  (21.2 %), The Netherlands (6.6 %); P = <0.0001). This 
implies that if treatment efficacy is higher, the proportion of serial isolates with long intervals will be 
smaller, which may result in a higher rate of change estimate. Consequently, the accuracy of rate 
calculations are limited by the local epidemiology and therefore rate estimates will be proportional to 
the effectiveness of the TB control programme. 
The epidemiological importance of calculating an evolutionary rate for isolates collected from patients 
with persistent disease is unclear, given that change is observed only in a very small and unique subset 
of the patients analyzed (3,6,15). Therefore, this data can not be easily extrapolated to the overall 
study population. Furthermore, the true extent of genetic diversity within a study population may be 
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masked by incomplete clonal replacement at the time of sputum collection, as extremely low numbers 
of clonal variants in the sputum specimes will not be detected due to the limited sensitivity of the 
DNA fingerprinting method. Therefore, strain variants will not be identified in patients where there 
has been an under-sampling of sputum specimens. Accordingly, it may be difficult to identify chains 
of transmission based only on genotypic identity (clustering of identical IS6110 banding patterns). 
Although, this study has highlighted the limitations of this sample set, we conclude that this patient 
set may provide information on how growth rate and/or anti-tuberculosis therapy  could influence the 
IS6110 mediated evolutionary rate. Furthermore, we do not exclude the possibility that change in the 
IS6110 banding pattern may be more frequent in other patient groups. To gain a greater insight into 
the rate of IS6110 change it will be essential to determine how transmission influences the 
evolutionary process (7).  
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Abstract 
Interpretation of the molecular epidemiological data of M. tuberculosis is dependent on the validity of 
the assumptions that have been made. It is assumed that the IS6110 banding pattern is sufficiently 
stable to define epidemiological events representing ongoing transmission. However, molecular 
epidemiological data also supports the observation that the IS6110 banding pattern may change over 
time. Factors affecting this rate may include the nature and duration of disease in a host and the 
opportunity to experience different host environments during the transmission cycle. To estimate the 
rate of IS6110 change occurring during the process of transmission, M. tuberculosis isolates from 
epidemiologically linked patients were genotypically characterized by RFLP (restriction fragment 
length polymorphism) analysis. The identification of IS6110 banding pattern changes during ongoing 
transmission suggested that a rate could be estimated. IS6110 change was significantly associated with 
strains with > 5 IS6110 elements (P = 0.013) and was not observed in low-copy isolates. The 
minimum rate of appearance of variant strains was calculated to be 0.14 variant cases per source-case 
per year. This data suggests that clustering of isolates based on identical RFLP patterns is expected to 
underestimate transmission in patients infected with high-copy isolates. A model based on the rate of 
appearance of both variant and invariant strains demonstrates that the genotypically defined 
population structure may change by 18.6% during the study period of approximately 6.5 years. The 
implications for the use of RFLP data for epidemiologic study are discussed.   
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Introduction 
The most extensively researched repeat sequence in the genome of M. tuberculosis is the transposon 
element IS6110, a member of the IS3 transposon family (13,17). This element may be repeated up to 
25 times per genome, and the distribution and stability of these elements in the chromosome of M. 
tuberculosis has led to the development of an internationally standardized DNA fingerprinting protocol 
to genotype clinical isolates (18,21). Interpretation of DNA fingerprinting data is based on the 
assumption that the IS6110 banding pattern is sufficiently stable to allow the grouping of strains with 
identical IS6110 genotypes as recent epidemiological events (termed clusters), while sufficiently 
variable to allow the classification of strains with unrelated IS6110 banding patterns (isolates with 
unique banding patterns) as unrelated epidemiological events (1,16). Furthermore, it is assumed that 
clustered isolates represent ongoing transmission between epidemiologically linked patients (5). This 
methodology has been used in numerous settings to quantify the relative proportion of recent 
epidemiological events and thereby estimate the extent of recently transmitted disease (1,16,23).  
While the methodology of generating RFLP (restriction fragment length polymorphism) data is 
highly standardized, the interpretation varies widely depending on the epidemiological question and 
assumptions made about the rate of change of RFLP patterns. For instance, in ascribing a case to be a 
falsely-positive diagnosis due to laboratory cross-contamination, it is usually assumed that the RFLP 
pattern should be exactly identical to another in the database, as it is unlikely that the organism will 
evolve a different pattern in the diagnostic laboratory (22). However, in well defined outbreak 
settings, occasional cases are observed where the RFLP pattern is closely related, but differs by one or 
two insertion elements (6). The latter data suggest that, as a strain spreads through the community, 
strain variants will evolve that are progeny of the same epidemic clone but manifest subtle differences 
in RFLP patterns (4). The rate of RFLP pattern change in a community is largely unknown, yet is an 
essential element in setting criteria for reporting isolates to be matched or unrelated.    
As a first step towards understanding the evolution of RFLP patterns, genotypic analysis of serial 
isolates collected from patients with persistent disease has been performed to estimate rates of IS6110 
banding pattern change over time (7,14,15,26). The frequency of banding pattern changes reported 
varied considerably between the different studies, and it was suggested that this may reflect 
(unspecified) differences in the epidemiology of disease in the different geographical regions (14). 
Assuming that the IS6110 banding pattern changes at an equal rate in different strains, de Boer et al. 
(1999) calculated an evolutionary rate by analyzing serial isolates from 544 patients with persistent 
disease. Twenty-five of these manifested altered banding patterns over time, permitting the 
extrapolation of a banding pattern half-life of 3.2 years. When this methodology was applied to data 
from San Francisco, a half-life of about 2 years was calculated (7).  
From these results it was concluded that the evolutionary rate of IS6110 banding pattern was 
sufficiently slow to allow molecular epidemiological calculations (7). However, the rate of IS6110 
banding pattern change as a bacterium travels through a community is largely unknown, and is 
expected to reflect both changes within a host during persistent disease and changes during the 
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transmission cycle, such as when the organism encounters a new host. One study from Germany, 
looking at cases with epidemiological links, found that pattern alterations in contacts who developed 
tuberculosis were rare (15). This study however had small numbers of transmission events and did not 
permit the analysis of chains of transmission, as occurs in a high incidence setting. In this study we 
investigated the rate of IS6110 banding pattern change in a high incidence community of the 
Western Cape Province of South Africa by studying RFLP patterns in patients who reside in the same 
or neighbouring households. These results are discussed in the context of the rate of appearance of 
variant strains and the influence of variant strains on the genotypic bacterial population structure as a 
function of time.  
Methods 
Study setting 
During the period from mid 1992 to December 1998, M. tuberculosis isolates were collected from 
patients attending healthcare clinics within two adjacent suburbs in Cape Town, South Africa (3). This 
community experiences an extremely high incidence of tuberculosis, with approximately 251 new 
bacteriologically confirmed adult cases per 100 000 population, per year (19). Before 1995, the 
National TB Program depended on sputum cultures for the diagnosis of tuberculosis with follow-up 
sputum samples requested by the attending physician on clinical grounds. Since 1995, the South 
African National TB Program has been conducted according to the WHO DOTS strategy with 
sputum taken for Ziehl-Neelsen smear at presentation for diagnosis, at 2 months for sputum 
conversion and again at six months after initiation of therapy to monitor response to therapy. As part 
of the research project, all Ziehl-Neelsen positive samples are sent for culture. Clinical information, 
including the residential address, of each patient was recorded at the time of diagnosis and this data 
was stored in a Microsoft Access database. 
RFLP generation and GelCompar Analysis 
All isolates were classified according to the internationally standardized DNA fingerprinting protocol, 
using the IS-3’ probe (18,21). The Southern blot autoradiographs were normalized and the IS-3' bands 
assigned using GelCompar 4.1 software. The assignments were visually checked by two independent 
persons, and only bands with an intensity of > 20 % of the average band intensity were scored as 
representing IS6110 mediated evolutionary events (8). Replicative transposition was identified when 
the evolved strain showed an additional IS6110 hybridizing band, while deletion of an IS6110 element 
was identified when an IS6110 hybridizing band was absent from the evolved strain. Variation in the 
electrophoretic mobility of an IS6110 hybridizing band was classified as a band shift representing a 
mutational event in the chromosomal domain flanking the IS6110 element. Banding pattern changes 
suspected of being the result of partial digestion of methylated restriction sites (20) were excluded. All 
band changes were confirmed by repeating the digestion at least once. Cluster analysis was done using 
the UPGMA (unweighted pair group method with arithmetic mean) and Dice coefficient (12). Each 
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IS-3’ banding pattern was assigned a cluster number and tabulated in a Microsoft Access table to 
enable linking of the DNA fingerprinting data to the clinical data.   
Study population 
Isolates collected from epidemiologically related patients: All patients residing in the same 
household (including the next door households (n ± 2) on the same side of the street) and infected 
with either identical strains or genotypically related strains (IS6110 banding pattern differing by up to 
5 hybridizing bands) were identified from the databases. It is assumed that patients residing in these 
households are epidemiologically linked and that their genotypically related or identical M. tuberculosis 
isolates represent ongoing transmission. These households were divided into two groups; 1) 
households where the strain genotype was invariant during the course of sampling and 2) households 
where the strain genotypes included a variant identified during the course of sampling. To avoid a 
possible bias in the number of patients included in the invariant patient group, strains with more than 
four changes in the IS6110 banding pattern were considered to reflect reinfection rather than 
evolution and were excluded from the study. In addition, if the variant strain was found to be present 
in the community prior to appearance in the patient, these patients were also excluded. In such cases, 
it was suspected that the patient may have been reinfected by a community source case. This stringent 
exclusion criteria excludes the possibility that the IS6110 banding pattern may revert to a previous 
evolutionary state, thereby conceivably underestimating the extent of IS6110 change.  
The appearance time interval was calculated as the time (days) from the date when the first isolate was 
collected in each household (source-case) to the date when the first isolate was collected from each 
secondary case.  
Rate calculation 
Assuming that the first case in each household was the source-case (2) and that this case infected all 
other cases in the household who subsequently developed disease, the rate at which variant isolates 
appeared (RV) (variant cases per source-case per year) as function of ongoing transmission (in the 
different households) can be described as follows: 
RV = CV/Nt0/tav  
Where CV is the number of cases with variant isolates (excluding subsequent transmission of the 
variant strain), Nt0 is the total number of source-cases, and tav is the average appearance time interval 
(years) where tav = ti/T, and ti is the sum of the appearance time intervals (years) and T is the number 
of transmission events. 
The rate at which invariant isolates appeared (RIV) (invariant cases per source-case per year) as a 
function of ongoing transmission is calculated as:  
RIV = CIV - Nt0/Nt0/tav  
Where CIV is the total number of cases with invariant isolates.  
44 Chapter 3 
 
 
Statistical analysis 
Fisher’s exact test was used to test whether changes in the IS6110 banding pattern were associated 
with the number of IS6110 insertions present in the evolving strain. In addition, the Fisher’s test was 
used to establish whether the appearance of variant isolates was related to a previous history of disease. 
The Mann-Whitney test was used to determine whether the appearance of variant isolates was related 
to the median sample collection period thereby demonstrating a correlation between appearance and 
time. 
Results 
Study population 
During the period from mid 1992 to the end of 1998, M. tuberculosis isolates were cultured from 865 
patients (representing a recovery of approximately 70 % of all culture positive patients) resident and 
attending the healthcare clinics in a suburb of Cape Town, South Africa (Figure 1) (3,23). Forty-six of 
these patients (5 %) were excluded from the study as their cultures were either contaminated or lost 
viability. Of the remaining patients, eight-hundred and seventeen patients (99.7 %) had an M. 
tuberculosis isolate genotypically classified by IS-3' DNA fingerprinting (Figure 1) (18,21).  
 
Figure 1. Flow chart showing patients included into the study. 
M. tuberculosis isolates collected from epidemiologically related patients 
To investigate the relationship between transmission and the appearance of strain variants, all patients 
who were epidemiologically linked (as they reside in the same household or adjacent households) were 
identified. A total of 248 patients from 105 households met the inclusion criteria. In eighty-three 
households, transmission of an invariant strain from 83 source-cases to 107 secondary cases was 
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observed (Figure 1). In the remaining 22 households the appearance of a variant strain/s was observed 
during ongoing transmission. Four of the households representing patients infected with a variant 
strain were excluded (4 source-cases and 4 secondary cases), as it was suspected that these patients 
may have been reinfected by a community contact. In the remaining 18 households, 21 patients were 
infected with a variant M. tuberculosis isolate originating from 18 source-cases (11 patients infected 
with an invariant isolate were also identified in these 18 households) (Figure 1). Analysis of the IS6110 
banding pattern changes (Figure 2) showed that 13 (62 %) of the variant strains evolved by replicative 
transposition, while 6 (29 %) evolved by deletion of one or more IS6110 elements. Only 1 (4.5 %) 
strain evolved by band shifts, while a further 1 strain (4.5 %) evolved by a combination of replicative 
transposition and band shifts. This suggests that replicative transposition is the predominant 
evolutionary mechanism.  
 
Figure 2. IS6110 restriction fragment length polymorphisms of M. tuberculosis isolates collected form 
epidemiologically linked patients. Each pair of lanes shows the IS6110 banding pattern of the source case (left) 
and the variant secondary case (right) resident in the same or neighbouring  household. 
Figure 3 shows a plot of the frequency of observed banding pattern changes as a function of IS6110 
copy number. Two major strain groups representing either low IS6110 copy number or high IS6110 
copy number strains were analyzed, as it has previously been suggested that these groups represent 
different evolutionary lineages which evolve independently (10,25). The absence of IS6110 banding 
pattern changes in strains with fewer than 6 IS6110 insertions is significant (Fisher’s exact test, P = 
0.013), demonstrating that the low IS6110 copy number strains evolve at a different rate from that of 
the high IS6110 copy strains. For this reason, the low copy number strains have been excluded from 
any rate calculations (see below). 
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Figure 3. Relative frequency of source-case strains generating either variant or invariant secondary cases in 
epidemiologically related episodes, as a function of the number of IS6110 insertions. 
Comparison of patients who were infected by a variant strain and those infected by an invariant strain 
did not identify significant demographic differences between the two patient groups (Table 1). 
Therefore, it is unlikely that the variant strains arose due to patient specific macro factors which could 
stimulate IS6110 mediated genome variation. Review of the clinical records of variant secondary cases 
showed that in 19 cases (90.5 %) the observed banding pattern changes occurred prior to the 
initiation of anti-tuberculosis therapy. Therefore, it is unlikely that tuberculosis therapy influences 
genomic evolution. The appearance of variant isolates was not associated with previous episode of 
disease (Fisher's exact test , P = 0.62). However, there is a weakly significant difference (Mann-
Whitney, P = 0.043) in the median time interval (between the first isolate of the source-case and the 
first isolate of the secondary case) for the patients with variant and invariant strains. This could 
suggest that the longer the time interval between infection and the development of disease the greater 
the chance of observing change.  
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Table 1. Demographics of patients recently infected within a household (excluding the source-
case), where the infecting M. tuberculosis strain has > 5 IS6110 hybridizing elements and is 
either variant or invariant from the source-case strain.  
Demographic Variant Invariant 
Cases 21 92 
Male 14 (67 %) 50 (54 %) 
Mean Age (years) 34 ± 11 33 ± 12 
Previous episode of TB 10 (48 %)* 36 (39 %) 
Pulmonary TB 19 (90 %) 91 (99 %) 
Median time (days) 739** 392 
*  (Fisher’s exact, P = 0.62) 
** (Mann-Whitney, P = 0.043) 
Given the epidemiological links for patients residing in the households studied, it is likely that any 
changes in the IS6110 banding pattern must have occurred during the interval between the collection 
of the first isolate (source-case) and the first variant isolate. Based on the assumption that the first 
patient to present with tuberculosis in each household infected all of the patients who subsequently 
presented with disease with a similar genotype (2), a rate of appearance of IS6110 variants can be 
expressed as a function of both time and number of infectious sources. Using the rate calculation RV = 
CV/Nt0/tav, the minimum average rate for which variant high copy number strains appear as 
tuberculosis cases is Rv = 0.140 variant cases/source-case/year. The rate of appearance of invariant 
isolates is RIV = 0.614 invariant cases/source-case/year.  
To determine the influence of genotypic variation on the bacterial population structure as defined by 
IS-3’ RFLP analysis, it is assumed that each household represents a subset of the study population. 
Within each household, strains can be broadly categorized as those that transmit and cause disease in 
a secondary case, and those that do not cause disease in a secondary case within the study period. As 
genotypic variation could not be identified in the latter, calculations have focused on determining a 
rate of change for strains which were transmitted and had the propensity to change (only high copy 
number strains with an IS6110 copy number of >5). We propose a simple model to describe the total 
number of variant and invariant strains (Nt1) appearing in the household population as a function of 
both transmission and evolution within a defined time interval (Figure 4). From this model the rate of 
genotypic change is calculated as: 
Nt1 = [RV x Nt0 + TV(RV x Nt0) + RIV x Nt0] x t1 + (1 – C)Nt0 
At the onset of the study time interval (t0) the number of source-cases will be Nt0. During the 
following time interval (t1) these cases will transmit disease to contacts within their respective 
households. The rate at which the contacts develop disease with a variant strain will be RV x Nt0. The 
rate of appearance of an invariant strain will be RIV x Nt0, while the rate of transmission of the variant 
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strains will be TV(RV x Nt0), where TV is a transmission rate. It is assumed that a proportion (C) of the 
source-cases will be cured. The number of infected patients at time t1 will be Nt1.  
 
Figure 4. Model describing genotypic change in the bacterial population. 
Applying this formula to the data (Table 2), 82 source-cases would yield 113 secondary cases 
(assuming that all the source-cases were cured during this time interval). Twenty-one of these cases 
will be expected to be newly evolved strain variants. This suggests that the genotypic population 
structure in this patient group will change by 18.6 % within the study period of approximately 6.5 
years. 
Table 2. Summary of the characteristics of the M. tuberculosis isolates with > 5 IS6110 
hybridizing elements which were transmitted within the context of the different households 
Characteristics  
Sum of appearance intervals (ti) (years) 206.5 
Total number of transmission events (T) 113 
Average appearance interval (tav = ti/T) (years) 1.83 
Number of source-cases (Nt0) 82 
Number of variants cases (CV) 21 
Number of invariants cases (CIV - Nt0) 92 
 
Cluster analysis of the DNA fingerprint database showed that the variant source-cases subsequently 
infected 5 patients. This result confirms that variant strains are amplified by secondary transmission 
and thereby will alter the genotypic bacterial population structure as a function of time.  
Discussion 
The advent of molecular epidemiology has permitted great advances in the study of tuberculosis and 
other infectious diseases. While the techniques needed for molecular epidemiological studies have 
become largely standardized, the interpretation of molecular epidemiological data remains dependent 
on a number of assumptions. One such assumption is that genotypic identity is a measure of recent 
epidemiological events, allowing an estimation of the degree to which disease is due to recent or 
ongoing transmission (1,11,16). However, in the molecular epidemiological analysis of M. tuberculosis, 
Nt0
Cure
R N T (R N )V 0 + V V 0t t
R NIV 0t
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this criterion excludes any change in the IS6110 banding patterns associated with transmission and 
therefore such isolates may be incorrectly classified as representing remote epidemiological events. The 
data presented in this study suggests that pattern changes will occur in strains with high IS6110 copy 
number and that the impact of these changes on epidemiological analysis should be considered.   
A number of practical and theoretical reasons exist for excluding strains differing by one or two bands 
from RFLP-defined clusters. Foremost among these are the simplicity of dichotomously classifying 
isolates as either having the exact match, or not.  While the imposition of identical matching may not 
always be appropriate, the alternative of accepting subtle alterations in patterns is problematic because 
isolates from chains of transmission will develop increasingly divergent patterns. Determining at what 
point the pattern is no longer similar enough then becomes an arbitrary process. In theory, this 
process may be facilitated by understanding the evolution of pattern change, however, previously 
published observations demonstrate that a single DNA fingerprinting probe is not able to accurately 
define evolutionary direction (9). Thus, a database may contain an RFLP pattern, A, for which there 
are two similar patterns (B and C), but it is usually not possible to determine if both B and C derive 
from A (at which point all three patterns should belong to the same cluster) or whether B derived 
from A which itself derived at some prior time from C (in which case the epidemiologically relevant 
cluster may include only A and B). Further complicating the interpretation is that a molecular clock of 
the IS6110 banding pattern during ongoing transmission is required to suggest rules by which variant 
strains should be included in or excluded from the clusters. As DNA fingerprinting databases become 
larger, representing longer time intervals and isolates from wider geographic regions, these questions 
will become more and more important. This is particularly the case in geographical regions where 
there is a high incidence of disease and large populations of genotypically related strains are found 
(24).  
In an effort to address some of these questions, this study analyzed the stability of the IS6110 banding 
pattern during the transmission of a strain from a source-case to a close contact. As transmission 
involves the passage of a strain from a diseased person to a contact (who subsequently developed 
disease), it is conceivable that evolutionary change will occur at any point within this time interval. 
Preliminary analysis of serial isolates of M. tuberculosis showed that evolutionary events are more likely 
to have occurred prior to sampling (data not shown), therefore to study change it is more appropriate 
to identify the original source-case strain for comparison. In this study, a significant number of IS6110 
band pattern changes were observed during transmission of M. tuberculosis isolates with > 5 copies of 
IS6110. This ability to change was not found to be associated with either the patient demographics or 
the exposure to anti-tuberculosis therapy. This implies that anti-tuberculosis drugs, in their the 
present form, do not significantly influence molecular strain identity and therefore the observed 
evolutionary changes reflect a natural genetic flux. The identification of chromosomal alterations 
permitted the calculation of a rate of appearance of 0.14 variant cases per source-case per year. The 
calculated rate implies that while the IS6110 banding pattern remains stable in the majority of 
epidemiologically linked events, changes in a subset of transmission events are expected to alter the 
genotypes observed by 18.6% over the course of a 6.5 year study (2.9% per year). As the patients 
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included in this study are a subset of the tuberculosis patients in the community, this rate of change 
applies to the broader tuberculosis patient population and suggests that RFLP variants will also occur 
during transmission events that do not occur within households. Using absolute genotypic identity of 
strains with > 5 IS6110 copies to estimate transmission in a community is therefore expected to result 
in an underestimate of transmission.   
The strong association between the ability to change and the number of IS6110 insertions 
demonstrates that mutation mediated by IS6110 in low copy strains is significantly slower than that 
detected in the high copy strains. Furthermore, no correlation between the number of IS6110 
elements per genome and evolutionary rate could be identified. Therefore, it would appear more 
prudent for molecular epidemiological calculations to treat these strain groupings separately rather 
than assuming that characteristics identified in one group of strains can be extrapolated to another 
group of strains. For this reason a rate of change was calculated using only the transmission data from 
patients infected with high copy number strains.   
The calculations presented herein also highlight the importance of the appearance rate of invariant 
strains. The absence of evolution within this group suggests that while genotypes are expected to 
evolve during an epidemiological study, certain genotypes will also persist for extended periods within 
a study population, representing endemic strains. The observation of such a genotype more than once 
during a study period may therefore represent either a new transmission event or independent 
reactivation events. The interpretation of such observations may be aided by further epidemiological 
information, including the pre-test likelihood of ongoing transmission suggested by additional 
knowledge about tuberculosis transmission in that community. For these numerous reasons, the use of 
identical genotypes to estimate recent epidemiological events requires due consideration. 
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Abstract 
The stability of the genotypic marker IS6110, used to define the epidemiology of M. tuberculosis, is one 
of the most important factors influencing the interpretation of DNA fingerprint data. We propose 
that evolved strains should be considered together with clustered strains to represent chains of 
ongoing transmission. We used a large fingerprint dataset, collected between 1992 and 1998 from a 
high-incidence community resident in Cape Town, South Africa, for this study. Inter-strain genetic 
distances were calculated by counting the banding pattern mismatches in the IS6110 DNA 
fingerprints from different isolates. This data demonstrates that the propensity to change by 1 or 2 
bands is independent of IS6110 copy number. Hence, the genetic distance between pairs of isolates 
can be simply expressed as the number of differences in the banding pattern. From this foundation, a 
data set has been generated which identifies newly evolved strains. Inclusion of these evolved strains 
into various molecular epidemiological calculations significantly increased the estimate of ongoing 
transmission in this study setting. The indication is that nearly all TB in this community is due to 
ongoing transmission. This has important implications for TB control as it indicates that current 
control measures are unable to reduce the level of transmission. This technique may also be applicable 
to the study of low-incidence TB outbreaks as well as the analysis of epidemiological data from other 
disease epidemics. 
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Introduction 
The discovery of repeated sequences, such as the transposable element IS6110, in the genome of M. 
tuberculosis has facilitated the accurate genotypic classification of the disease causing organism infecting 
an individual within the context of a community (16). Restriction fragment length polymorphism 
(RFLP) data has become the primary, standardized tool for the molecular epidemiology of M. 
tuberculosis, greatly enhancing the understanding of the tuberculosis epidemic in different settings 
(2,7,9,14,19). The interpretation of this data remains complex, however, and is dependent on a 
thorough understanding of the stability of IS6110 as a marker of relatedness (5,6,12,21,23). 
It is generally accepted that, in order for a marker to be useful for epidemiological tracking, its rate of 
evolution must be low enough so that epidemiologically linked cases will have identical RFLP patterns 
(recent transmission) (2,7,14); while being sufficiently rapid so as to enable the discrimination of 
closely related cases from those more distantly related (i.e. transmission vs. reactivation). Unique RFLP 
patterns, therefore, are regarded as reflecting reactivation of dormant infections, influx of strains from 
an outside community or cases transmitted from unidentified sources (2,7,14). This scenario, while 
convenient, is an oversimplification as it ignores the possibility that, as an organism multiplies within 
its host, it may give rise to clonal variants of itself, (6,11,22,23) characterized by minor changes in the 
IS6110 RFLP banding pattern. These evolved strains may, in turn, be transmitted to new hosts 
(12,21), leading, over time, to increasing genetic diversity in the bacterial population. 
Assuming a constant rate of mutation, genetic distance (GD), defined as the number of mutational 
events separating two strains, may be regarded as an indicator of the evolutionary time since their 
divergence from a common ancestor. Thus, a high degree of similarity between two strains implies 
close temporal coupling. Conversely, the greater the evolutionary time elapsed since divergence, the 
higher the probability of accumulating mutations and therefore the greater the GD. Studies of the 
stability of IS6110 fingerprints have demonstrated a half-life in the order of 2 to 3.2 years (6,11,23). 
These authors have concluded that this rate of change is sufficiently low so as to facilitate 
epidemiological tracking. However, the calculated rate is also high enough to significantly impact the 
interpretation of relatedness in molecular epidemiological studies, especially those where the study 
duration is similar to, or longer than the half-life of the marker system. Given this non-zero rate of 
IS6110 fingerprint variation, clonal variants, appearing within a relatively short time-frame, and 
differing by a few bands, may represent recent evolution and therefore be regarded as constituting an 
ongoing transmission chain (12,21,23). In a recent study we found evidence for this and reported that 
the manifestation of evolution was associated with transmission (21). We suggested that these events 
probably reflect the overall evolutionary dynamics of the bacterial population in the study setting. 
Failure to account for recent evolution in assessing epidemiological transmission may, therefore, hinder 
our understanding of the factors driving the epidemic. This is the case for most currently employed 
algorithms which regard clonal variants as belonging to independent transmission chains or 
reactivation events (2,7,14,19). 
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In this study we have examined the effect of evolution within transmission chains on the interpretation 
of M. tuberculosis molecular epidemiological data. We used a systematic approach based on inter-strain 
GD to group strains into molecular 'superclusters' representing chains of ongoing transmission. 
Analysis of this data indicates that the rate of evolution of M. tuberculosis strains remains constant and 
is largely independent of IS6110 copy number. We estimated the amount of ongoing transmission to 
be at least 20 percent higher than predicted by more established methods (14). Our results show that 
the incorporation of evolution in the algorithms quantifying the extent of ongoing transmission may 
have a profound influence on our understanding of the disease dynamics with consequent implications 
for epidemiological control strategies. 
Methods 
This study forms part of a larger, long-term molecular epidemiological project which was approved by 
the ethics committee of Stellenbosch University. 
Study population: During the period: mid 1992 to December 1998, M. tuberculosis isolates were 
collected from patients resident and attending healthcare clinics in two adjacent suburbs in Cape 
Town, South Africa (3). In this community, approximately 350 new bacteriologically confirmed adult 
cases per 100 000 population are reported each year. Prior to 1996, all patients were treated at one of 
the primary care clinics by directly observed therapy, although there was no systematic surveillance for 
cure rates. In 1996 the WHO DOTS strategy was implemented with all its attendant requirements 
resulting in the availability of cure rates. 
DNA fingerprinting 
Each isolate was classified by DNA fingerprinting using the internationally standardized protocol 
(16,20). The resulting autoradiographs were scanned and analysed using the program, GelCompar II 
(Applied Maths, Belgium). M. tuberculosis isolates with fewer than six IS6110 bands were excluded 
from the study as it has previously been shown that the IS6110 banding patterns in these strains show 
very little diversity (21), precluding their use in epidemiological tracking (14). A total of 168 isolates 
suspected of being cross-contaminated (17) or identified as non-tuberculosis mycobacteria were 
excluded from the study. 
Genetic distance 
The RFLP fingerprints were aligned, using GelCompar, to maximize the number of matching bands 
between each fingerprint pair, with tolerance parameters allowing for a 6 percent shift in each pattern 
as a whole and a 0.4 percent variance in individual band positions. This yielded 332 strains (as defined 
by distinct IS6110 patterns), having >five IS6110 elements, from 708 disease cases. Cases from the 
same patient were distinguished on the basis of IS6110 strains differing by more than 4 bands. An 
exhaustive, pair-wise comparison between each IS6110 banding pattern was performed using a band 
matching algorithm (GelCompar II) to generate a GD matrix. This consisted of an N by N table of 
the number of mismatched IS6110 bands between each pair of strains. The results were imported into 
a Microsoft Access database as a table of strain pairs with their corresponding GD’s. Based on the 
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assumption that recent evolutionary events are represented by a maximum of four banding pattern 
differences (6,21), strain pairs with a GD of ≤ four were assigned a putative transmission status of 
source or secondary based on order of appearance in the community. These assignments were made 
subsequent to the application of the following filters: 1) Strains occurring only in patients who were 
<12 years of age or who did not present with pulmonary tuberculosis were excluded as possible 
sources as they were considered unlikely to transmit the bacillus (1). 2) Strain pairs where the time 
interval between the last case of the source strain and the first case of the secondary strain was greater 
than a defined interval (2 or 5 years) were excluded. These intervals were arbitrarily chosen to 
represent the minimum and maximum period within which progression to active disease would be 
considered recent infection. For each remaining secondary strain, the source with the Nearest Genetic 
Distance (NGD) (i.e. that one being the most similar) was selected as being the most probable 
candidate. Where two or more possible source strains had the same NGD, candidacy was equally 
apportioned between them. 
To assess the propensity of the IS6110 RFLP to change, as a function of the number of insertion 
elements present in the genome, we determined the number of variant strains produced by source 
strains, categorized by their number of IS6110 bands, as a proportion of all new cases attributable to 
those source strains. 
Estimation of recent transmission 
To calculate the extent of ongoing transmission, strain pairs were linked together into transmission 
chains on the basis of common source or secondary strain type using a custom written Perl script. 
(Source code available at http://www.sun.ac.za/med_biochem/) This process was performed five times 
for each maximum NGD in the range 0 to 4. Isolates belonging to strain pairs having NGD’s less 
than, or equal to the chosen limit were grouped into ‘superclusters’. Ongoing transmission was 
determined using the formula: (N-S)/T where N = the number of cases grouped in superclusters, S = 
the number of superclusters and T = the total number of cases in the study. Because the probability 
of detecting a primary index case diminishes with increasing temporal proximity to the study 
commencement date, we formulated an alternative estimate of ongoing transmission where the 
calculation of S was limited to those superclusters initiated after the first 18 months of the study. 
Thus, ongoing transmission is defined as (NE+NL–SL)/T, where NE is the number of cases in 
superclusters initiated within the first 18 months of the study and NL and SL are the number of cases 
in superclusters initiated after the first 18 months of the study and the number of superclusters into 
which they are grouped, respectively. 
Results 
During the period from mid 1992 to the end of 1998, 1630 M. tuberculosis isolates were cultured from 
866 patients resident and attending the healthcare clinics in two adjacent suburbs of Cape Town, 
South Africa. Of these, 164 isolates were excluded as their cultures were either contaminated, lost 
viability, or were subsequently found to be non-tuberculosis mycobacteria. The remaining 807 
60 Chapter 4 
 
 
patients corresponded to 849 disease cases as some patients reported with multiple, consecutive 
infections. This represented approximately 70 percent of all bacteriologically confirmed cases resident 
in the community. The isolates representing these cases were subjected to RFLP analysis using the 
internationally standardized method in combination with the IS6110 probe. A total of 342 different 
IS6110 banding patterns were identified. Ten of these banding patterns, representing 140 cases, 
possessed <6 IS6110 insertions and were excluded from further analysis as it has previously been 
shown that these strain genotypes are extremely stable and are therefore unsuitable for 
epidemiological tracking (14). 
Pair-wise analysis of the 332 high-copy-number IS6110 banding patterns was used to quantify the 
number of differences between all possible strain pairs. From this data set a total of 3019 strain pairs 
with ≤ 4 differences were identified, of which 1168 fulfilled the case inclusion criteria and reflected 
NGD pairs. In this study, we have assumed that strains with an NGD of one to four reflect recent 
evolutionary events, as previous studies have shown that up to four IS6110 banding pattern changes 
may occur during recent transmission (12,21) or persistent disease (11,22,23). 
 
Figure 1. The number of variant strains produced as a proportion of observed transmission events from sources 
cases with a defined number of IS6110 bands. Variant strains were produced by the loss or gain of IS6110 
hybridizing bands. Values are for strain pairs with Nearest Genetic Distance (NGD) = 1, 2, 3 & 4. The data 
shown is for a maximum inter-strain interval of 2 years. 
Analysis of these strain pairs showed that the propensity to evolve by either one or two mutational 
events (NGD = 1 or 2 ) appears to be independent of the number of IS6110 hybridizing bands 
present in the source strain (see Figure 1). This result differs from previous assumptions which have 
suggested that the rate of change was proportional to the number of IS6110 elements in the source 
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
0.0
0.2
0.4
0.6
0.8
NGD1 NGD2 NGD3 NGD4
Bands
Av
er
ag
e 
nu
m
be
r 
of
 v
ar
ia
nt
s 
/ t
ra
ns
m
is
si
on
Genetic Distance 61 
 
 
strain (13,15). IS6110 mediated mutational events generating three or four banding pattern changes 
(NGD = 3 or 4 ) were also found to occur at a constant frequency in strains with 8 to 16 IS6110 
insertions (Figure 1). However, such events were largely absent from strains with 17 to 25 IS6110 
insertions (Figure 1), suggesting that multiple transposition events do not occur or are selected against 
in very high-copy number strains. 
The absence of a clear correlation between propensity to change and the IS6110 copy number implies 
a simple relationship between mutational events (up to an NGD = 4) and time, which is independent 
of the IS6110 copy number. This is demonstrated in Figure 2, where it is shown that the production 
of variant strains as a proportion of all new cases is constant for the different NGD values. However, it 
is also clear that there was a considerable amount of instability in the first 18 months, suggesting that 
this early phase reflects a lead-in period in which the data is incomplete. For this reason, data from this 
period was excluded from rate calculations. 
 
Figure 2. The frequency of new variant strains appearing in the community, as a proportion of observed 
transmissions over time elapsed since the study epoch. The data shown is for a maximum inter-strain interval of 2 
years and is plotted as a 5-month moving average. 
The number of variant strains appearing in the community, which could be linked by NGD to an 
identifiable source strain, divided by the total number of observed transmissions, from month 19 to 
the end of the study period, is a measure of the rate of variant strain production. The estimates of 
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these rates are given in Table 1. The rate at which variant strains were produced was 13.8 and 10.0 
percent of transmissions for NGD = 1 & 2 respectively, using a 2-year inter-strain interval.  
Table 1. Estimates of the rate of variant strain production as a proportion of new cases due to 
transmission appearing per month. 
 Nearest Genetic Distance 
 NGD1 NGD2 NGD3 NGD4 
Rate 
(variants/transmission) 0.1384 0.0998 0.0644 0.0445 
R² 0.9997 0.9983 0.9930 0.9988 
 
Using NGD as a measure of recent evolutionary events, occurring during the process of transmission, 
it was possible to define genotypically related groups of strains (superclusters) representing ongoing 
transmission chains. From these calculations, assuming a 2-year maximum inter-strain interval, 
between 54 and 140 isolates, previously classified as unique, were included into superclusters for 
NGD = 1 and NGD = 4, respectively. Using the formula (N-S)/T (14), the extent of recent 
transmission ranged from 66 to 89 percent. However, these values may be an under-estimate due to 
the possible erroneous assignment of primary index status to cases in the early phase of the study. To 
circumvent this problem we propose the formula (NE+NL–SL)/T in which it is assumed that the source 
cases can only be defined in superclusters initiated after the first 18 months of the study. Using this 
formula we estimate the extent of recent transmission to be between 73 percent and 94 percent  
Table 2. The degree of superclustering and the standard and alternative calculations of recent 
transmission for various allowable ranges of NGD. Values are presented for both 2- and 5-year 
maximum inter-strain intervals. 
 Nearest Genetic Distance 
 NGD 0 NGD 0→1 NGD 0→2 NGD 0→3 NGD 0→4 
Inter-strain interval  2 yr 5 yr 2 yr 5 yr 2 yr 5 yr 2 yr 5 yr 
Superclustered Cases (N) 497 552 836 589 957 616 1096 638 1087 
Superclusters 109 85 92 71 81 59 77 55 64 
% Superclustering (N/T) 70.2 78.0 84.9 83.1 90.1 87.0 93.9 90.1 94.9 
% Recent transmission 
((N-S)/T) 54.8 66.0 75.5 73.2 82.5 78.7 87.3 82.3 89.3 
% Recent transmission 
(NE+NL–SL)/T 63.0 72.9 81.4 79.4 87.5 84.5 92.4 87.9 93.8 
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Discussion 
The simplistic interpretation of DNA fingerprinting data disregards the fact that the genome is in a 
state of flux (23), evolving at a rate that will influence the interpretation of molecular epidemiological 
data (6,11,12,21,23). 
In this study we have used an algorithmic method to explore the implications of IS6110 RFLP pattern 
evolution on the understanding of an epidemic within a high-incidence community. Closely related M. 
tuberculosis strains were linked according to nearest genetic distance. In contrast to previous studies 
(13), this method of analysis shows that IS6110 evolution is independent of the number of IS6110 
hybridizing bands present in the source strain. Consequently, genetic distance is purely a measure of 
the number of band mismatches. However, a number of assumptions have been made in the interests 
of simplification in the calculation of genetic distance. Firstly, the loss or gain of a band have been 
assumed to occur at the same rate and therefore, assigned an equal GD. Since >60 percent of IS6110 
fingerprint changes occur by replicative transposition, a more refined method might assign a higher 
GD to band loss. Secondly, a band shift has been counted as two events, i.e. a combination of a loss 
and a gain. The true frequency of this type of event is obscured by multiple events, but is probably 
sufficiently rare to validate this assumption. 
Analysis of the NGD data shows that closely related variant strains are appearing in the community at 
a constant annual rate. Thus, for a maximum NGD of 1 or 2 (using a 2-year inter-strain interval), we 
found 14 to 24 percent of transmission events produced variant strains. This figure is similar to a 
previous estimate where we found that approximately 18.6 percent of transmission events within 
households generated a variant strain (21). The high proportion of newly evolved variant strains 
confirms that the M. tuberculosis strain population is diversifying at a constant rate in the study setting 
and that the process of its evolution is linked to transmission, significantly influencing molecular 
epidemiologic calculations. 
Consequently, studies depending on the stratification of cases according to genetic identity will under-
estimate the extent of transmission or incorrectly group cases for risk factor analysis. The factoring of 
NGD into clustering calculations suggests that transmission estimates may be 20 percent higher than 
predicted by previously accepted formulae (14). However, the accuracy of this calculation is influenced 
by a number of factors: 1) The number of source cases initiating transmission chains. To minimize the 
over-estimation of the number of primary index cases, we proposed an alternative formula in which it 
is assumed that clusters identified in the first 18 months of the study were initiated by source cases 
occurring prior to the onset of the study. 2) The estimate assumes a 100 percent sample recovery. In 
this study only 70 percent of cases were included and therefore, possible source or secondary cases may 
have been missed, leading to an under-estimate of transmission (10). 3) Currently, there is little data 
on the extent of M. tuberculosis transmission in areas surrounding the study community. As this region 
experiences an extremely high incidence of disease, it is probable that patients may have been infected 
by sources outside of the community. 4) While we have demonstrated the propensity to change, this 
study also shows that most of the transmitted strains remain identical to their source, persisting in the 
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community for extended periods. Using the current methodology it is not possible to differentiate 
transmission from reactivation of such strains, possibly leading to an over-estimate of transmission. 
Considering these limitations, we propose that the calculations presented here probably represent a 
conservative estimate of the true extent of disease due to transmission. Mathematical modelling 
predicts that ± 95 percent of cases should correspond to transmission given the high infection pressure 
in this community (18)(PB Fourie, J Lancaster, K Weyer and N Beyers, Medical Research Council of 
South Africa, Unpublished Manuscript; E Vynnycky, London School of Hygiene & Tropical Medicine, 
Personal communication, 2002). 
Depending on the parameters chosen, this study estimates the proportion of the local epidemic due to 
ongoing transmission to be between 66 and 94 percent. This is considerably higher than the 55 
percent estimated using genetic identity as a measure of transmission. From these results, we conclude 
that the epidemic is predominantly driven by transmission and not, as indicated by conventional 
calculations, by reactivation of dormant infections. A positive implication of this conclusion is that 
interventions which target transmission have the potential to dramatically impact the epidemic. In a 
setting of passive case-finding, largely based on positive smear-microscopy results, it is hypothesized 
that the majority of transmission events occur prior to diagnosis and treatment. This is a component 
of the epidemic which is not targeted by the present WHO DOTS strategy. Based on these results, it 
is envisaged that interventions which interrupt transmission should coincide with a decrease in GD-
based superclustering (8). We suggest that GD should prove be a useful tool in the analysis of 
longitudinal molecular epidemiological data which will aid in determining the efficacy of M. 
tuberculosis control strategies with a focus on reducing transmission. 
While the current study focused on a community with a high prevalence of TB, we believe that the 
approach presented here may also be relevant to lower-incidence communities. Given the sizeable 
evolutionary rates reported in studies conducted in such areas (6,12,23), a GD-based analysis of the 
data may well be expected to produce an estimate of recent transmission significantly different from 
that obtained by conventional calculations. The rapid diversification of M. tuberculosis isolates in the 
New York outbreak of strain W provides further weight to this argument (4). We feel that the above 
evidence indicates the need for a similar study to be done on a low TB-incidence community. In 
addition, we suggest that this technique is not limited to the study of M. tuberculosis, but may also 
prove useful in the analysis of epidemiological data from other disease epidemics. 
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Programming 
Matrix.pl 
# This Perl script reformats the distance matrix output from Gelcompar II into a list of 
# isolates pairs (identified by their Gelcompar keys) with their associated genetic distance.  
 
open INPUT,"<matrix.txt" or die "Can't open file: matrix.txt\n"; 
open OUTPUT,">distance.txt" or die "Can't open file: distance.txt\n"; 
 
while (<INPUT>) { 
 chomp; 
 $matrix[$record++] = [split /\s+/]; 
} 
$records=0; 
for $line (0..$#matrix) { 
 for $position (1..$line+1) { 
  $rdistance = int($matrix[$line][$position]+0.5); 
  if ($matrix[$line][0] ne $matrix[$position-1][0]){ 
   print OUTPUT "$matrix[$line][0]\t$matrix[$position-1][0]\t$rdistance\n"; 
  } 
 } 
} 
 
Transmission_chains.pl 
# This Perl script links a list of epidemiologically linked strain pairings into transmission 
# chains. The input file format is a simple tab-delimited, 2 column table of  
# strain types with a single header row. The output is a list of strain 
# types with the transmission chain to which they belong. 
 
open INPUT,"<pairs.txt" or die "Can't open file: pairs.txt"; 
 
$count = 0; 
<INPUT>; # Discard column labels in 1st line 
while (<INPUT>) { # Load pairs matrix and initialise chains 
 chomp; 
 ($src,$sec)=split /\t/; 
 $pairs[$src][$sec] = $pairs[$sec][$src] = ++$count; 
 $pairs[$src][0] = $pairs[$sec][0] = 1; # a valid pair exists for this position –>  
          # saves processing empty positions 
} 
close INPUT; 
 
$is3 = $#pairs; 
$changeFlag = 1; 
$itterate = 0; 
 
while ($changeFlag==1){ 
 $itterate++; 
 $changeFlag = 0; 
 foreach $row (1..$is3){ 
  if ($pairs[$row][0]!=1){ # Next row if this one is empty 
   next; 
  } 
  $chain = $count; 
  foreach $col (1..$is3){ # Find the lowest chain number for this row 
   if ($pairs[$row][$col] > 0){ 
    if ($pairs[$row][$col] < $chain){ 
     $chain = $pairs[$row][$col]; 
    } 
   } 
  } 
  foreach $col (1..$is3){ # Set all chain numbers in this row = the lowest for the row 
   if ($pairs[$row][$col] > 0){ 
    if ($pairs[$row][$col] > $chain){ # If needed, make change and set flag 
     $pairs[$row][$col] = $chain; 
     $changeFlag = 1; 
    } 
   } 
  } 
 } 
 foreach $col (1..$is3){ 
  if ($pairs[$col][0]!=1){ # Next column if this one is empty 
   next; 
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  } 
  $chain = $count; 
  foreach $row (1..$is3){ # Find the lowest chain number for this col 
   if ($pairs[$row][$col] > 0){ 
    if ($pairs[$row][$col] < $chain){ 
     $chain = $pairs[$row][$col]; 
    } 
   } 
  } 
  foreach $row (1..$is3){ # Set all chain numbers in this col = the lowest for the col 
   if ($pairs[$row][$col] > 0){ 
    if ($pairs[$row][$col] > $chain){ # If needed, make change and set flag 
     $pairs[$row][$col] = $chain; 
     $changeFlag = 1; 
    } 
   } 
  } 
 } 
} 
 
foreach $row (1..$is3){ 
if ($pairs[$row][0]!=1){ 
 next; 
} 
COL: foreach $col (1..$is3){ 
  if ($pairs[$row][$col] > 0){ # Find the chain for this strain 
   $strains{$row} = $pairs[$row][$col]; # and put it in a hash 
   last COL; 
  } 
 } 
} 
open OUTPUT,">chains.txt" or die print "Can't open file: chains.txt"; 
print OUTPUT "IS6110\tChain\n"; 
foreach $strain (keys %strains){ # Print out the strains with their chains 
 print OUTPUT "$strain\t$strains{$strain}\n"; 
} 
close OUTPUT; 
print "$itterate itterations\n"; 
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Abstract 
Many molecular epidemiological investigations of M. tuberculosis are reported using data collected over 
relatively short timeframes. We postulated that such studies would tend to under-estimate the 
amount of disease in a community attributable to ongoing transmission. To test this hypothesis we 
used 12-year datasets of both real and simulated epidemics with the latter being based on two possible 
models of transmission. We analysed the effect of viewing the datasets through time windows of 
varying sizes on the measured degree of strain clustering as an indicator of ongoing transmission. We 
found that shorter windows significantly under-estimated transmission and that this effect was 
inversely correlated with the size of a cluster. Accordingly, we recommend that molecular 
epidemiological studies of M. tuberculosis, for the purposes of estimating transmission, be conducted 
over a minimum of three to four years and that the distribution of cluster-size be taken into account in 
the interpretation of such data. 
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Introduction 
Molecular epidemiology has established its position as an essential tool in the understanding of 
tuberculosis (TB). However, as with any analytical instrument, the answers it provides are only as 
good as the data which is analysed. Technical issues aside, there are often logistical constraints 
imposed on epidemiological studies. Firstly, such studies tend to be expensive which leads to 
difficulties in obtaining funding for long-term projects, particularly as there may be little return in the 
short-term. Many published studies, therefore, report results from data collected over relatively short 
intervals of 1 to 2 years.6 In addition, even when a long-term study has been initiated, the academic 
pressure to publish often leads to publication early in the life of a study. While short-term studies may 
be acceptable in the case of epidemics of acute infections, this is not necessarily the case in a disease as 
complex as TB. The ability of Mycobacterium tuberculosis to exist as a latent infection for many years7 
and the fact that a case of TB may take up to two years (or more) after infection to present as active 
disease, greatly complicate the interpretation of epidemiological data.11 Further exacerbating these 
difficulties is the prolonged treatment period with the concomitant risk of failure due to drug-
resistance or lack of compliance on the part of the patient. Secondly, molecular data is often 
unobtainable from a significant proportion of the patients as a result of non-viability of bacterial 
cultures, contamination, laboratory error, failure of patients to report to health-care facilities or failure 
to obtain a culture sample due to patients lost to the health-care system before commencement of 
treatment (initial defaulters). Studies in different settings with varying incidences of TB show different 
degrees of transmission as indicated by the level of clustering (disease cases infected with the same 
bacterial strain).1,6 The effect of under-sampling on estimates of transmission, derived from this 
measurement, can be dramatic and its magnitude is dependent on the relative distribution of cluster-
sizes in the M. tuberculosis strain population.2  
All epidemiological studies are subject to ‘edge effects’ in which the temporal boundaries of a study 
introduce artefactual anomalies as a result of chains of transmission which extend beyond these points 
in time. This can cause both a reduction in the apparent size of clusters, which may result in clustered 
strain being seen as unique, or even the complete loss of strains. 
We hypothesise that calculations derived from molecular epidemiological data that describe a TB 
epidemic, such as the extent of clustering5 and recent transmission6, will be affected in a manner 
similar to that of under-sampling by the duration of the study interval. 
In this paper we aimed to investigate the nature and magnitude of the effect of varying study 
durations on epidemiological parameters by analysing subsets of a 12-year hypothetical dataset to 
determine a minimum interval which would provide reliable estimates of these values. We compare 
the results from this model to those from a 12-year longitudinal study in a setting with a high 
incidence of TB.  
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Methods 
Simulation data: Using a Perl script (available  on request from corresponding author), we generated 
and analysed simulated populations of 20 000 cases, in clusters (cases having identical strains) of a 
defined size (2 to 15) for each simulation. Briefly, the script generated 20 000/cluster-size index cases 
separately for each cluster-size, at random time-points over a 30-year period, with subsequent 
transmission cases being generated from their source cases with likelihoods of occurring within each of 
the following five 1-year periods of 54.5%, 22.4%, 16.9%, 4.7% and 1.5% respectively11. These 
subsequent cases were assigned randomly to each of the 12 months within the year to which they had 
been allocated. We created these datasets according to two models of transmission: 1) Each case in a 
cluster generated only one daughter case (linear transmission model); 2) Any existing case in a cluster 
had an equal chance of generating the next daughter case (random transmission model). We used data 
from years 16 to 27 for the analysis, discarding the initial 15 and all subsequent years to eliminate 
leading-in and tailing-off anomalies caused by the generation process. 
Study population: As part of an ongoing molecular epidemiological study, sputum samples were 
collected for culture at diagnosis from all new and retreatment TB patients who attended primary 
health care clinics and who were resident in an epidemiological field site in Cape Town, Western 
Cape, South Africa during the period January 1993 to December 2004. This community has an 
extremely high notification rate for TB of 761/100 000 per year for all forms of TB.10 This study forms 
part of a larger, long-term molecular epidemiological project which was approved by the ethics 
committee of Stellenbosch University. 
DNA fingerprinting: Sputum isolates were collected from all TB patients and cultured in BACTEC 
460, MGIT 960 (Becton Dickinson, Franklin Lakes, NJ USA) or on Löwenstein-Jensen medium. 
These were then sub-cultured on Löwenstein-Jensen medium and DNA was extracted as previously 
described.12 
We classified each isolate by IS6110 DNA fingerprinting using the internationally standardized 
protocol.9,13 The RFLP fingerprints were aligned, using GelCompar II (Applied Maths, Sint-Martens-
Latem, Belgium), to maximize the number of matching bands between each fingerprint pair, with 
tolerance parameters allowing for a 5 % shift in each pattern as a whole and a 0.6 % variance in 
individual band positions. Strains were identified according to distinct IS6110 banding patterns using 
Gelcompar II. Strains having fewer than 6 bands were excluded from this study due to their low rate 
of evolution which precludes the application of clustering calculations based on IS6110. We defined 
transmission chains (clusters) as a series of cases having the same strain of M. tuberculosis with inter-
case intervals of up to 2 years. 
Data analysis: We analysed the real and simulated datasets as sliding window periods of 1 to 12 
years. Clustering6 and recent transmission (n-1 formula)5,6 were calculated according to the published 
formulas for each sliding window and reported as an average for each window size. In the case of the 
simulated data, we further averaged these parameters over repeated analyses of 20 datasets for each 
cluster-size to reduce the variability introduced by the random case generator. 
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In the analysis of the real data, we determined the number cases incorrectly classified as have unique 
genotypes by subjecting a subset of the data which excluded true unique cases to the same analysis. 
Any cases subsequently observed to be unique would therefore be classified as such erroneously. 
The results were analysed using Graphpad Prism 5 (La Jolla, CA USA). 
Results 
Analysis of Simulated data 
To investigate the effect of study duration on estimates of clustering, we required a simulated dataset 
which modelled the transmission of M. tuberculosis in a real epidemic setting. To this end, we 
considered two transmission models (described above) representing extreme alternatives: a) linear 
transmission; b) random transmission. In order to evaluate these models, we tested their predictions 
regarding subsequent serial intervals within a transmission chain by comparing these against the 
pattern observed for the real data. The linear transmission model predicts that the intervals between 
each case and the next case of the same strain should, on average, remain constant, independent of the 
size of the cluster at that point in time. In contrast, the random transmission model, predicts that the 
serial intervals between clustered cases should decrease at a rate inversely proportional to the current 
cluster size as the number of possible source cases increases. To determine which model most 
accurately simulated the reality, we analysed a subset of the real data which excluded strains observed 
within the first two years to ensure that all recent transmission chains started with the first case. 
Allowing for a lead-in period of two years, we plotted the average serial interval for newly-emerged 
strains as a function of cluster-size at that time-point. We found that the interval decays exponentially 
at a rate of 0.344/case (data not shown) when fitted to the equation: SI = SI0*x
(-k), where SI = serial 
interval, SI0 = the first serial interval, x = the cluster-size-1 and k = the rate constant. As the 
theoretical rate constant for the linear model is 0, and for the random model is 1, this result suggests 
that the reality lies somewhere between the two alternatives, tending toward the linear transmission 
model. Consequently, we included both models in subsequent analysis. 
For the analysis of the simulated datasets, we separated the hypothetical epidemic into clusters of 
specific size in order to demonstrate the how the cluster-size distribution influences the degree of error 
associated with study duration. As the difference in the effect observed diminishes exponentially with 
increasing cluster-size, we limited our investigation of the simulated data to clusters of 15 or fewer 
cases. We found that estimated clustering was dramatically influenced by the duration of the study 
window, resulting in an under-estimate, in the worst scenario, of 71.4 ± 2.3% and 73.5 ± 2.5% (for 
the linear and random models respectively) for clusters of two cases using a one-year window (Figure 
1). We also noted that this effect is highly dependent on the size of a cluster with smaller clusters 
being more severely affected so that the corresponding under-estimates for clusters of 15 cases were 
52.5 ± 1.8% and 16.5 ± 1.4% for the linear and random models respectively. Estimates of recent 
transmission are even more dramatically affected as, in this case, each cluster is reduced in size by 1 
(accounting for the index case), yielding values under-estimated by 63.6 ± 0.9% and 63.5  ± 0.8% of 
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expected for clusters of two cases, and 72.4  ± 1.1% and 38.9 ± 1.2 of expected for clusters of 15 
cases using a one-year window, for the linear and random models respectively (data not shown). As the 
window-size increases, estimates of clustering approach, but do not reach 100 % for window-size less 
than infinity as there will always be some loss of cases at the temporal boundaries. Once again, this is 
more noticeable for smaller clusters. Whereas small clusters (2 or 3 cases) behave similarly, irrespective 
of the model used, predictions for larger clusters are less affected by the width of the study window in 
the random transmission model (compare Fig. 1A and 1B). 
 
Figure 1. Estimated clustering for simulated clusters of 2 to 15 cases (from bottom to top) as a function of study 
length using the A) linear and B) random transmission models. 
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Analysis of real data 
Unlike the simulated data, which is divided equally into clusters of 2 to 15, the real-world situation is 
far more complex. Table 1 shows the distribution of cases within clusters of various sizes for the 
dataset derived from the study community, as determined from the full 12-year period. It is 
immediately apparent that the distribution is far from uniform and includes both unique strains and 
clusters far larger than 15. The latter represent strains which are endemic to the community and span 
the entire study period. The analysis presented below is based on the total strain population found in 
the study community and the magnitude of the under-estimates at different window-sizes is 
dependent on the relative frequency distribution of the cluster-sizes. 
Table 1. Distribution of cases by cluster-size 
Cluster-size 
Cases 
Cape Town 
South Africa 
San Francisco 
USAa 
Zaragoza 
Spainb 
Alabama 
USAc 
1 (unique) 508 282 215 1038 
2 172 40 46 96 
3 105 39 18 57 
4 116 16 20 40 
5 40 10 15 20 
6 24 0 6 24 
7 7 0 21 63 
8 24 8 16 32 
9 18 0 0 36 
10 40 10 0 10 
11 11 0 0 22 
12 24 0 12 0 
13 26 0 0 0 
14 0 0 0 28 
15 30 15 0 15 
16 0 0 0 16 
21 0 0 0 21 
23 0 23 0 0 
26 0 0 0 26 
30 0 30 0 0 
35 35 0 0 0 
38 0 0 0 38 
41 41 0 0 41 
44 44 0 0 0 
64 64 0 0 0 
85 0 0 85 0 
136 136 0 0 136 
a Small PM 1994 2-year study 1 
b Lópes-Calleja AI 2007 4-year study 11 
c Kempf M-C 2005 (state-wide) 6-year study 12 
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We subjected the real dataset to a similar analysis to that of the simulated data by viewing it as a 
series of rolling time windows of varying sizes. As was the case for the simulated data, we found that 
the average estimates of clustering and recent-transmission, over all windows of a particular size, 
decreased as the window-size was reduced (Fig. 2). 
Figure 2. Average percentage clustering ({) and recent-transmission (n-1 formula1) () with SDs of all cases in the 
real dataset analysed by sliding windows of varying sizes. 
We found values for clustering and recent-transmission for the full 12-years of 65.3% and 52.8% 
respectively, which were reduced to averages of 44.6 ± 7.4% and 30.9 ± 6.6% for one-year windows. 
In accordance with these findings, we further found that the number of cases incorrectly classified as 
unique (not forming part of a transmission chain) increased with decreasing window-size to a 
maximum average of 23 ± 3.3 per year (representing 19.1% of the dataset) for a one-year study 
period (data not shown). 
We were able to repeat this analysis separately for clusters of 2, 3 and 15 and found that the plots of 
clustering for these three subsets matched what would be expected from the simulation (Fig. 3). 
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Figure 3. Percentage clustering of real data by window-size for clusters of 2 ({), 3 () and 15 (V) cases. SDs are 
omitted for clarity, being high as a result of very low numbers of cases at each point. 
Discussion 
From the analysis of both simulated and real data, it is clear that the duration of an epidemiological 
study has a significant influence on the calculated parameters describing the degree of transmission in 
any particular study context. We have demonstrated that, as the time-window through which an 
epidemic is viewed is shortened, the apparent degree of clustering diminishes at an increasing rate, 
resulting in an under-estimation of the proportion of disease that is attributable to ongoing 
transmission. While our theoretical analysis assumes an epidemic is equilibrium over the 12-year 
duration, the principal still applies in the case of a changing bacterial population as may be seen from 
our analysis of the real data. 
It is also apparent that the magnitude of this effect is strongly influenced by cluster-size, with smaller 
clusters being more vulnerable to the effects of shorter study periods. Thus, the extent of under-
estimating the proportion of disease due to transmission will be dependent on the relative distribution 
of cluster-sizes found in the population, being an average of the under-estimates for each cluster-size 
in the proportion in which it is represented. We observe that it is generally the case that real datasets 
are dominated by clusters of smaller size (Table 1). In this light, it is interesting to note that, if an 
epidemic contains a large proportion of small clusters, clustering will always be significantly under-
estimated for studies of practical duration as a result of the cases which are lost at the temporal 
boundaries (Fig. 1). 
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Our analysis of the inter-case intervals for the real data indicated that the transmission pattern lies 
between those of the two theoretical models, favouring that of the linear model. This is most likely 
due to a combination of a limited window available for spreading infection before the commencement 
of treatment and the limited number and overlapping nature of the social contacts of persons forming 
part of a chain of transmission.8 
In evaluating the two models of transmission patterns, we noted that larger clusters were less affected 
by window-size in the random transmission model. This is because, as the cluster-size increases in this 
model, the inter-case intervals decrease with the consequence that a large cluster will tend to be 
spread over a smaller time period than in the case of the linear transmission model. As transmission 
and incubation periods may vary from one community to another, these factors may introduce further 
variability into the calculation of clustering with more linear transmission patterns and longer inter-
case intervals exacerbating the effect of reduced study duration. 
We further observe that, as a result of temporal variation, the shorter the study, the higher the 
variance associated with the estimates of transmission (Fig. 2). This effect will be exacerbated by 
smaller datasets in settings with a low incidence of TB. We therefore suggest that ‘snapshot’ studies of 
an epidemic will tend to be inaccurate and unreliable. 
The phenomenon of underestimation of the level of clustering by under-sampling has already been 
noted by Glynn, et al.2 The effect of under-sampling will interact with the effects of study-duration, 
shown here, in a two-fold manner. Not only will it compound the observed decrease in the level of 
clustering directly, but it will also tend to shift the apparent distribution of cluster-sizes towards 
smaller clusters, thus, indirectly, further exacerbating the effect of study-duration. The combination, 
therefore, of a low sampling rate in a study of short duration can be expected lead to a significantly 
distorted picture of the epidemic under investigation. 
As estimates of clustering/recent transmission are surrogates for the efficacy of TB control programs, it 
is imperative that they be as accurate as possible. Studies which incorrectly attribute a large 
proportion of disease to reactivation of latent TB or influx from other regions may inform the 
adoption of suboptimal strategies within the TB control program. 
A further cause for concern is the incorrect identification of cases as having unique genotypes within 
the population. As a result of the loss of cases, both by under-sampling and study window edge-
effects, small clusters may be reduced to single cases. Unique strains are generally regarded as 
reflecting reactivation and as having an impaired ability to transmit. As such, they are often used in 
studies related to pathogen-based risk-factors for transmission and an error in their identification 
would invalidate such investigations. 
Any study, therefore, which depends on the estimation of transmission using clustering calculations, 
or on the identification of cases according to their transmissibility will be affected by the issues 
presented in this paper. In the light of these results, it is our recommendation that molecular 
epidemiological studies of M. tuberculosis, for the purposes of estimating transmission, be conducted 
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over a minimum of three to four years and that the distribution of cluster-size be taken into account as 
a possible source of bias in the interpretation of such data. 
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Programming 
Window_Clustering.pl 
# This Perl script calculates the average clustering (or recent transmission) with SD using 
# sliding windows with window sizes of 1 to n years for an n year study period. 
# The input file has 1 header row (which is not used) followed by the data. 
# The first column is the strain with subsequent columns being the case-count for that strain 
# for each of the years in the study. Each column is separated by a tab. 
# e.g. 
# Strain 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
# 132 0 0 0 0 0 0 0 0 1 4 1 1 
# 133 0 0 0 0 0 2 2 1 3 0 0 0 
# 134 0 0 1 1 2 1 3 0 0 0 0 0 
# 135 1 2 3 0 0 0 0 0 0 0 0 0 
# 136 2 1 1 0 0 0 0 0 0 0 0 0 
# 138 1 1 4 0 0 0 0 0 0 0 0 0 
# 139 0 0 0 0 0 0 0 0 0 1 1 3 
# 141 0 0 0 0 0 0 0 1 3 1 1 1 
 
open INFILE, "<pivot.txt" or die "Can't open data file 'pivot.txt'"; 
open OUTFILE, ">result.txt" or die "Can't open data file 'result.txt'"; 
 
$header = <INFILE>; 
chomp $header; 
($trash,@years) = split /\t/, $header; # Column labels in 1st line 
$maxwinsize = scalar(@years); 
 
while (<INFILE>){ 
 next unless m/.+/; 
 ($strain,@cases) = split/\t/; 
 $pivot{$strain} = [@cases]; 
} 
 
print OUTFILE "AvClustering\tSD\tAvRtransmission\tSD\n"; 
 
for $winsize (1 .. $maxwinsize){ # Iterate through each window size 
 @casecount = (); 
 # Iterate through all possible windows for this window size 
 for $window (1 .. $maxwinsize - $winsize + 1){ 
  foreach $strain (keys %pivot){ 
   foreach $year ($window - 1 .. $window-1 + $winsize - 1){ 
    # Sum the cases for each strain over each year in the window 
    $casecount[$window]{$strain} += $pivot{$strain}[$year];  
   } 
  } 
 } 
 $sumtotal = $sumuniques = $sumstrains = $sumclustering =  $sumrtrans = 0; 
  @total = @strains = @uniques = (); 
  for $window (1 .. $maxwinsize - $winsize + 1){ 
  foreach $strain (keys %pivot){ 
 
   if ($casecount[$window]{$strain} > 0){ # If there are any of this strain in this 
window 
    # Sum the cases for each  strain over each window of this windowsize 
    $total[$window] += $casecount[$window]{$strain};  
    $strains[$window]++; 
    if ($casecount[$window]{$strain} == 1){ 
     $uniques[$window]++; 
    } 
   } 
  } 
  if ($total[$window] > 1){ 
   $sumclustering += ($total[$window] - $uniques[$window]) / $total[$window] * 100; 
   $sumrtrans += ($total[$window] - $strains[$window]) / $total[$window] * 100; 
   $sumtotal += $total[$window]; 
   $sumuniques += $uniques[$window]; 
   $sumstrains += $strains[$window]; 
  } 
 } 
 
 $windowcount = $maxwinsize - $winsize + 1; 
 $avclustering = $sumclustering / $windowcount; 
 $avrtrans = $sumrtrans / $windowcount; 
 $avtotal = $sumtotal / $winsize; 
 $avuniques = $sumuniques / $winsize; 
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 $avstrains = $sumstrains / $winsize; 
  
 $sum_of_squares_clust = $sum_of_squares_rt = 0; 
 for $window (1 .. $windowcount){ 
  if ($total[$window] > 1){ 
   $sum_of_squares_clust += ((($total[$window] - $uniques[$window]) / $total[$window]) 
* 100 - $avclustering)**2; 
   $sum_of_squares_rt += ((($total[$window] - $strains[$window]) / $total[$window]) * 
100 - $avrtrans )**2; 
  } 
 } 
 $SD_clust = sqrt( $sum_of_squares_clust / ($windowcount) ); 
 $SD_rt = sqrt( $sum_of_squares_rt / ($windowcount) ); 
 print OUTFILE "$avclustering\t$SD_clust\t$avrtrans\t$SD_rt\n"; 
} 
 
close INFILE; 
close OUTFILE; 
 
Simulation.pl 
# This Perl script generates a series of simulated tuberculosis epidemics of specific 
# clustersizes from $minclustersize to $maxclustersize. Each epidemic contains 20000 cases 
# which are used to calculate % clustering etc. using rolling windows of 1 to $winsizemax. 
# Transmission may be linear (one case gives rise to one case) or random (any existing case 
# may produce the next case in that cluster) according to the value of $random_model. 
# 
# 
$itterations = 20; # The number of times to run this analysis 
$cases = 20000; # Constant defining dataset size 
$random_model = 1; # Set to 0 for linear model 
$minclustersize = 2; 
$maxclustersize = 15; 
$yearspan = $maxclustersize * 2; # The number of years over which cases can be generated 
        # (create lead-in and lead-out period equal to maxclustersize) 
$yearmin = $maxclustersize + 1; # Start of cluster analysis (exclude lead-in period of 
       # maxclustersize) 
$winsizemax = 12; # The largest window size to analyse 
 
sub roundup { 
 my($number) = shift; 
 return int($number + .999); 
} 
 
for $itteration (1 .. $itterations){ 
 print "Itteration: $itteration\n"; 
 @straincount = (); 
 # Generate the dataset 
 print "Generating dataset\n"; 
 for $clustersize ($minclustersize .. $maxclustersize){ 
  $previous_strain = 0; 
  @casedate = (); 
  for $case (1 .. $cases){ 
   # Assign strain type to each case based on the current clustersize 
   $strain = roundup($case/$clustersize); 
   if ($strain == $previous_strain){ 
    $generator = 0; # Set to be the index case; 
#   Random source start 
    if ($random_model = 1){ 
# Choose which existing case will generate a new case with each having a 1/(no. of previous 
# cases of this strain) chance this time round 
     while (rand() > 1/@casedate){ 
# If generator number is > the number of existing cases for this strain 
      if ($generator++ == @casedate){ 
       $generator = 0; # Reset to be the index case; 
      } 
     } 
    } 
#   Random source End 
    $yearselector = int(rand()*1000); 
    $randmonth = int(rand()*11+1); 
# Population month of previous case plus 1 to 11 months or 12 to 23 months etc. up to 5 years 
# in ratio of 54.5%, 22.4%, 16.9%, 4.7% and 1.5% 
    SWITCH: { 
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     $month = $casedate[$generator] + $randmonth, last SWITCH if ($yearselector 
<= 545); 
     $month = $casedate[$generator] + 11 + $randmonth, last SWITCH if 
($yearselector <= 545+224); 
     $month = $casedate[$generator] + 23 + $randmonth, last SWITCH if 
($yearselector <= 545+224+169); 
     $month = $casedate[$generator] + 35 + $randmonth, last SWITCH if 
($yearselector <= 545+224+169+47); 
     $month = $casedate[$generator] + 47 + $randmonth; 
    } 
   } else { 
    @casedate = (); 
    $month = int(rand()*$yearspan) * 12 + int(rand()*12+1); 
   } 
   push @casedate, $month; # Temp var to calculate year for next case of same strain 
   $previous_strain = $strain; # Temp var to compare with the next one 
   $year = int($month / 12); 
   $straincount[$clustersize][$strain][$year]++; 
  }  
 } 
 # Store cumulative clustering, RTrans and their STDs in 2D arrays (e.g. 
$clustering[$clustersize][$winsize]) 
 # At the end, of all the itterations, divide the totals in each cell by $itterations. 
 print "Calculating statistics for clustersize:\n"; 
 for $clustersize ($minclustersize .. $maxclustersize){ 
  print "\t$clustersize\n"; 
  for $winsize (1 .. $winsizemax){ # Iterate through each window size 
   @casecount = (); 
   # Iterate through all possible windows for this window size 
   for $window (1 .. $winsizemax - $winsize + 1){ 
    for $strain (1 .. (scalar(@{$straincount[$clustersize]}) -1) ){ 
     for $year ($yearmin + $window - 1 .. $yearmin + $window-1 + $winsize - 1){ 
      $straincount[$clustersize][$strain][$year] += 0; # Assign 0 if null 
      # Sum the cases for each strain over each year in the window 
      $casecount[$window]{$strain} += 
$straincount[$clustersize][$strain][$year]; 
     } 
    } 
   } 
#   $sumtotal = $sumuniques = $sumstrains = $sumclustering =  $sumrtrans = 0; 
   $sumuniques = $sumclustering =  $sumrtrans = 0; 
   @total = @strains = @uniques = (); 
   for $window (1 .. $winsizemax - $winsize + 1){ 
    for $strain (keys %{$casecount[$window]}){ 
     # If there are any of this strain in this window 
     if ($casecount[$window]{$strain} > 0){ 
      # Sum the cases for each  strain over each window of this windowsize 
      $total[$window] += $casecount[$window]{$strain}; 
      $strains[$window]++; 
      if ($casecount[$window]{$strain} == 1){ 
       $uniques[$window]++; 
      } 
     } 
    } 
    $sumclustering += ($total[$window] - $uniques[$window]) / $total[$window] * 
100; 
    $sumrtrans += ($total[$window] - $strains[$window]) / $total[$window] * 100; 
    $sumuniques += $uniques[$window]; 
#    $sumtotal += $total[$window]; 
#    $sumstrains += $strains[$window]; 
   } 
   $windowcount = $winsizemax - $winsize + 1; 
   $avclustering = $sumclustering / $windowcount; 
   $avrtrans = $sumrtrans / $windowcount; 
   $avuniques = $sumuniques / $windowcount; 
#   $avtotal = $sumtotal / $windowcount; 
#   $avstrains = $sumstrains / $windowcount; 
    
   $sum_of_squares_clust = $sum_of_squares_rt = $sum_of_squares_u = 0; 
   for $window (1 .. $windowcount){ 
    $sum_of_squares_clust += ( (($total[$window] - $uniques[$window]) / 
$total[$window]) * 100 - $avclustering )**2; 
    $sum_of_squares_rt += ( (($total[$window] - $strains[$window]) / 
$total[$window]) * 100 - $avrtrans )**2; 
    $sum_of_squares_u += ( $uniques[$window] - $avuniques )**2; 
   } 
   $SD_clust = sqrt( $sum_of_squares_clust / ($windowcount) ); 
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   $SD_rt = sqrt( $sum_of_squares_rt / ($windowcount) ); 
   $SD_u = sqrt( $sum_of_squares_u / ($windowcount) ); 
   $clustering[$clustersize][$winsize] += $avclustering; 
   $clusteringSD[$clustersize][$winsize] += $SD_clust; 
   $rtrans[$clustersize][$winsize] += $avrtrans; 
   $rtransSD[$clustersize][$winsize] += $SD_rt; 
   $unique[$clustersize][$winsize] += $avuniques; 
   $uniqueSD[$clustersize][$winsize] += $SD_u; 
  } 
 } 
} 
 
open OUTFILE_C, ">Cresult.txt" or die "Can't open data file 'Cresult.txt'"; 
open OUTFILE_RT, ">RTresult.txt" or die "Can't open data file 'RTresult.txt'"; 
open OUTFILE_U, ">Uresult.txt" or die "Can't open data file 'Uresult.txt'"; 
print OUTFILE_C "Windowsize"; 
print OUTFILE_RT "Windowsize"; 
print OUTFILE_U "Windowsize"; 
for $clustersize ($minclustersize .. $maxclustersize){ 
 print OUTFILE_C "\tAvClust_$clustersize\tSD_$clustersize"; 
 print OUTFILE_RT "\tAvTrans_$clustersize\tSD_$clustersize"; 
 print OUTFILE_U "\tAvUniques_$clustersize\tSD_$clustersize"; 
} 
print OUTFILE_C "\n"; 
print OUTFILE_RT "\n"; 
print OUTFILE_U "\n"; 
for $winsize (1 .. $winsizemax){ 
 print OUTFILE_C "$winsize"; 
 print OUTFILE_RT "$winsize"; 
 print OUTFILE_U "$winsize"; 
 for $clustersize ($minclustersize .. $maxclustersize){ 
  $clustering[$clustersize][$winsize] = $clustering[$clustersize][$winsize]/$itterations; 
  $clusteringSD[$clustersize][$winsize] = 
$clusteringSD[$clustersize][$winsize]/$itterations; 
  print OUTFILE_C 
"\t$clustering[$clustersize][$winsize]\t$clusteringSD[$clustersize][$winsize]"; 
  $rtrans[$clustersize][$winsize] = $rtrans[$clustersize][$winsize]/$itterations; 
  $rtransSD[$clustersize][$winsize] = $rtransSD[$clustersize][$winsize]/$itterations; 
  print OUTFILE_RT "\t$rtrans[$clustersize][$winsize]\t$rtransSD[$clustersize][$winsize]"; 
  $unique[$clustersize][$winsize] = $unique[$clustersize][$winsize]/$itterations; 
  $uniqueSD[$clustersize][$winsize] = $uniqueSD[$clustersize][$winsize]/$itterations; 
  print OUTFILE_U "\t$unique[$clustersize][$winsize]\t$uniqueSD[$clustersize][$winsize]"; 
 } 
 print OUTFILE_C "\n"; 
 print OUTFILE_RT "\n"; 
 print OUTFILE_U "\n"; 
} 
close OUTFILE_C; 
close OUTFILE_RT; 
close OUTFILE_U; 
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Abstract 
Mycobacterium tuberculosis strains can be classified into a number of major clades according to defined 
evolutionary markers. It is hypothesised that strains comprising these clades have evolved different 
properties which may influence a local strain population structure. To investigate this, we analysed the 
incidence of tuberculosis caused by the predominant clades (Beijing, Haarlem, LAM, Quebec and the 
Low-Copy Clade) found in a community within the Cape Town metropole in South Africa over a 12-
year period. We found that, while the incidence of cases infected with strains of the Haarlem, LAM, 
Quebec and the Low-Copy Clades remained relatively stable, that of cases of the Beijing clade 
increased exponentially over time, with a doubling time of 4.86 years (P=0.018). This growth was 
exclusively attributable to drug-susceptible strains. Although drug-resistant Beijing cases remained 
constant in number, non-Beijing drug-resistant cases declined over time (P=0.007). Drug-susceptible 
Beijing-infected cases had a greater proportion of smear-positive sputa than their non-Beijing 
counterparts (P=0.013) and were less likely to be successfully treated (retreatment cases) (P=0.026). 
Recent evidence suggests that these differences likely reflect enhanced pathogenicity rather than 
transmissibility. The rapid emergence of Beijing strains demonstrates adaptation to conditions within 
the study community and poses a grave challenge to future TB control. 
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Introduction 
DNA fingerprinting has enabled the accurate classification of Mycobacterium tuberculosis strains, thereby 
facilitating their geo-temporal tracking. Comparative genotyping has shown that strains can be 
classified according to genotypic similarity 1. Such classification schemes are hierarchical in nature, 
ranging from the clustering of apparently identical clones 2,3 up to the grouping of anciently related, 
major, global lineages (clades) 4. Each of these levels in the classification hierarchy is informative in 
addressing different questions and has provided novel insights into the dynamics of the disease within 
host populations, both globally and locally. This has included: estimating the extent of recent 
transmission 2, defining the mechanism of recurrence 5,6, identifying outbreaks 7,8, demonstrating 
global phylogenies 4, as well as calculating the extent of laboratory cross-contamination 9. 
Molecular epidemiological analysis of tuberculosis (TB) epidemics in different settings has shown that 
they are usually composites of a number of phylogenetically unrelated clades 10, each characterised by 
the inheritance of unique genomic markers (including insertions, deletions, single nucleotide 
polymorphisms, and expansion and contraction of repeat sequences)11-13. 
The accumulation of chromosomal mutations may also be associated with the evolution of clade 
specific phenotypes 11-13.as suggested by the observation that strains representative of three major 
global clades (Beijing, Haarlem and East-African-Indian) and M. canetti demonstrated different 
immunopathologies in the mouse infection model 14. Accordingly, we hypothesise that the genetic 
diversity of the bacterial strains present within an epidemic setting may give rise to an array of 
pathogenic characteristics. Such a bacterial population would be subject to selective pressures which 
may give rise to phenotypic variations affecting host-pathogen interactions and, consequently, 
influencing the structure of the bacterial strain population within a particular host population 4,15. 
However, the nature of any such changes in the bacterial strain population over time is currently 
unknown. 
Recent studies have used molecular epidemiological techniques to interrogate longitudinal databases 
to demonstrate changes in the incidence of tuberculosis cases and rates of clustering, to identify groups 
and sub-groups at risk of contracting disease and to identify risk factors for both reactivation and the 
emergence of drug-resistant strains 16-19. However, these studies failed to report temporal changes in 
the M. tuberculosis population structure. Thus, risk factors which could alter the M. tuberculosis strain 
population structure over time remain largely unknown, with the exception that immigration was the 
greatest factor defining the population structure in low incidence settings 20. 
In this study we describe changes in the population structure of M. tuberculosis strains cultured from 
patients resident in an epidemiological field site in Cape Town 21, South Africa over a twelve-year 
period. We evaluated the potential influence of clinical, demographical and bacterial factors on the 
changes observed 
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Methods 
Definition of a case: A case of tuberculosis was defined as a treatment episode having one of the 
following clinical outcomes: cured or successfully treated, failed, interrupted (provided such 
interruption exceeded two months), died, initial default, transferred out and unknown 21. With the 
exception of ‘death’, standardised outcomes were not available for drug-resistant cases and could 
therefore not be reported. For this study, we analysed the sub-set of cases for which an RFLP was 
available. Each case was associated with a specific strain of M. tuberculosis, identified by IS6110 RFLP 
as described below. All subsequent retreatment episodes were regarded as separate cases (disease 
episodes). Cases were defined as smear-positive if they had at least one positive (including scanty) 
sputum smear.  
Study population: According to the National TB Program guidelines, new cases are routinely 
investigated by sputum smear, while retreatment cases are routinely examined by sputum smear and 
culture. However, as part of an ongoing molecular epidemiological study, an attempt was made to 
collect sputum samples for culture at diagnosis from all new and retreatment tuberculosis patients 
who attended primary health care clinics and who were resident in an epidemiological field site in 
Cape Town, Western Cape, South Africa 22 during the period January 1993 to December 2004. 
Census data provided by Statistics South Africa from 1996 and 2001 showed that the population had 
remained stable both in terms of number (±36 300) and age distribution (data not shown). At least 
99% of patients were of indigenous South African origin (non-migrant population) (data not shown). 
In this community, an average of 320 new bacteriologically-confirmed (having a smear- or culture-
positive specimen) adult cases per 100 000 population were reported for the years 1993 to 1998 23.  
Sputum smear microscopy (fluorescent staining) and/or culture in BACTEC 460, MGIT 960 (Becton 
Dickinson, Franklin Lakes, NJ USA) or on Löwenstein-Jensen media was done by the National Health 
Laboratory Service (routine laboratory services to the primary health care clinics) or our laboratories at 
Stellenbosch University, Faculty of Health Sciences, to confirm the presence of M. tuberculosis. Clinical 
and demographic data including previous history of tuberculosis, gender and age, smear positivity and 
drug-susceptibility test results (if requested), were recorded in a database. Chest radiography was not 
done routinely by the national program and was therefore not included in this study. HIV testing was 
not routinely done in the initial years of this study although a recent survey of 366 new adult smear 
positive tuberculosis cases (2000 to 2002) in this epidemiological field site showed that 10% were 
HIV positive.  
Drug-susceptibility testing was done by the National Health Laboratory Service, using the indirect 
proportion method on Löwenstein-Jensen medium containing critical concentrations of 0.2 μg/ml 
Isoniazid and 30 μg/ml Rifampicin. In this study, drug-resistance was defined as resistance to either 
Isoniazid or Rifampicin or both (MDR-tuberculosis).  
All data was captured and stored in a database. To ensure confidentiality, all data was unlinked from 
the patients’ names. This study forms part of a larger, long-term molecular epidemiological project 
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which has been approved by the ethics committee of the Faculty of Health Sciences of Stellenbosch 
University. 
DNA fingerprinting: Sputum isolates were collected from all tuberculosis patients and cultured on 
MGIT and/or Löwenstein-Jensen media. DNA was extracted as previously described 24. Each isolate 
was classified by IS6110 DNA fingerprinting 25,26 and spoligotyping 27 using internationally 
standardized protocols. Strains were identified according to distinct IS6110 banding patterns using 
Gelcompar II (Applied Maths, Sint-Martens-Latem, Belgium) as previously described 28 and were 
subsequently grouped into evolutionary clades which were classified based on their spoligotype 
signatures 29,30. Within the study community, strains having fewer than 6 IS6110  bands (low-copy 
clade) comprise a single lineage as defined by IS6110 (as previously described 30) and were therefore 
regarded as a single clade. Sub-lineages of the Beijing clade were identified as previously described 11. 
The proportion of cases arising as a result of on-going transmission was calculated according to the 
formula (clustered cases – index cases)/total cases 2, where transmission chains were defined as a series 
of cases having isolates with identical IS6110 DNA fingerprints (identified using Gelcompar II), with 
inter-case intervals of less than 2 years and each transmission chain assumed to be initiated by a single 
index case. A transmission chain unique case was defined as one having no other cases with the 
identical strain occurring within 2 years either side. Cases classified as retreatment after 
failure/interruption were regarded as a continuation of the preceding episode and were excluded from 
this calculation. 
Statistical analysis: Cases from each clade were compared in terms of: age, sex, prior history of 
tuberculosis, treatment outcome, duration of treatment and smear positivity. As the treatment 
regimen differs between new and re-treatment cases, these groups were analysed separately with 
respect to treatment duration and outcome. Clades were compared in terms of: number of strains, 
transmission chain size, proportion of ongoing transmission, frequency of drug-resistance. This data 
was analysed to identify bacterial, demographic and/or clinical risk factors which may influence 
temporal changes in each clade’s contribution to the epidemic. 
Statistical analysis was done using Graphpad Prism 5 (La Jolla, CA USA). A p-value of less than 0.05 
was considered as statistically significant.  
Non-linear regression of the annual incidence of cases from the various clades was plotted using the 
exponential equation: , where X is the study year, Y0 is the incidence in year one of the 
study and k is the rate constant, expressed in inverse years. The doubling time is calculated as ln2/k. It 
was assumed that the growth (either positive or negative) in the incidence of cases infected with a 
particular strain population could be described by an exponential equation. 
The reproductive rates for each clade (divided into drug-susceptible and resistant cases) were 
calculated as 1 plus the rate constant (k), which was derived from the exponential non-linear 
regression plot of annual incidence. 
)*(
0 *
XkeYY =
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Results 
During the period 1993 to 2004, a total of 2 727 cases of tuberculosis were recorded (notified) from 
2 150 patients, of whom 425 had multiple episodes (2 to 5) of disease. A subset of 1 921 (70%) cases 
had a M. tuberculosis culture and an IS6110 RFLP fingerprint with >98% classified as pulmonary TB. 
There was no difference in the proportion of new to retreatment cases between those having an RFLP 
and those that did not. Cases included in the analysis represented 546 strains (distinct IS6110 banding 
patterns) which could be grouped into 8 clades of which 5 predominated: Beijing, Latin American – 
Mediterranean (LAM), Low Copy-number (LC), Haarlem and Quebec (Table S1). Together these 5 
clades comprised 84% of the strain population. 
Non-linear regression analysis of the annual case numbers of tuberculosis cases according to their 
respective clades showed that the numbers of cases in the Haarlem, LAM, LC and Quebec clades did 
not change significantly over the study period (Figure 1). However, the number of cases with a Beijing 
genotype strain increased significantly as a function of time, with an estimated doubling time of 4.86 
years (95% CI, 3.55 to 7.72).  
Figure 1. Annual number of cases belonging to the 5 major M. tuberculosis clades with the remaining cases 
grouped as ‘Other’. Calculated doubling times in years were: Beijing (♦) = 4.86, LAM (■) = 34.79, LC () = 
40.71, Haarlem (8) = -43.43, Quebec (▲) = -10.35, Other (○) = -19.25. 
To determine whether the increase in the incidence of cases with a Beijing strain was driven by drug-
resistance, the non-linear regression analysis was repeated, separating cases classified by routine testing 
as drug-resistant and drug-susceptible. This analysis showed that the increase in incidence was driven 
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exclusively by drug-susceptible Beijing genotype strains. For this clade, we estimated doubling times 
of 3.89 years (95% CI, 2.85 to 6.15) and 252.0 years (95% CI, 11.26 to +infinity) for drug-
susceptible and drug-resistant cases, respectively (Figure 2 and Table 1). The doubling time for drug-
susceptible cases from the remaining clades (non-Beijing) was estimated to be 76.56 years (95% CI, 
12.75 to +infinity). Among the drug-resistant non-Beijing-infected cases, the incidence of all the 
clades declined over time although this was only significant in the case of the LC clade which 
decreased with a halving time of 4.48 years (95% CI, 2.63 to 14.97) (Table S1). We found that the 
Beijing clade had a significantly higher proportion of drug-resistant cases than non-Beijing clades 
(Fisher’s exact test OR, 2.24; 95% CI, 1.63 to 3.07; P < 0.001) and that, within the drug-resistant 
subset, Beijing-infected cases were significantly more likely to be due to transmission (Fisher’s exact 
test OR, 8.66; 95% CI, 3.88 to 19.34; P < 0.001) (Table 2). 
 
Figure 2. Annual number of drug-susceptible (♦) and drug-resistant (○) cases of the Beijing clade of M. tuberculosis. 
Calculated doubling times in years were: Drug susceptible = 3.89, Drug resistant = 252.0. 
We have previously reported that the local Beijing strain population is dominated by sub-lineage 7 
(72%) 11. To determine whether the increase in the incidence of cases with drug-susceptible Beijing 
genotype strains was dependent on the phylogenetic sub-lineage, the non-linear regression analysis 
was repeated for cases with strains belonging to sub-lineages 1 to 6 combined and sub-lineage 7. 
Doubling times for these two groups were found to be 3.69 years (95% CI, 2.45 to 7.45) and 3.94 
years (95% CI, 2.80 to 6.66) respectively. These growth rates are not significantly different (extra 
sum-of-squares F-test) and therefore cases with a drug-susceptible Beijing strain were regarded as a 
single population for this study. 
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Table 1. Clinical and demographic analysis of Beijing vs. non-Beijing drug-susceptible and drug-resistant cases. 
 Drug-susceptible n (%) Drug-resistant n (%) 
 Beijing Non-Beijing Odds Ratio
a (95% CI) 
P value Beijing Non-Beijing 
Odds Ratioa (95% CI)
P value 
Cases 381 1356 71 113
Reproductive rate [k + 1] (1/years) 1.178 1.009 P = 0.018b 1.003 0.873 P = 0.007b
Doubling Time (years)
(95% CI) 
3.89
(2.85 to 6.15) 
76.56
(12.75 to +∞)  
252.00
(11.26 to +∞) 
-5.47
(-11.78 to -3.57)  
Male 239 (62.7) 774 (57.1) 1.27 (1.01 to 1.61)P = 0.045 35 (49.3) 73 (64.6) 
0.53 (0.29 to 0.98)
P = 0.046 
Smear positive 301 (79.0) 981 (72.3) 1.45 (1.08 to 1.96)P = 0.013 51 (71.8) 83 (73.7) NS 
Median Age (years) 33.6 35.2 NSc 37.0 32.9 NSc
New Casesd 225 (59.1) 810 (59.7) NS 23 (32.4) 30 (26.5) NS
Successfully treated 177 (78.7) 595 (73.5) NS
Treatment Interrupted 21 (9.3) 94 (11.6) NS
Treatment Failed 2 (0.9) 10 (1.2) NS
Died 3 (1.3) 25 (3.1) NS 2 (8.7) 2 (6.7) NS
Median Treatment Period (days) 186 190 NSc
Retreatment Casesd 145 522 48 82
Successfully treated 76 (52.4) 330 (62.2) 0.65 (0.45 to 0.94)P  = 0.026    
Treatment Interrupted 34 (23.4) 97 (18.6) NS
Treatment Failed 0 (0.0) 8 (1.5) NS
Died 5 (3.4) 18 (3.4) NS 6 (12.5) 6 (7.3) NS
Median Treatment Period (days) 222 225 NSc
NS = Not significant 
With the exception of ‘death’, standard outcome definitions were not available for drug-resistant cases and results could therefore not be reported. Results for other, non-listed outcomes 
are also not reported. Median treatment period could not be reported for drug-resistant cases as they are not necessarily exclusively treated at the community clinic. 
a Statistical analysis done using Fishers exact test except where otherwise specified 
b Extra sum-of-squares F-test; c Mann-Whitney U test; d 11 Beijing and 25 non-Beijing cases could not be classified as either ‘New’ or ‘Retreatment’ 
  
Table 2. Molecular epidemiological analysis of Beijing vs. non-Beijing drug-susceptible and drug-resistant cases. 
 Drug-susceptible Drug-resistant 
 Beijing Non-Beijing Odds Ratio
a (95% CI)
p-value Beijing Non-Beijing 
Odds Ratioa (95% CI)
p-value 
Casesb 352 995 63 63 
Strainsc 76 429 17 48 
Transmission chains 95 543 17 48 
Maximum transmission
chain clustersize 128 42  37 4  
Unique cases 64 399 12 39 
Clustered transmission
chains (clusters) 31 144  5 9  
Clustered transmission
chain cases 
(%) 
288 
(81.8) 
596 
(59.9) 
3.01 (2.23 to 4.06) 
P < 0.001 
51 
(81.0)
24 
(38.1) 
6.91 (3.08 to 15.51) 
P < 0.001 
Transmitted casesd 257 452 3.25 (2.49 to 4.24)P < 0.001 46 15 
8.66 (3.88 to 19.34)
P < 0.001 
Recent Transmission (%)e 73.0 45.4 73.0 23.8 
Clustering data and analysis is derived from transmission chains defined as cases having identical strains with inter-strain intervals of <2 years. 
a Statistical analysis done using Fishers exact test 
b Case numbers differ from those in table 1 for two reasons: 1) Cases classified as retreatment after failure/interruption were excluded. 2) Data for the Non-Beijing groups excluded cases 
from the LC clade (n=302) due to the poor resolution of IS6110 with fewer than 6 copies. Seven patients acquired resistance and were therefore counted in both the sensitive and 
resistant categories. 
c Some strains fall into both drug-susceptible and –resistant groups. 
d Cases in clusters – Number of transmission chains (corresponding to the index cases) 
e (Cases in clusters – Number of transmission chains) / Total number of cases (24) 
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In order to identify factors which may be associated with the observed increase in cases with drug-
susceptible Beijing genotype strains, we compared clinical and /or demographic parameters were 
compared between cases with Beijing and non-Beijing strains. Table 1 shows the comparisons for both 
drug-susceptible and drug-resistant strains. We found that cases with drug-susceptible Beijing strains 
had a significantly greater proportion of sputum smear-positive disease than cases with drug 
susceptible strains of other genotypes (Fisher’s exact test OR, 1.45; 95% CI, 1.08 to 1.96; P = 
0.013). There was no difference between the drug-resistant groups or between drug-resistant and 
drug-susceptible cases of the Beijing clade. Among the drug-susceptible cases, we found a weak 
association between male gender and Beijing genotype (Fisher’s exact test OR, 1.27; 95% CI, 1.01 to 
1.61; P = 0.045). Conversely, cases infected with drug-resistant Beijing strains were less likely to be 
male than drug-resistant non-Beijing-infected cases (Fisher’s exact test OR, 0.53; 95% CI, 0.29 to 
0.98; P = 0.046). Within the Beijing clade, drug-susceptible cases were more likely to be male than 
drug resistant cases (Fisher’s exact test OR, 1.74; 95% CI, 1.05 to 2.90, P = 0.035). With the 
exception of a slightly lower rate of successful treatment for drug-susceptible re-treatment cases of the 
Beijing clade (Fisher’s exact test OR, 0.65; 95% CI, 0.45 to 0.94, P  = 0.026), no differences between 
Beijing and non-Beijing-infected cases could be found in terms of episode outcome, the proportion of 
new vs. retreatment cases (Fisher’s exact test), and median duration of treatment or median age at 
diagnosis (Mann-Whitney U test). There was also no difference between the rates of growth of new vs. 
retreatment cases of drug-susceptible Beijing-infected cases (Extra sum-of-squares F-test). 
To determine whether clade specific pathogenicity factors (ability to spread and cause disease) were 
associated with the increase in incidence of cases with Beijing genotype strains, the molecular 
epidemiological characteristics of the Beijing and non-Beijing strains were analysed. Both drug-
susceptible and resistant Beijing strains were more often clustered than non-Beijing strains, (Fisher’s 
exact test OR, 3.01; 95% CI, 2.23 to 4.06; P < 0.001, and OR, 6.91; 95% CI, 3.08 to 15.51; P < 
0.001 respectively) (Table 2). This implies a higher rate of transmission for both groups and suggests 
that Beijing genotype strains are more likely to spread and cause disease that non-Beijing strains. 
Discussion 
In this 12-year, longitudinal study of an urban community with a high incidence of TB, we have 
analysed the temporal dynamics of the prevalent M. tuberculosis clades. We demonstrate that the 
bacterial population structure has changed significantly over time. This was largely due to an increase 
in the incidence of cases with Beijing genotype strains. A previous worldwide survey of the Beijing 
clade also found that these strains were emerging, both in South Africa and other countries, including 
Argentina, Cuba, Malawi, Vietnam, the countries of the former Soviet Union and parts of Western 
Europe 31. In some of these countries the emergence of this genotype was highly associated with drug 
resistance. In our longitudinal study, the superior rate of increase of this clade was exclusively due to 
drug-susceptible strains and was common to all sub-lineages tested. Hence, the acquisition of drug-
resistance and the subsequent transmission of resistant strains of M. tuberculosis cannot account for the 
observed rise in the number of Beijing genotype cases. We cannot, however, exclude the possibility of 
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increased drug tolerance in Beijing strains, although this might be expected to lead to an increased 
rate of treatment failure in this clade, which was not observed (data not shown). Accordingly, we 
propose that the drug-susceptible Beijing strains represent a highly pathogenic genotype when 
compared to drug-susceptible strains from the other clades present in the study community. Our 
analysis has also shown, by a reduction in the rate of generation of new cases, that the evolution of 
drug-resistance has had a strong influence on the pathogenicity of Beijing genotype strains, thereby 
confirming that the mutations conferring resistance incur a significant fitness cost 32. In spite of this, 
however, these drug-resistant Beijing strains have remained as pathogenic as most drug-susceptible 
non-Beijing strains. In addition, from the fact that the drug-susceptible and drug-resistant Beijing 
strain groups show the same degree of clustering, it is apparent that the attenuation of the latter is in 
the rate and/or likelihood of their progression to active disease rather than their ability to transmit. A 
similar loss of fitness, following the acquisition of drug-resistance, was seen for strains of the LC and 
LAM clades, although this was not statistically significant for the latter. Case numbers were too low in 
the other clades to make any meaningful observations. We found that drug-resistant Beijing strains 
showed a higher level of transmissibility when compared to drug-resistant non-Beijing strains, 
supporting the notion of the superior overall fitness of the former despite the resistance-derived fitness 
loss mentioned above (Table 2). It should be noted that estimates of transmission assume equivalence 
in the marker’s discriminatory power for the different clades. Thus, if the IS6110 RFLP pattern of the 
Beijing clade strains were more stable than those of other strains, as has been suggested by van 
Soolingen, et al.33, it would result in an apparently higher rate of transmission for the former. 
Our attempt to identify factors which could explain the increased pathogenicity of the Beijing clade 
showed that higher levels of bacilli were present in the sputum specimens of patients infected with 
these strains. However, this difference was small and is therefore unlikely to explain fully the 
magnitude of the observed growth rate. 
The lower rate of successful treatment in drug-susceptible Beijing-infected, retreatment cases may 
contribute to the success of this clade, but this observation is probably too small to fully account for 
it’s success. Furthermore, this was not observed for new cases. Therefore, we propose that Beijing 
genotype strains have evolved properties which enhance their propensity to cause disease following 
infection compared to other clades. This hypothesis is supported by results from studies in BALB/c 
mice, co-infected with Beijing (HN878) and non-Beijing (CDC1551) strains, which have 
demonstrated differential growth rates with the Beijing strain growing more rapidly 34. Further 
support comes from the recent observation that, while Beijing-type strains transmit equally as well as 
strains of other clades, they have a greater propensity to cause active disease after infection 35. This 
may be explained by the Beijing strains’ reported ability to modulate the host immune system in 
favour of a Th2 response while non-Beijing strains tend to induce a Th1 response 36. Reed et al. 
determined that an important factor in this ability is the presence in Beijing strains of an intact pks1-
15 gene, responsible for the production of phenolic glycolipids, which inhibit the release of pro-
inflammatory factors by monocyte-derived macrophages 37. Subsequently, it has been shown that, 
while the pks1-15 gene product plays a role in host immune modulation, it is neither required nor 
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solely sufficient for hyper-virulence 38. In addition, Theus et al. reported that virulent Beijing strains 
show increased growth in macrophages and inhibition of TNF- release 39. 
It has also been suggested that the success of Beijing genotype strains is due to their ability to evade 
the protective effect of BCG vaccination 40. It is therefore tempting to speculate that the same may 
apply to the relative success of the Beijing clade in high TB incidence communities where many, if not 
most, of the residents have been naturally vaccinated by infection. However, our attempt to 
substantiate this failed to demonstrate that Beijing genotype strains were more likely to cause re-
infection after a previous episode of disease (data not shown). The possibility must be acknowledged, 
however, that recent, prior disease may (at least in the short-term) predispose the patient to 
susceptibility towards re-infection rather than providing protection against re-infection 41. In addition, 
the extremely high rate of infection may itself militate against any attempt to demonstrate this 
phenomenon in this community. 
We conclude that the Beijing clade is particularly well adapted to the conditions prevalent in this high 
incidence community. The emergence of Beijing genotype strains with increased pathogenicity may have 
important implications for the Tuberculosis Control Program. Early diagnosis and effective treatment is 
essential to curb the spread of these strains. In addition, contact tracing may have added value, although this 
poses great challenges in TB endemic regions. Furthermore, it is important to ensure that future vaccines 
provide adequate protection against these strains. The observation that drug-resistant Beijing strains retain a 
higher level of pathogenicity/fitness is a cause for concern and implies that novel intervention strategies are 
necessary to control the spread of drug-resistance. This can be achieved by the development and 
implementation of rapid diagnostics, provision of appropriate therapy, ensuring treatment adherence 
and intensified screening of contacts. However, in order for diagnosis and treatment to be effective it 
is essential that communities are educated to improve health seeking behaviour and thus minimise 
diagnostic delay and the opportunity for transmission. 
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Table S1. Clinical and demographic analysis by clade of drug-susceptible and drug-resistant cases. 
With the exception of ‘death’, standard outcome definitions were not available for drug-resistant cases and results could therefore not be reported. Results for other, non-listed 
outcomes are also not reported. Median treatment period could not be reported for drug-resistant cases as they are not necessarily exclusively treated at the community clinic. 
Cases that could not be classified as either ‘New’ or ‘Retreatment’ are not reported.  
Clade Beijing 
n (%) 
Haarlem 
n (%) 
LAM 
n (%) 
LC 
n (%) 
Quebec 
n (%) 
Other 
n (%) 
 S R S R S R S R S R S R 
Cases 381 (19.8) 71 (3.7) 130 (6.8) 4 (0.2) 513 (26.7) 31 (1.6) 299 (15.6) 44 (2.3) 131 (6.8) 10 (0.5) 283 (14.7) 24 (1.3) 
Doubling Time (years)
95% CI 
3.9
2.89 to 6.19 
252.0 
11.3 to +∞ 
-82.6
-∞ to -18.5
-1.4
-∞ to -0.6 
25.5
7.9 to +∞ 
-8.9
-∞ to -3.4 
13.0 
6.3 to +∞ 
-4.5
-15.0 to -2.6
-12.7
-∞ to -4.9 
-3.2
-∞ to -1.4 
-21.7
-∞ to -6.8 
-10.1 
-∞ to -3.7 
Reproductive rate [K 
+ 1] (1/years) 
1.178 1.003 0.992 0.507 1.027 0.924 1.053 0.847 0.947 0.782 0.97 0.933 
Male 239 (62.7) 35 (49.3) 60 (46.2) 4 (100) 311 (60.6) 22 (71.0) 169 (56.5) 23 (52.3) 65 (49.6) 7 (70.0) 169 (59.7) 17 (70.8) 
Smear positive 301 (79.0) 51 (71.8) 96 (73.9) 4 (100) 370 (72.1) 22 (71.0) 227 (75.9) 30 (68.2) 89 (67.9) 8 (80.0) 199 (70.3) 19 (79.2) 
Median Age (years) 33.6 37.0 35.7 32.9 34.2 33.5 35.8 28.4 35.7 36.1 36.7 33.1 
New Cases 225 (59.1) 23 (32.4) 79 (60.8) 0 (0.0) 331 (64.5) 6 (19.4) 165 (55.2) 17 (38.6) 80 (61.1) 4 (40.0) 155 (54.8) 3 (12.5) 
Successfully 
treated 177 (78.7) - 62 (78.5) - 252 (76.1) - 112 (67.9) - 57 (71.3) - 112 (72.3) - 
Treatment 
Interrupted 
21 (9.3) - 8 (10.1) - 30 (9.1) - 26 (15.8) - 15 (18.8) - 15 (9.7) - 
Treatment Failed 2 (0.9) - 0 (0.0) - 4 (1.2) - 2 (1.2) - 1 (1.3) - 3 (1.9) - 
Died 3 (1.3) 2 (8.7) 2 (2.5) 0 (0.0) 7 (2.1) 0 (0.0) 9 (5.5) 0 (0.0) 2 (2.5) 1 (25.0) 5 (3.2) 1 (33.3) 
Median Treatment
Duration (days) 
186  195  190  189  189  191  
Retreatment Cases 145 48 50 4 169 24 129 27 48 6 126 21 
Successfully 
treated 76 (52.4) - 32 (64.0) - 116 (68.6) - 81 (62.8) - 29 (60.4) - 72 (57.1) - 
Treatment 
Interrupted 
34 (23.5) - 5 (10.0) - 31 (18.3) - 29 (22.5) - 11 (22.9) - 21 (16.7) - 
Treatment Failed 0 (0.0) - 1 (2.0) - 1 (0.6) - 1 (0.8) - 0 (0.0) - 5 (4.0) - 
Died 5 (3.5) 6 (12.5) 2 (4.0) 0 (0.0) 4 (2.4) 1 (4.2) 5 (2.3) 4 (14.8) 2 (4.2) 1 (16.8) 5 (4.0) 0 (0.0) 
Median Treatment
Duration (days) 
222  227  229  231  214  219  
  
Table S2. Molecular epidemiological analysis by clade of drug-susceptible and drug-resistant cases 
Clade Beijing Haarlem LAM LC Quebec Other  
 S R S R S R S R S R S R 
Strains 76 17 42 2 198 19 16 9 59 9 130 18 
Transmission chains 95 17 54 2 256 20 23 10 74 80 159 18 
Max transmission chain 
clustersize 128 37 41 1 42 4 - - 8 2 13 4 
Unique cases 64 12 42 2 185 16 11 5 55 6 117 15 
Clustered transmission 
chains (clusters) 31 5 12 0 71 4 12 5 19 2 42 3 
Clustered transmission 
chain cases 
(%) 
288 
(81.8) 
51 
(81.0) 
83 
(66.4) 
0 
(0.0) 
396 
(61.5) 
11 
(40.7) - - 
66 
(54.5) 
4 
(40.0) 
151 
(56.3) 
9 
(37.5) 
Recent Transmission (%) 73.0 73.0 56.8 0.0 46.8 25.9 - - 38.8 20.0 40.7 25.0 
Clustering data and analysis is derived from transmission chains defined as cases having identical strains with inter-strain intervals of <2 years. 
Cases classified as retreatment after failure/interruption were excluded. 
Clustering analysis for the LC clade could not be done due to the poor resolution of IS6110 with fewer than 6 copies 
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Figure S1. Annual incidence of drug-susceptible cases belonging to the 5 major M. tuberculosis clades with the 
remaining cases grouped as ‘Other’. Calculated doubling times in years: Beijing (♦) = 3.89, LAM (■) = 25.49, 
LC () = 13.01, Haarlem (8) = -82.57, Quebec (▲) = -12.72, Other (○) = -21.72 
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Figure S2. Annual incidence of drug-resistant cases belonging to the 5 major M. tuberculosis clades with the 
remaining cases grouped as ‘Other’. Calculated doubling times in years: Beijing (♦) = 252, LAM (■) = -8.90, LC 
() = -4.48, Haarlem (8) = -1.40, Quebec (▲) = -3.15 
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Abstract 
This study describes a comparative analysis of Beijing Mycobacterial Interspersed Repetitive Unit 
(MIRU) types of Mycobacterium tuberculosis isolates from Cape Town (South Africa) and East Asia. The 
results show a significant association between the frequency of occurrence of strains from defined 
Beijing sublineages and the human population from whom they were cultured [P<0.0001]. 
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Main Text 
Mycobacterium tuberculosis strains with the Beijing genotype have been shown to be globally widespread 
and are particularly prevalent in East Asia, where over 80% of strains from the Beijing region are of 
this genotype (5). It has been hypothesized that Beijing strains have evolved unique properties 
including the ability to evade the protective effect of BCG vaccination (19) and the ability to spread 
more efficiently than non-Beijing strains (2). However, clinical presentation of tuberculosis caused by a 
Beijing strain was found to vary between different geographical settings (3-5,16). Currently it is not 
known whether the observed variability in clinical presentation is a function of the Beijing strain 
population found in particular geographical settings, a function of the genetic composition of the 
human population, or a combination of these two variables. 
This study aimed to test the hypothesis that host-pathogen compatibility determined the Beijing 
strain population structure in different host populations in different geographical settings. M. 
tuberculosis cultures from patients of mixed ancestry (14) who were resident in Cape Town, South 
Africa (20), were classified as Beijing genotype by spoligotyping (10). Beijing strains were assigned to 
phylogenetic sublineages as previously described (8) and were genotyped by MIRU typing (17). 
During the study period January 1993 to December 2004, twenty-five MIRU types were identified 
among 321 tuberculosis cases with a Beijing strain (Table 1). A comparison between the MIRU type 
data from Beijing strains from Cape Town and previously published MIRU type data from Beijing 
strains from East Asia (1,9,12,13,15,18) showed that 9 of the Beijing MIRU types were shared 
between these geographical settings (MT01, MT08, MT11, MT18, MT19, MT21, MT28, MT33 and 
MT54) (Table 1). This suggests that the 9 shared Beijing MIRU types represent founder strains that 
were introduced into Cape Town from East Asia, as the latter is thought to be the evolutionary origin 
of strains with a Beijing genotype (5,7,12). The definition of founder MIRU types was supported by 
their disproportionately high number (n = 267) as compared to those with non-founder MIRU types 
(n = 54) in tuberculosis patients from Cape Town [z-test for the hypothesis that proportion of 
founder MIRU types = 0.5, P = 0.001]. 
Superposition of the Beijing MIRU type data onto the previously described phylogenetic tree of the 
Beijing strain family (8) provided a framework to predict the evolutionary order in which the 25 
Beijing MIRU types had evolved (Figure 1). From this prediction the Beijing MIRU types could be 
partitioned into 7 Beijing sublineages. The number of founder Beijing MIRU types was variable 
among the different Beijing sublineages (Figure 1). Twenty-four of the Beijing MIRU types were 
unique to their respective sublineages, while the remaining Beijing MIRU type (MT11) was shared by 
three different sublineages 2, 3 and 6 (Figure 1 and Table 1). Suggesting that MT11 was an ancestral 
Beijing MIRU type (12) 
To determine the propensity of Beijing strains from different sublineages to spread in the human 
population in Cape Town, the number of cases in circulation within each sublineage was compared to 
the number of founder strains for that sublineage (Table 1). The number of representatives of these 
founder strains was shown to be over-represented in sublineage 7 (n = 233 cases from 1 founder 
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strain) vs. sublineage 1 to 6 (n = 88 cases from 8 founder strains) [z-test for the hypothesis that 
proportion of sublineage 7 cases = 0.11 (1/9), P =0.001]. In comparison, the founder Beijing MIRU 
types MT01, MT08, MT11, MT18, MT19 MT21, MT33 and MT54 were over-represented in the 
human population in East Asia as compared to South Africa [China (73/130), Hong Kong (108/211), 
Vietnam (25/37) and Singapore (45/56) vs. Cape Town (79/321); Fisher’s exact test Odds Ratio (OR) 
= 4.20; CI95% 3.06 to 5.77, P =0.0001)]. 
A significant association was observed between the frequency of occurrence of strains from defined 
Beijing sublineages and the human population from whom they were isolated [sublineage 1 to 6, Cape 
Town (n = 88) and East Asia (n = 253) vs. sublineage 7, Cape Town (n = 233) and East Asia (n = 
43); Fisher’s exact test OR = 15.58; CI95% 10.38 to 23.38, P =0.0001]. 
It is unlikely that these findings can be explained by multiple importations of founder strains from 
sublineage 7 in preference to founder strains from sublineages 1 to 6 given that immigrants to South 
Africa were derived from many different geographical regions in East Asia and that sublineage 7 
founder strains are less frequently observed in East Asia. Accordingly, we propose that the situation in 
Cape Town represents an approximation to a common starting point for all the introduced founder 
strains, with those best adapted to the local population spreading most efficiently. This could be due 
to the innate characteristics of the strains within defined Beijing sublineages or the local host 
population. Susceptibility to M. tuberculosis per se has frequently been associated with HLA genotype 
(11), and HLA allele frequencies are known to differ widely between human populations having 
different histories, with certain alleles totally absent in some populations. Our conclusion differs from 
that of Gagneux et al. (6) as we demonstrate that strains from a defined sublineage (subset of strains 
from an evolutionary lineage) may have been selected by a human population in a defined 
geographical setting. 
 
  
Table 1. Geographical distribution of Beijing MIRU types from Asia and South Africa. 
 
  
    Number of copies in polymorphic MIRU loci  Number of strains (%) 
MIRU 
type 
Beijing 
sublineage b 2 4 10 16 20 23 24 26 27 31 39 40   RUSc,d CHNd HKe VNMd SGPf BGDg CT-SA 
                                           
MT01a 4 2 2 3 3 2 5 1 7 3 4 3 3   1 (2.2) 5 (3.8) 7 (3.3)     2 (16.7) 1 (0.3)  
MT02 NA 2 2 3 3 2 5 1 5 3 5 3 3   27 (60.0) 2 (1.5) 4 (1.9)   2 (3.6) 7 (58.3)   
MT04 NA 2 2 3 2 2 5 1 5 3 5 3 3   1 (2.2)     1 (2.7)       
MT05 NA 2 2 3 3 2 5 1 4 3 5 3 3   1 (2.2)             
MT07 NA 2 2 3 3 2 5 1 5 3 6 3 3   2 (4.4)             
MT08a 6 2 2 3 2 2 5 1 7 3 5 3 3   1 (2.2) 2 (1.5) 3 (1.4)       2 (0.6)  
MT09 NA 2 2 3 3 2 5 1 7 3 5 3 1   1 (2.2)     1 (2.7)       
MT11a 
2 
2 2 3 3 2 5 1 7 3 5 3 3 
 
10 (22.2) 42 (32.3) 77 (36.5) 10 (27.0) 39 (69.6) 
 3 (0.9) 
3 
    
2 (0.6) 
6 8 (2.5) 
MT12 NA 2 2 1 3 2 5 1 7 3 5 3 3   1 (2.2) 1 (0.8)           
MT13 NA 2 2 3 3 2 6 1 7 1 5 3 1      8 (3.8) 1 (2.7)       
MT14 NA 2 2 3 3 2 5 1 7 3 6 3 3    2 (1.5) 3 (1.4) 1 (2.7) 2 (3.6)     
MT16 NA  2  2 3 3 2 5 1 7 3 5 3 2    5 (3.8) 12 (5.7)   5 (8.9)     
MT17 NA 2 2 3 4 2 5 1 7 3 5 3 3    1 (0.8)     1 (1.8)     
MT18a 6 2 2 3 3 2 5 1 7 3 5 4 3    2 (1.5) 5 (2.4)   2 (3.6)   7 (2.2) 
MT19a 5 2 0 3 3 2 5 1 7 3 5 3 3      2 (0.9) 1 (2.7)     39 (12.1) 
MT20 7 2 2 2 3 2 5 1 7 4 5 4 3              19 (5.9) 
MT21a 6 2 2 3 3 2 5 1 8 3 5 3 3    4 (3.1) 6 (2.8) 2 (5.7) 4 (7.1)   13 (4.0) 
MT25 7 2 2 2 3 2 5 1 7 3 3 4 3        18 (5.6) 
MT26 6 2 2 3 3 2 5 1 7 3 5 4 4              1 (0.3) 
MT27 7 2 2 2 3 2 5 1 3 3 5 4 3        1 (0.3) 
MT28a 7 2 2 2 3 2 5 1 7 3 5 4 3    16 (12.3) 23 (10.9) 4 (10.8)     189 (58.9) 
MT29 6 2 2 3 3 2 5 1 7 4 5 3 3              1 (0.3) 
MT33a 6 NA 2 3 3 NA NA NA 6 3 5 3 3    11 (8.5) 4 (1.9) 12 (32.4)     3 (0.9) 
MT37 NA NA 2 3 3 NA NA NA 2 3 5 3 3    2 (1.5)       1 (8.3)   
MT43 NA NA 2 3 3 NA NA NA 6 3 4 3 3            2 (16.7)   
MT44 NA NA 2 2 3 NA NA NA 7 3 5 3 3    6 (4.6) 9 (4.3) 1 (2.7)       
MT47 NA NA 2 3 3 NA NA NA 7 1 5 3 1    3 (2.3) 6 (2.8) 3 (8.1)       
MT48 NA NA 2 3 3 NA NA NA 4 3 4 3 3    2 (1.5)           
  
RUS – Russia; CHN – China; HK – Hong Kong; VNM – Vietnam; SGP – Singapore; BGD – Bangladesh; CT-SA – Cape Town South Africa 
NA – not available, a founder MIRU types , b according to (8), c according to (13), d according to (12), e according to (9), f according to (15), g according to (1) 
    Number of copies in polymorphic MIRU loci  Number of strains (%) 
MIRU 
type 
Beijing 
sublineage b 2 4 10 16 20 23 24 26 27 31 39 40   RUSc,d CHNd HKe VNMd SGPf BGDg CT-SA 
MT49 NA NA 2 7 2 NA NA NA 7 3 4 3 3    3 (2.3)           
MT50 NA NA 2 5 2 NA NA NA 7 3 4 3 3   2 (1.5)      
MT51 NA NA 2 3 2 NA NA NA 5 1 5 3 3   2 (1.5)      
MT52 NA NA 2 3 3 NA NA NA 6 3 5 3 2   2 (1.5)      
MT53 NA NA 2 3 3 NA NA NA 7 3 5 1 3    2 (1.5)           
MT54a 6 NA 2 3 3 NA NA NA 7 3 5 2 3    7 (5.4) 4 (1.9)        1 (0.3) 
MT55 NA NA 2 2 3 NA NA NA 5 3 3 4 3    2 (1.5)           
MT56 NA NA 2 2 3 NA NA NA 9 3 5 4 3    2 (1.5)           
MT57 NA NA 2 2 3 NA NA NA 7 3 5 2 3    2 (1.5)           
MTSing76 NA 2 2 6 2 2 5 1 7 3 4 3 3          1 (1.8)     
MTZAF1 1 2 2 3 3 2 5 1 6 3 5 3 1              1 (0.3) 
MTZAF2 5 2 3 3 3 2 5 1 7 3 5 3 3              1 (0.3) 
MTZAF3 6 2 2 3 3 2 5 1 7 2 5 3 3              3 (0.9) 
MTZAF4 6 2 2 3 3 2 5 1 5 3 5 3 3        1 (0.3) 
MTZAF5 6 2 2 4 3 2 6 1 5 3 3 2 3        1 (0.3) 
MTZAF6 7 2 2 2 3 2 5 1 7 4 4 4 3        1 (0.3) 
MTZAF7 7 2 2 2 3 2 5 1 8 4 5 4 3        1 (0.3) 
MTZAF8 7 2 2 2 3 2 5 1 9 3 5 3 3        1 (0.3) 
MTZAF9 7 2 2 2 3 2 5 1 7 3 4 4 3        1 (0.3) 
MTZAF10 7 2 2 2 3 2 5 1 5 3 5 4 3        1 (0.3) 
MTZAF11 7 2 2 4 3 2 5 1 5 3 3 2 3        1 (0.3) 
MTHK1 NA 2 2 3 3 2 5 1 7 3 5 3 4    6 (2.8)     
MTHK2 NA 2 2 3 3 2 5 1 7 3 5 5 3    5 (2.4)     
MTHK3 NA 2 2 3 4 2 5 1 7 3 5 3 2    5 (2.4)     
MTHK4 NA 2 1 3 3 2 5 1 7 3 5 3 3    4 (1.9)     
MTHK5 NA 2 2 3 3 2 5 1 6 3 5 3 4    3 (1.4)     
MTHK6 NA 2 0 3 3 2 5 1 7 3 5 3 4    3 (1.4)     
MTHK7 NA 2 2 3 3 2 5 1 7 3 5 4 2    2 (0.9)     
MTHK8 NA 2 2 3 3 2 5 1 8 3 5 5 3    2 (0.9)     
MTHK9 NA 2 2 2 3 2 5 1 7 3 5 3 2    2 (0.9)     
MTHK10 NA 2 2 3 3 2 5 1 6 3 7 3 3    2 (0.9)     
MTHK11 NA 2 2 3 3 2 2 1 7 4 4 3 3    2 (0.9)     
MTHK12 NA 2 2 2 3 2 5 1 7 3 5 4 4      2 (0.9)         
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Figure 1. Evolutionary scenario of Beijing MIRU types according to Beijing sublineages. Beijing MIRU types 
were grouped according to their respective Beijing sublineages (8) and the most parsimonious evolutionary order 
was proposed. Beijing MIRU types are indicated within each box. Founder Beijing MIRU types are indicated by a 
bold box. Unknown Beijing MIRU types are indicated by “?”.  
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In summary, the global success of the Beijing lineage may reflect either the selection of defined 
sublineages in different geographical settings by distinct human populations, or the adaptation of 
strains in a defined sublineage to spread more readily in a distinct human population. We 
acknowledge that these contrasting conclusions cannot be easily distinguished with the data available. 
However, the emergence of a sublineage of Beijing strains with increased pathogenicity may have 
important implications for the Tuberculosis Control Program. Early diagnosis and contact tracing will 
be essential to curb the spread of these strains. Furthermore, it will be important to ensure that future 
vaccines protect against these strains. 
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ABSTRACT 
IS6110-Restriction Fragment Length Polymorphism (RFLP) genotyping is the most widely used 
genotyping method to study the epidemiology of Mycobacterium tuberculosis. However, due to the 
complexity of the IS6110-RFLP genotyping technique and the interpretation of RFLP data, Mycobacterial 
Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat (MIRU-VNTR) genotyping has been 
proposed as the new genotyping standard. This study aimed to determine the discriminatory power of 
different MIRU-VNTR locus combinations relative to IS6110-RFLP genotyping, using a collection of 
Beijing genotype M. tuberculosis strains with a well established phylogenetic history. Clustering, diversity 
index, clustering concordance, concordance among unique genotypes, divergent and convergent evolution 
were calculated for 7 combinations of 27 different MIRU-VNTR loci and compared to IS6110-RFLP. Our 
results confirmed previous findings that MIRU-VNTR genotyping could be used to estimate the extent of 
recent or ongoing transmission. However, molecular epidemiological linking of cases varied significantly 
depending on the genotyping method used. We conclude that IS6110-RFLP and MIRU-VNTR loci 
evolve independently and at different rates which leads to discordance between transmission chains 
predicted by the respective genotyping methods. Concordance between the two genotyping methods 
could be improved by the inclusion of genetic distance into the clustering formula for some of the MIRU-
VNTR loci combinations. In summary, our findings differ from previous reports, which may be explained 
by the fact that in low incidence settings, the genetic distance between epidemiologically unrelated 
isolates was sufficient to define a strain using either marker, whereas in high incidence settings, 
continuous evolution and persistence of strains revealed the weaknesses inherent to these markers. 
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INTRODUCTION 
Over the past two decades, molecular genotyping methods have enhanced our understanding of the 
epidemiology of tuberculosis (TB) in numerous geographical settings. These methods have enabled geo-
temporal tracking of Mycobacterium tuberculosis strains with the view to identifying source cases responsible 
for TB outbreaks (2), tracking of recent and ongoing disease transmission (31), distinguishing between re-
infection and relapse (28), evaluation of the effectiveness of Direct Observed Therapy Short-course 
(DOTS) based TB control programs (4,16), and identification of global genetic lineages (6). Ideally, 
molecular genotyping tools should be inexpensive, highly discriminative, deliver rapid results, be 
straightforward to perform and produce easily interpretable results that allow for accurate inter-laboratory 
comparisons (universally comparable databases).  
Three genotyping methods are currently widely used in molecular epidemiological studies of TB: IS6110-
Restriction Fragment Length Polymorphism (RFLP) genotyping (27), spoligotyping (13) and 
Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat (MIRU-VNTR) 
genotyping (21,22). Currently, IS6110-RFLP genotyping is the most widely used genotyping method 
(27). However, this method is time-consuming, laborious and complex. Furthermore, differences in 
application can make inter-laboratory comparisons difficult and the data generated may have limitations 
(i.e. comparison of strains with high vs. low IS6110 copy numbers). More recently, the validity of the 
calculation of IS6110-RFLP clustering, as a surrogate for transmission, has been questioned as the IS6110 
banding pattern may change during transmission (33,35). A nearest genetic distance (NGD) model has 
been evaluated to incorporate IS6110 banding changes into the calculation of ongoing transmission (24). 
The term cluster has also been questioned in studies which have compared contact tracing data with 
IS6110-RFLP data (3,26). In response, numerous studies have been conducted to try to identify 
alternative methods that have the ability to accurately describe epidemiological events in different settings 
at a similar discriminatory level to that of IS6110-RFLP genotyping. One of the most promising methods 
is MIRU-VNTR genotyping, a PCR-based method for detecting the number of tandem repeats at a given 
genetic locus. Supply et al. (21) defined a set of 15 MIRU-VNTR loci for molecular epidemiological 
investigations and a set of 24 MIRU-VNTR loci for phylogenetic analysis of M. tuberculosis strains 
worldwide. In support of this, another study concluded that this “real-time” MIRU-VNTR genotyping 
approach was highly applicable for population-based studies (18). This view was reinforced by a study 
conducted in the Brussels region, where the authors concluded that a standardized MIRU-VNTR 
genotyping method could be a new reference for epidemiological and phylogenetic screening of M. 
tuberculosis strains (15).  
A study from Japan (9) investigated the differentiation power of the proposed 15- and 24-loci MIRU-
VNTR genotyping methods for strains with the Beijing genotype and concluded that the analysis of these 
loci were of limited use for discriminating strains of this genotype. In their study they showed that VNTR 
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loci 3820, 3232 and 4120 were highly polymorphic in Beijing genotype strains and thus proposed the use 
of these loci to enhance the discriminatory power of the proposed 15-MIRU-VNTR genotyping method. 
However, other studies have excluded these loci due to difficulties associated with the reproducibility of 
PCR amplification (14,21,36).  
Subsequently, a study in Hong Kong, which also examined strains of the Beijing genotypes, showed that 
a different combination of 12 VNTR and QUB (Queen’s University of Belfast) loci gave a Hunter-Gaston 
discriminatory index value which was almost equal to that obtained in IS6110-RFLP genotyping (11,12). 
However, this was refuted by a more recent study from China which suggests that MIRU-VNTR 
genotyping may over-estimate transmission in isolates with the Beijing genotype (10). Collectively, these 
findings suggest that the selection of MIRU-VNTR loci for optimal differentiation of M. tuberculosis 
requires further validation in different geographical settings. To date, the performance of the MIRU-
VNTR genotyping method has not been evaluated in an epidemic setting, nor has it been tested within 
the context of a robust M. tuberculosis phylogeny.  
In this study the discriminatory power of different MIRU-VNTR locus combinations was determined as 
previously described (7,9,21,22) and compared to the IS6110-RFLP genotyping method using a collection 
of Beijing genotype M. tuberculosis strains with a well established phylogenetic history (8). The results are 
discussed in the context of concordance between the different genotyping methods in their ability to 
define a strain and to accurately describe the epidemiology of TB in a high incidence setting.  
METHODS 
Study Population 
Sputum samples were collected during the period from January 1993 to December 2004 from new and 
retreatment TB patients who were resident and attending healthcare clinics in an epidemiological field 
site in Cape Town, South Africa (31). This study forms part of a larger, long-term molecular 
epidemiological project which has been approved by the ethics committee of Stellenbosch University. 
IS6110 RFLP fingerprinting 
M. tuberculosis isolates were cultured on MGIT (Becton Dickinson, USA) or Löwenstein-Jensen media and 
DNA was extracted as previously described (32). Each isolate was classified by IS6110-RFLP genotyping 
(27) and spoligotyping (13) using internationally standardized protocols. IS6110-RFLP patterns were 
analyzed using Gelcompar II (Applied-Maths, Sint_Martens_latem, Belgium) with tolerance settings 
allowing a 5% shift in lane position and a 0.6% variation in individual band position to compensate for 
minor technical error. Isolates were assigned as members of the Beijing genotype if they had the 
characteristic Beijing spoligotype (30). Only the first M. tuberculosis isolate from each case was included for 
subsequent analysis. Each Beijing isolate was grouped into one of seven phylogenetic sublineages 
according to 40 different genetic markers, as previously described (8). 
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DNA Sequencing 
The DNA sequence of the katG, rpoB, embB and rrs genes of isolates classified as members of the Beijing 
sublineage 5 were determined as previously described (19,25). 
MIRU-VNTR typing 
Twenty seven MIRU-VNTR loci were amplified by PCR as described previously (7,9,21,22). The number 
of repeats at each genomic locus was calculated according to the electrophoretic mobility of the 
corresponding PCR product (23). Alleles were assigned numerical values according to the number of 
repeats present in that genomic locus. Isolates were genotypically classified according to seven different 
MIRU-VNTR locus combinations (Table 1). 
Analytical Calculations 
Estimation of clustering: A cluster (representing either recent or ongoing transmission: < 2 year and 
unrestricted interval, respectively) was defined as a series of isolates having the same genotype (IS6110-
RFLP or MIRU-VNTR), while isolates with unique IS6110-RFLP or MIRU-VNTR genotypes were 
considered as representing reactivation or influx of disease into the study community (20). Secondary 
analyses which incorporated the concept of evolution during transmission were done using datasets 
(genotypes according to IS6110-RFLP or a particular MIRU-VNTR locus combination) in which isolates 
separated by a single evolutionary event were combined into transmission chains with a genetic distance 
of one (24). 
Estimation of genetic diversity: The genetic diversity for each individual MIRU-VNTR loci, each of the 
seven MIRU-VNTR locus combinations (Table 1) and the IS6110-RFLP fingerprints was calculated as 
, where xi is the frequency of the ith allele at the locus, n is the number of isolates 
in the sample, and the term n/(n - 1) is a correction for bias in small samples (17). 
Estimation of matching and mismatching concordance: Concordance between the IS6110-RFLP 
genotypes and the respective MIRU-VNTR genotypes was calculated as follows: Each isolate was paired 
with every other isolate in the dataset and their genotypes (IS6110-RFLP and MIRU-VNTR) were scored 
as either a match (identical) or mismatch (non-identical). Matching concordance between the respective 
genotyping methods was calculated according to the number of paired isolates having a match for both of 
the methods as a proportion of the total number of pairs having matching IS6110-RFLP genotypes. This 
is a measure of agreement between two methods as to whether any two isolates form part of the same 
transmission chain. Mismatching concordance was calculated as the number of paired isolates having non-
matching genotypes for both of the methods as a proportion of the total number of pairs having non-
matching IS6110-RFLP genotypes. This is a measure of agreement between two methods that any two 
isolates do not form part of the same transmission chain.  
))1/((1 2 −−= ∑ nnxh i
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Table 1. MIRU-VNTR locus combinations. 
 MIRU Locus Combinations 
 12-MIRUa 
12-MIRU 
+ ETR A, 
B, Cb 
12-MIRU + 
hyper-
variable 
loci 
15-MIRU-
VNTRc 
15-MIRU-
VNTR + 
hyper-
variable 
locid 
24-MIRU-
VNTRc 
24-MIRU-
VNTR + 
hyper-
variable 
loci 
MIRU02 z z z   z z 
MIRU04 z z z z z z z 
MIRU10 z z z z z z z 
MIRU16 z z z z z z z 
MIRU20 z z z   z z 
MIRU23 z z z   z z 
MIRU24 z z z   z z 
MIRU26 z z z z z z z 
MIRU27 z z z   z z 
MIRU31 z z z z z z z 
MIRU39 z z z   z z 
MIRU40 z z z z z z z 
VNTR1955    z z z z 
VNTR2165/ETR-A  z  z z z z 
QUB11b    z z z z 
QUB26b    z z z z 
VNTR0424    z z z z 
VNTR2401    z z z z 
VNTR4156    z z z z 
VNTR 3690    z z z z 
ETR-C  z  z z z z 
VNTR 2347      z z 
ETR-B  z    z z 
Mtub 34      z z 
QUB3232   z  z  z 
VNTR3820   z  z  z 
VNTR 4120   z  z  z 
zlocus included 
a according to (22), b according to (7), c according to (21), d according to (9), e this study 
Estimation of concordance among unique genotypes: Concordance between uniquely occurring 
IS6110 genotypes and the MIRU-VNTR genotypes was calculated as the proportion of isolates having 
unique IS6110 genotypes that also had unique MIRU-VNTR genotypes. 
Estimation of the number of convergent events: Convergent evolution was identified by drawing 
connecting lines between each IS6110-RFLP genotype and each MIRU-VNTR genotype for which 
isolates had been found having that genotype combination (Figure 1). Convergent evolution was defined, 
conservatively, as the existence of isolates representing each of the four possible combinations of two 
IS6110-RFLP genotypes (e.g. IS1 and IS2) and two MIRU-VNTR genotypes (e.g. M1 and M2) (Figure 1). 
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This scenario would only be possible if one of the MIRU-VNTR genotypes had evolved more than once, 
assuming that the chance of IS6110-RFLP genotype convergence was significantly lower than that of 
MIRU-VNTR genotype convergence. The validity of this method was confirmed by plotting the IS6110-
RFLP genotypes onto a phylogenetic tree constructed using the MIRU-VNTR data in combination with 
the neighbor-joining algorithm (data not shown) (34). 
Figure 1. An example of MIRU-VNTR (Mx) and IS6110 (ISx) genotypes. The connecting lines represent the 
MIRU-VNTR and IS6110 genotype combinations observed in M. tuberculosis isolates in the study 
setting. M1 and M2 are both linked to IS1 and IS2 and therefore represent a convergent event. 
Neither M3 nor M4 share common connections to more than one ISx with any other Mx. Their 
connecting lines therefore indicate simple, linear evolution. 
Estimation of the number of divergent events: A divergent evolutionary event was scored for each 
MIRU-VNTR genotype which existed in combination with only one IS6110-RFLP genotype and where 
this IS6110-RFLP genotype was found in combination with more than one MIRU-VNTR genotype 
(Figure 1). This implies that the MIRU-VNTR genotype arose subsequent to the IS6110-RFLP genotype. 
A divergence event was also added for each convergent event, since a convergent event implies a prior 
divergent event. 
Sensitivity and specificity calculations: The sensitivity and specificity (and positive and negative 
predictive values) of the IS6110-RFLP and respective MIRU-VNTR genotyping methods were calculated 
using Graphpad Prism 5 software (La Jolla, CA USA) for their ability to correctly identify an 
independently genotyped drug-resistant cluster. 
RESULTS 
IS6110-RFLP genotyping identified 74 different strains among the 321 isolates with the Beijing 
spoligotype collected over a 12 year period (Table 2). Of these strains, 272 were grouped into 25 clusters 
(containing between 2 and 100 isolates) and 49 were unique strains. The overall percent clustering was 
calculated to be 84.7% using the n/T formula (1). Each isolate was subsequently genotyped with 27 
MIRU-VNTR loci and analyzed according to 7 different MIRU-VNTR locus combinations (Table 1 and 
IS1
IS2
IS3
M1
M2
M3
M4
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Supplemental data). The performance of these locus combinations, in relation to the IS6110-RFLP 
genotyping method, was determined either over a 12-year period (Table 2) or over six consecutive 2-year 
periods (Table 3). In both analyses the traditional 12-MIRU loci genotyping method under-estimated the 
number of genotypes (strains) identified and thereby over-estimated the percentage of clustering (Table 2 
and 3). The inclusion of Exact Tandem Repeat (ETR) alleles A, B and C to the 12-MIRU loci set did not 
significantly improve the number of strains detected or the estimate of clustering (Table 2 and 3). 
Analysis of the isolates using the newly proposed 15- and 24-MIRU-VNTR locus combinations increased 
the number of strains identified, however, the discriminatory power of these locus combinations remained 
lower than that observed using IS6110-RFLP genotyping (Table 2 and 3). Consequently, these locus 
combinations over-estimated clustering. The addition of the VNTR loci 3232, VNTR 4120 and VNTR 
3820 to the 12-, 15- and 24-MIRU-VNTR locus combinations increased the number of strains detected 
and thereby produced clustering estimates similar to or slightly lower than that of IS6110-RFLP 
genotyping (Table 2 and 3). This implies that some MIRU-VNTR loci combinations could be selected as 
epidemiological markers to estimate the extent of both recent (<2 year interval) and ongoing 
transmission (unrestricted interval) in settings with a high incidence of strains with the Beijing genotype.  
To determine whether a correlation existed between the definitions of a strain according to IS6110-RFLP 
or MIRU-VNTR genotyping methods, the respective genotypes were compared. From the results shown 
in Table 2 it is evident that a strain classified as a cluster according to IS6110-RFLP genotyping, may in 
some instances be classified as unique according to the different MIRU-VNTR locus combinations or vice 
versa. Using a pair-wise analysis, we estimated the degree of matching concordance between the IS6110-
RFLP and MIRU-VNTR genotyping methods to range between 39% and 68% depending on the locus 
combinations used (Table 2 and 3). The inclusion of additional MIRU-VNTR loci decreased the degree of 
matching concordance, as a result of an increased rate of divergence caused by more rapid evolution, with 
the hyper-variable loci having the greatest effect. Conversely, the inclusion of additional loci increased the 
degree of mismatching concordance, as well as concordance between strains identified as having unique 
genotypes according to both genotyping methods (IS6110-RFLP and MIRU-VNTR). A consequence of 
more rapid evolution was the increased risk of convergent evolutionary events (Table 2).  
To determine whether concordance between the respective genotyping methods could be improved, the 
analysis was repeated to allow for genetic distance (GD) = 1, i.e. evolution of single MIRU-VNTR loci or 
single band changes in the IS6110 pattern within the definition of a cluster. The results showed that the 
inclusion of genetic distance had a significant influence on the MIRU-VNTR definition of a cluster, 
collapsing many of the genotypes (Table 2 and Supplemental data 1). This was less pronounced for 
IS6110-RFLP (Table 2 and Supplemental data 1). Matching concordance was improved by allowing for 
evolution of the MIRU-VNTR genotypes; however, mismatching concordance was concomitantly reduced 
for genotypes based on the 12-MIRU loci combinations. This may be explained by the loss of 
discriminatory power as a result of the collapsing of genotypes, associated with a low rate of evolution. In 
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contrast, mismatching concordance was improved for 15- and 24-MIRU-VNTR combinations due to the 
higher evolutionary rate of these markers. However, the concordance among unique genotypes remained 
low (Table 2). 
To establish which of the genotyping methods provided the most accurate description of ongoing 
transmission in the study setting, the largest group of drug-resistant isolates (found within sublineage 5) 
was selected, based on identical mutations conferring resistance to isoniazid, rifampicin, ethambutol and 
streptomycin (see Supplemental data 2). These isolates represent the continuing spread of a previously 
described MDR-TB outbreak (29). A total of 35 isolates were identified with the katG315 AGC to ACC, 
rpoB531 TCG to TTG, embB306 ATG to ATA and rrs513 CAG to CCG mutations, forming a single 
drug-resistance-based cluster (Figure 2). The sensitivity, specificity and positive and negative predictive 
values related to the ability of the different markers to identify the drug-resistant cluster are given in 
Table 4. While the sensitivities of all the markers were high, with some of those based on MIRU-VNTR 
loci outperforming IS6110-RFLP, the specificity of all MIRU-VNTR markers was substantially lower 
than that of IS6110-RFLP. The inclusion of genetic distance (single events) within the definition of a 
cluster appeared to improve the sensitivity of most of the markers, but concomitantly decreased the 
specificity of the MIRU-VNTR markers. The specificity of IS6110 was not affected by the inclusion of 
genetic distance. Positive predictive values were not significantly affected by allowing for evolution of the 
markers, however, with the exceptions of IS6110, which increased, and the 24 MIRU + 3 hyper-variable 
loci, which remained unchanged, the negative predictive values for all markers were reduced to zero. 
 
 
Figure 2. IS6110-RFLP banding patterns of Beijing sublineage 5 isolates sharing identical katG, rpoB, embB and rrs gene 
mutations. The isolate numbers are indicated in bold, while the IS6110-RFLP cluster number are indicated in 
standard text (these numbers correspond to the numbers given in the Supplemental data 2).  
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To determine whether MIRU-VNTR genotyping could be used as a method to phylogenetically group 
strains with the Beijing genotype, the correlation between MIRU-VNTR genotype and Beijing sublineage 
was quantified. As sublineages 3 and 4 and sublineages 5 and 6 were distinguished solely on the basis of 
IS6110 in our dataset, these two pairs of sublineages were combined for the purposes of this analysis. 
Table 2 shows that the respective MIRU-VNTR locus combinations correctly grouped >96% of the 
isolates according to their sublineage designation in comparison to the 100% of IS6110-RFLP 
genotyping. The incorporation of genetic distance reduced the ability of genotyping methods based on the 
12-MIRU locus combinations to correctly group isolates (Table 2). 
  
Table 2. Comparison between molecular epidemiological data generated over a 12 year interval by IS6110-RFLP and MIRU-VNTR 
genotyping methods 
a according to (22), b according to (7), c according to (21), d according to (9), e this study , f according to (15), N/A not applicable 
   MIRU-VNTR Locus Combinations 
  
IS6110-
RFLP 
12-MIRUa
12-MIRU 
+ 
ETR A, B, 
Cb
12-MIRU
+ hyper-
variable 
locie
15-MIRU-
VNTRc 
15-MIRU-
VNTR  
+ hyper-
variable locid
24-
MIRU-
VNTRc 
24-MIRU-
VNTR  
+ hyper-
variable locie
GD = 0 
Genotypes (n) 74 27 39 67 47 83 57 91 
Clustering (%) 84.7 95.0 91.2 84.1 89.4 78.8 87.2 77.3 
Unique IS6110 genotypes (n = 49) with  
unique MIRU-VNTR genotypes (n)
N/A 6 8 14 12 19 12 19 
Unique IS6110 genotypes (n = 49) with  
clustered MIRU-VNTR genotypes (n) 
N/A 43 41 35 37 30 37 30 
Clustered IS6110 genotype (n = 272) with 
unique MIRU-VNTR genotypes (n) 
N/A 10 18 38 22 49 28 54 
Clustered IS6110 genotype (n = 272) with 
clustered MIRU-VNTR genotypes (n) 
N/A 262 254 234 250 223 244 218 
Pair-wise matching concordance (%) 100 68 60 53 67 51 52 39 
Pair-wise mismatching concordance (%) N/A 69 72 71 68 71 73 81 
Concordance between unique strains (%) 100 20.4 22.4 28.6 34.7 40.8 40.8 42.9 
Converged genotypes (n) N/A 3 5 5 3 5 7 9 
Diverged genotypes (n) N/A 14 26 47 27 58 38 68 
Diversity indexf 0.85 0.63 0.67 0.7 0.63 0.7 0.72 0.78 
GD = 1 
Genotypes (n) 40 3 4 11 11 20 15 27 
Pair-wise matching concordance (%) 100 99 99 96 99 96 99 96 
Pair-wise mismatching concordance (%) N/A 2 3 8 80 82 83 88 
Concordance between unique strains (%) 100 0 4 4 15 30 22 41 
Beijing sublineage discrimination GD=0 (%) 100 96 96 99 99 99 99 99 
Beijing sublineage discrimination GD=1 (%) 99 1 1 3 99 99 99 99 
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Table 3. Comparison between molecular epidemiological data generated over six consecutive 2 year 
intervals by IS6110-RFLP and MIRU-VNTR genotyping methods 
  MIRU-VNTR Locus Combinations 
 
IS6110-
RFLP 
12-
MIRUa 
12-
MIRU 
+ 
ETR A, 
B, Cb 
12-MIRU 
+  
hyper-
variable 
locie  
15-
MIRU-
VNTRc 
15-MIRU-
VNTR  
+  
hyper-
variable 
locid 
24-
MIRU-
VNTRc 
24-MIRU-
VNTR 
+  
hyper-
variable 
locie 
Average No strains (range) 
 17.9  
(7-20) 
9.9 
(5-14) 
10.9 
(7-14) 
15.4 
(8-22) 
12.0 
(5-17) 
16.6  
(7-23) 
13.6  
(7-19) 
18.1 
(9-25) 
Average No clusters (range) 
6.1  
(4-10) 
4.6  
(2-7) 
4.9  
(3-7) 
4.0  
(2-6) 
3.7  
(2-5) 
3.6  
(2-6) 
4.6  
(3-6) 
4.3  
(3-7) 
Average % clustering (range) 
74.5  
(55.4-
86.7) 
85.1 
 (60.0-
93.1) 
83.1  
(60.0-
91.7) 
73.1  
(60.0-77.8)
80.3 
 (66.7-
93.1) 
70.7  
(57.6-76.4) 
77.8 
 (60.0-
89.7) 
67.7  
(54.5-75.0)
Average % pair-wise 
matching concordance 
(range) 
100 69.7 (60-80) 
63.7 
(44-72) 
52.7 
(40-58) 
68.2 
(45-78) 
51.0 
(22-63) 
55.0 
(44-69) 
40.2 
(22-51) 
Average % pair-wise mis-
matching concordance 
(range) 
N/A 
92.8 
(72-99) 
95.0 
(84-99) 
94.0 
(77-99) 
92.3 
(70-99) 
94.0 
(76-100) 
95.2 
(84-99) 
95.0 
(84-99) 
a according to (22); b according to (7); c according to (21); d according to (9); e this study; N/A not applicable  
  
Table 4. Sensitivity and specificity (and positive and negative predictive values) of the IS6110-RFLP and respective MIRU-VNTR 
genotyping methods for their ability to correctly identify an independently genotyped drug-resistant cluster characterized by unique 
mutations in the katG, rpoB, embB and rrs genes 
  MIRU-VNTR Locus Combinations
 IS6110-
RFLP 
12-MIRUa  
12-MIRU + 
ETR A, B, Cb 
12-MIRU  
+ hyper-variable 
locie  
15-MIRU-
VNTRc 
15-MIRU-VNTR 
+ hyper-variable 
locid 
24-MIRU-
VNTRc 
24-MIRU-VNTR 
+ hyper-variable 
locie 
GD=0 
Sensitivity 0.83 0.66 - 0.93 
1.00
0.90 - 1.00 
0.97
0.85 - 1.00 
0.80
0.63 - 0.92 
0.91
0.77 - 0.98 
0.74
0.57 - 0.88 
0.91
0.77 - 0.98 
0.74
0.57 - 0.88 
Specificity 
1.00 
0.48 - 1.00 
0.20
0.01 - 0.72 
0.20
0.01 - 0.72 
0.20
0.01 - 0.72 
0.40
0.05 - 0.85 
0.40
0.05 - 0.85 
0.40
0.05 - 0.85 
0.40
0.05 - 0.85 
Positive 
Predictive 
Value 
1.00 
0.88 - 1.00 
0.90 
0.76 - 0.97 
0.89 
0.75 - 0.97 
0.88 
0.71 - 0.96 
0.91 
0.77 - 0.98 
0.90 
0.73 - 0.98 
0.91 
0.77 - 0.98 
0.90 
0.73 - 0.98 
Negative 
Predictive 
Value 
0.45 
0.17 - 0.77 
1.00 
0.03 - 1.00 
0.50 
0.01 - 0.99 
0.13 
0.00 - 0.53 
0.40 
0.05 - 0.85 
0.18 
0.02 - 0.52 
0.400 
0.0534 - 0.85 
0.18 
0.02 - 0.52 
GD=1 
Sensitivity 
0.94 
0.81 - 0.99 
1.00
0.72 – 1.00 
1.00
0.72 – 1.00 
0.97
0.85 - 1.00 
1.00
0.72 – 1.00 
0.94
0.81 - 0.99 
1.00
0.72 – 1.00 
0.74
0.57 - 0.88 
Specificity 1.00 0.48 - 1.00 
0.00
0.00 - 0.54 
0.00
0.00 - 0.54 
0.00
0.00 - 0.52 
0.00
0.00 - 0.537 
0.00
0.00 - 0.52 
0.00
0.00 - 0.54 
0.40
0.05 - 0.85 
Positive 
Predictive 
Value 
1.00 
0.89 - 1.00 
0.88 
0.72 – 0.95 
0.88 
0.72 – 0.95 
0.87 
0.73 - 0.96 
0.88 
0.72 – 0.95 
0.87 
0.72 - 0.96 
0.88 
0.72 – 0.95 
0.90 
0.73 - 0.98 
Negative 
Predictive 
Value 
0.71 
0.29 - 0.96 ND ND 
0.00 
0.00 - 0.98 ND 
0.00 
0.00 - 0.84 ND 
0.18 
0.02 - 0.52 
Sensitivity, specificity and predictive values are given with their 95% confidence intervals 
a according to (22); b according to (7); c according to (21); d according to (9); e this study; ND: not determinable 
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DISCUSSION 
IS6110-RFLP genotyping is the most widely used genotyping method used to investigate and 
understand the epidemiology of M. tuberculosis (27). However, studies comparing IS6110-RFLP 
molecular epidemiological and contact tracing data, have questioned the validity of the definition of 
transmission (3,26). In order to address these concerns MIRU-VNTR genotyping using either 15- or 
24-MIRU-VNTR loci combinations have been extensively evaluated as the new genotyping standard 
for molecular epidemiological studies of M. tuberculosis (21). Concordance between MIRU-VNTR 
genotyping and contact tracing data was found to be superior to that of IS6110-RFLP in low 
incidence settings (15,18). However, these MIRU-VNTR locus combinations have not been fully 
tested in geographical regions where TB is endemic or within a robust M. tuberculosis phylogeny. Our 
results confirm previous findings (9,15,18,21) which have suggested that MIRU-VNTR genotyping, 
using carefully-selected locus combinations, could be used to estimate the extent of recent or ongoing 
transmission. The inclusion of the 3 hyper-variable loci improved the discriminatory power of the 
MIRU-VNTR genotyping method in this Beijing lineage, thereby supporting a previous suggestion 
for their inclusion (9). However, the use of these loci needs further evaluation in other evolutionary 
lineages as difficulties associated with amplification reproducibility have been reported (14,21,36). 
We conclude that the PCR-based MIRU-VNTR genotyping method could be applied as an 
epidemiological tool to measure the performance of a TB control program over time in a defined 
geographical setting. However, the observed concordance in the estimate of recent and ongoing 
transmission when using the IS6110-RFLP or MIRU-VNTR genotyping methods was only 
coincidental. A subsequent analysis of the MIRU-VNTR data, in comparison to the IS6110-RFLP 
genotyping data, revealed that the classification of a strain according to its genotype differed 
significantly depending on the genotyping method used. Accordingly our study showed that the 
degree of matching and mismatching concordance as well as concordance among unique strains was 
low. This led to discordance between the transmission chains predicted by the respective genotyping 
methods. Matching concordance increased when genetic distance was incorporated into the clustering 
calculation for all of the MIRU-VNTR combinations. However, this effect was offset in the case of 12-
MIRU-based markers by the concomitant reduction in mismatching concordance which was not the 
case for the 15- and 24-MIRU-VNTR combinations. From this, it is apparent that the additional loci 
included in the 15- and 24-MIRU-VNTR combinations (with or without the addition of the hyper-
variable loci) improved the overall concordance of MIRU-VNTR with respect to IS6110-RFLP. This 
may be due to these loci being inherently less stable and therefore more informative. However, a 
caveat to the inclusion of genetic distance in the clustering formula is that epidemiologically unrelated 
cases may be incorrectly linked within a transmission chain. 
Our analysis of the drug-resistant cluster to elucidate which of the genotyping methods provided the 
most accurate reflection of the epidemiology, highlighted shortcomings of both the IS6110-RFLP and 
MIRU-VNTR genotyping methods. This analysis supported a previous study which demonstrated 
that ongoing transmission was characterized by the evolution of variant IS6110-RFLP genotypes while 
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simultaneously preserving existing genotypes (33). A similar observation was found when using the 
different MIRU-VNTR locus combinations. This could be explained by the fact that the evolution of 
different loci could take place both convergently and divergently. Together, these results substantiate 
previous findings which have suggested that the definition of ongoing transmission according to 
IS6110-RFLP or MIRU-VNTR genotyping should include closely related genotypes (18,24,35). 
However, when allowing for single MIRU-VNTR changes within the definition of a cluster, the 
MIRU-VNTR genotyping method collapsed many of the sublineage 5 isolates into a limited number 
of clusters. As a result, most of the isolates were grouped as resistant, giving the method a high 
sensitivity, but in doing so, compromising specificity. In contrast, the identification of isolates within 
the drug-resistant cluster was largely retained by IS6110-RFLP despite the inclusion of genetic 
distance. This suggests that IS6110-RFLP in combination with genetic distance provides a more 
accurate reflection of ongoing transmission of this MDR-TB outbreak in this setting. This finding is 
important for the interpretation of molecular epidemiological data in settings where contact tracing is 
extremely difficult. However we acknowledge that the concordance between IS6110-RFLP and 
transmission needs further investigation in different settings and in M. tuberculosis strains with different 
genetic backgrounds. 
Our results differ from previous studies (15,18) which have demonstrated a close correlation between 
IS6110-RFLP and MIRU-VNTR genotyping. These studies were conducted in low incidence Western 
European settings where the TB epidemic is primarily driven by reactivation and immigration (5). In 
these settings, efficient TB control programs would largely prevent recent and ongoing transmission 
and the subsequent generation of closely related clonal variants. Thus genetic diversity is predicted to 
be preserved. In most instances, this would imply that the strains cultured from TB cases would be 
genetically distantly related and thus would not share either IS6110-RFLP banding patterns or 
MIRU-VNTR genotypes. Accordingly, MIRU-VNTR genotyping would discriminate strains at a level 
similar to that of IS6110-RFLP genotyping. In contrast, our high incidence setting has promoted the 
evolution of a large number of genetically closely related strains which are maintained within the host 
population. The genetic distance between these strains is often of such a nature that strains either have 
identical IS6110-RFLP genotypes and variant MIRU-VNTR genotypes or vice versa. Accordingly, we 
hypothesize that the degree of discordance between IS6110-RFLP and MIRU-VNTR genotyping is 
dependent on the genetic distance between isolates. This is supported by the observation that 
distantly related isolates from the different Beijing sublineages have evolved distinct IS6110-RFLP and 
MIRU-VNTR genotypes. 
In summary, we conclude that both IS6110-RFLP and MIRU-VNTR genotyping methods have 
limitations in defining chains of transmission of Beijing genotype M. tuberculosis strains in this high 
incidence setting.  
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Table S1. Cross-tabulation of marker genotypes 
The tables below show cross-tabulations of the numbers of cases classified into transmission chains 
according to IS6110 and each of the MIRU-VNTR combinations, allowing for evolution by single 
events in either marker. 
IS6110- 
RFLP 
 genotypes 
GD=1 
12-MIRU genotypes (GD=1) 
 
1 2 3 Total 
1 219 1  220 
2 1 
  
1 
3 1   1 
4 1 
  
1 
5 4   4 
6 33 
  
33 
7 1   1 
8 9 
  
9 
9 8   8 
10 1 
  
1 
11 1   1 
12 1 
  
1 
13 1   1 
14 1 
  
1 
15 2   2 
16 1 
  
1 
17 2   2 
18 1 
  
1 
19 3   3 
20 1 
  
1 
21 4  1 5 
22 1 
  
1 
23 1   1 
24 1 
  
1 
25 1   1 
26 1 
  
1 
27 2   2 
28 2 
  
2 
29 1   1 
30 1 
  
1 
31 2   2 
32 1 
  
1 
33 2   2 
34 1 
  
1 
35 1   1 
36 1 
  
1 
37 1   1 
38 1 
  
1 
39 1   1 
40 1 
  
1 
Total 319 1 1 321 
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IS6110- 
RFLP 
 genotypes 
GD=1 
12-MIRU + ETR A, B, C (GD=1) 
 
1 2 3 4 Total 
1 219 
 
1 
 
220 
2 1    1 
3 1 
   
1 
4 1    1 
5 4 
   
4 
6 33    33 
7 1 
   
1 
8 9    9 
9 8 
   
8 
10 1    1 
11 1 
   
1 
12 1    1 
13 1 
   
1 
14 1    1 
15 2 
   
2 
16 1    1 
17 2 
   
2 
18 1    1 
19 3 
   
3 
20 1    1 
21 4 
  
1 5 
22 1    1 
23 1 
   
1 
24 1    1 
25 1 
   
1 
26 1    1 
27 2 
   
2 
28 2    2 
29 1 
   
1 
30  1   1 
31 2 
   
2 
32 1    1 
33 2 
   
2 
34 1    1 
35 1 
   
1 
36 1    1 
37 1 
   
1 
38 1    1 
39 1 
   
1 
40 1    1 
Total 318 1 1 1 321 
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IS6110- 
RFLP 
 genotypes 
GD=1 
12-MIRU + hyper-variable loci (GD=1)  
1 2 3 4 5 6 7 8 9 10 11 Total 
1 216  1 1 1     1  220 
2 1 
          
1 
3 1           1 
4 1 
          
1 
5 4           4 
6 32 1 
         
33 
7 1           1 
8 9 
          
9 
9 8           8 
10 1 
          
1 
11 1           1 
12 1 
          
1 
13 1           1 
14 1 
          
1 
15 2           2 
16 1 
          
1 
17 2           2 
18 1 
          
1 
19 2        1   3 
20 1 
          
1 
21 4          1 5 
22 1 
          
1 
23 1           1 
24 1 
          
1 
25 1           1 
26 1 
          
1 
27 2           2 
28 2 
          
2 
29 1           1 
30 
       
1 
   
1 
31      1 1     2 
32 1 
          
1 
33 2           2 
34 1 
          
1 
35 1           1 
36 1 
          
1 
37 1           1 
38 1 
          
1 
39 1           1 
40 1 
          
1 
Total 311 1 1 1 1 1 1 1 1 1 1 321 
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IS6110- 
RFLP 
 genotypes 
GD=1 
15-MIRU-VNTR (GD-1) 
 
1 2 3 4 5 6 7 8 9 10 11 Total 
1 
 
219 
       
1 
 
220 
2  1          1 
3 1 
          
1 
4 1           1 
5 
 
4 
         
4 
6 33           33 
7 1 
          
1 
8 9           9 
9 8 
          
8 
10 1           1 
11 1 
          
1 
12 1           1 
13 1 
          
1 
14 1           1 
15 2 
          
2 
16 1           1 
17 2 
          
2 
18 1           1 
19 3 
          
3 
20 1           1 
21 4 
         
1 5 
22         1   1 
23 
 
1 
         
1 
24 1           1 
25 
    
1 
      
1 
26      1      1 
27 
      
2 
    
2 
28        2    2 
29 
 
1 
         
1 
30    1        1 
31 
  
2 
        
2 
32  1          1 
33 
 
2 
         
2 
34 1           1 
35 1 
          
1 
36  1          1 
37 1 
          
1 
38  1          1 
39 
 
1 
         
1 
40 1           1 
Total 77 232 2 1 1 1 2 2 1 1 1 321 
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IS6110- 
RFLP 
 genotypes 
GD=1 
15-MIRU-VNTR + hyper-variable loci (GD=1)  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total 
1    216 1 1 1            1  220 
2 
   
1 
                
1 
3                1     1 
4 
              
1 
     
1 
5    4                 4 
6 32 1 
                  
33 
7 1                    1 
8 9 
                   
9 
9 8                    8 
10 1 
                   
1 
11 1                    1 
12 1 
                   
1 
13 1                    1 
14 1 
                   
1 
15 2                    2 
16 1 
                   
1 
17 2                    2 
18 1 
                   
1 
19 2             1       3 
20 1 
                   
1 
21 4                   1 5 
22 
                 
1 
  
1 
23    1                 1 
24 1 
                   
1 
25          1           1 
26 
          
1 
         
1 
27            2         2 
28 
            
2 
       
2 
29    1                 1 
30 
        
1 
           
1 
31        2             2 
32 
   
1 
                
1 
33    2                 2 
34 1 
                   
1 
35   1                  1 
36 
   
1 
                
1 
37                 1    1 
38 
   
1 
                
1 
39    1                 1 
40 1 
                   
1 
Total 71 1 1 229 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 1 321 
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IS6110- 
RFLP 
 genotypes 
GD=1 
24-MIRU-VNTR (GD=1) 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Total 
1 
 
219 
           
1 
 
220 
2  1              1 
3 1 
              
1 
4 1               1 
5 
 
4 
             
4 
6 33               33 
7 1 
              
1 
8 9               9 
9 8 
              
8 
10        1        1 
11 1 
              
1 
12 1               1 
13 1 
              
1 
14       1         1 
15 
       
2 
       
2 
16 1               1 
17 2 
              
2 
18 1               1 
19 3 
              
3 
20        1        1 
21 
        
4 
     
1 5 
22             1   1 
23 
 
1 
             
1 
24 1               1 
25 
     
1 
         
1 
26          1      1 
27 
          
2 
    
2 
28            2    2 
29 
 
1 
             
1 
30    1            1 
31 
  
2 
            
2 
32  1              1 
33 
 
2 
             
2 
34 1               1 
35 1 
              
1 
36  1              1 
37 1 
              
1 
38  1              1 
39 
 
1 
             
1 
40     1           1 
Total 67 232 2 1 1 1 1 4 4 1 2 2 1 1 1 321 
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IS6110- 
RFLP 
genotypes 
GD=1 
24-MIRU-VNTR + hyper-variable loci (GD=1)  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Total 
1    216 1 1 1                   1  220 
2 
   
1 
                       
1 
3                      1      1 
4 
                    
1 
      
1 
5    4                        4 
6 32 1 
                         
33 
7 1                           1 
8 
        
9 
                  
9 
9          8                  8 
10 
               
1 
           
1 
11 1                           1 
12 1 
                          
1 
13 1                           1 
14 
              
1 
            
1 
15                2            2 
16 1 
                          
1 
17 2                           2 
18 1 
                          
1 
19 2            1               3 
20 
               
1 
           
1 
21                 4          1 5 
22 
                       
1 
   
1 
23    1                        1 
24 
                        
1 
  
1 
25              1              1 
26 
                 
1 
         
1 
27                   2         2 
28 
                   
2 
       
2 
29    1                        1 
30 
          
1 
                
1 
31        2                    2 
32 
   
1 
                       
1 
33    2                        2 
34 1 
                          
1 
35   1                         1 
36 
   
1 
                       
1 
37                       1     1 
38 
   
1 
                       
1 
39    1                        1 
40 
           
1 
               
1 
Total 43 1 1 229 1 1 1 2 9 8 1 1 1 1 1 4 4 1 2 2 1 1 1 1 1 1 1 321 
 
  
Table S2. Sublineage 5 drug-resistance mutations and MIRU-VNTR repeat numbers 
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Isolate N
o 
IS
6110 R
FLP 
Inh 
R
if 
katG
 m
utation  
rpoB
 m
utation   
em
bB 
rrs 
S
ubLineage 
M
IR
U
02 
M
IR
U
04 
M
IR
U
10 
M
IR
U
16 
M
IR
U
20 
M
IR
U
23 
M
IR
U
24 
M
IR
U
26 
M
IR
U
27 
M
IR
U
31 
M
IR
U
39 
M
IR
U
40 
V
N
TR
1955 
V
N
TR
2165 
Q
U
B
11b 
Q
U
B
26b 
V
N
TR
0424 
V
N
TR
2401 
V
N
TR
4156 
V
N
TR
3690 
E
TR
-C
 
V
N
TR
2347 
E
TR
-B
 
M
tub34 
Q
U
B
3232 
V
N
TR
3820 
V
N
TR
4120 
1945 551 S R         1 2 2 3 3 2 5 1 6 3 5 3 1 4 5 5 9 4 4 4 3 4 3 2 3 D A 9 
2701 515 NT NT         2 2 2 3 3 2 5 1 7 3 5 3 3 4 5 6 9 4 4 6 3 3 3 2 3 D C 9 
2704 515 NT NT         2 2 2 3 3 2 5 1 7 3 5 3 3 4 5 6 9 4 4 6 3 3 3 2 3 D C 9 
4690 660 S S         2 2 2 3 3 2 5 1 7 3 5 3 3 4 5 6 9 4 4 6 3 3 3 2 3 D C A 
1453 907 NT NT         3 2 2 3 3 2 5 1 7 3 5 3 3 4 5 6 9 4 4 6 3 3 3 2 3 D C 9 
4510 907 NT NT         3 2 2 3 3 2 5 1 7 3 5 3 3 4 5 6 9 4 4 5 3 3 3 2 3 D C 9 
1176 484 NT NT         4 2 2 3 3 2 5 1 7 3 4 3 3 6 5 5 7 4 4 4 3 3 3 2 3 F D B 
129 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
252 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
357 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
502 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 8 D 2 
513 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
553 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
698 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
785 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1028 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1098 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1154 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1281 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1306 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 3 D A 
1464 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1909 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
2024 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
2074 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 1 3 2 3 E D A 
2173 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 3 D A 
2236 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D 9 
2600 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 3 D A 
3096 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
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3111 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
3368 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
3568 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
3797 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
4344 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
4414 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 2 3 3 3 3 2 3 E D A 
5008 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
5516 213 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
953 218 S S WT WT not tested not tested 5 2 3 3 3 2 5 1 7 3 5 3 3 5 5 3 8 4 4 3 3 3 3 2 3 C D A 
1646 240 S S WT WT not tested not tested 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
819 294 S S WT WT not tested not tested 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1149 316 S R WT 526 (CAC to TAC) not tested not tested 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 3 8 4 4 3 3 3 3 2 3 E D A 
1944 405 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 2 3 3 3 3 2 3 C 3 A 
2125 535 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
2147 535 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
3556 606 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
3908 667 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
4158 716 R R 315 (AGC to ACC) 531 (TCG to TTG) 306 (ATG to ATA) 513 (CAG to CCG) 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 B 3 7 
4570 810 NT NT WT WT not tested not tested 5 2 0 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E D A 
1125 205 S S         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 5 6 4 4 3 3 3 3 2 3 D D 3 
407 206 S S         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 5 6 4 4 3 3 3 3 2 3 D D 3 
261 219 NT NT         6 2 2 3 3 2 5 1 6 3 5 3 3 5 4 5 8 4 4 3 3 3 3 2 3 D D A 
354 219 S S         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
1307 219 NT NT         6 2 2 3 3 2 5 1 6 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
1641 219 NT NT         6 2 2 3 3 2 5 1 6 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
5573 219 S S         6 2 2 3 3 2 5 1 5 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 C D A 
954 220 S S         6 2 2 3 3 2 5 1 8 3 5 3 3 5 4 5 8 4 4 3 3 3 3 2 3 D D A 
1716 220 S R         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 D D A 
1973 220 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
2332 220 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 2 3 3 3 3 2 3 D C A 
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3166 220 R S         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
4036 220 R S         6 2 2 3 3 2 5 1 8 3 5 3 3 5 4 5 8 4 4 3 3 3 3 2 3 C D A 
4104 220 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 C D A 
4473 220 R NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D A 
4493 220 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 C D A 
4576 220 R S         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 C D 2 
4880 220 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 C D A 
1189 223 R S         6 2 2 3 3 2 5 1 7 3 5 4 4 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
318 307 S S         6 2 2 3 3 2 5 1 7 3 5 4 3 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
1507 307 NT NT         6 2 2 3 3 2 5 1 7 3 5 4 3 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
204 319 S S         6 2 2 3 3 2 5 1 7 2 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 E 3 9 
919 319 S S         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 3 D A 
2387 319 S S         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 2 3 3 3 3 2 3 D D 9 
3514 319 NT NT         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 D 3 9 
700 322 NT NT         6 2 2 3 3 2 5 1 8 3 5 3 3 5 5 5 8 4 4 3 3 3 3 2 3 D D B 
1844 323 R NT         6 2 2 3 3 2 5 1 7 3 5 4 3 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
3027 323 NT NT         6 2 2 3 3 2 5 1 7 3 5 4 3 5 4 1 8 4 4 3 4 3 1 2 3 B D A 
4456 323 S S         6 2 2 3 3 2 5 1 7 3 5 4 3 5 5 1 8 4 4 3 3 3 1 2 3 C D A 
1696 343 NT NT         6 2 2 3 3 2 5 1 7 3 5 4 3 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
1823 345 NT NT         6 2 2 3 3 2 5 1 7 3 5 3 3 8 5 5 8 4 4 3 3 3 3 2 3 D D 9 
1892 402 NT NT         6 2 2 3 3 2 5 1 7 4 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 B D A 
3255 618 NT NT         6 2 2 4 3 2 6 1 5 3 3 2 3 4 5 3 7 4 4 3 1 3 3 2 1 3 8 2 
3361 618 S S         6 2 2 3 3 2 5 1 7 3 5 2 3 5 5 1 8 4 4 3 3 3 1 2 3 D D A 
3654 618 NT NT         6 2 2 3 3 2 5 1 7 3 5 4 3 5 4 1 8 4 4 3 3 3 1 2 3 D D A 
3257 650 NT NT         6 2 2 3 2 2 5 1 7 3 5 3 3 5 3 3 8 4 4 3 3 3 3 2 3 C D 8 
4126 650 NT NT         6 2 2 3 2 2 5 1 7 3 5 3 3 5 5 3 8 4 4 3 3 3 3 2 3 D D 8 
3518 669 R S         6 2 2 3 3 2 5 1 7 2 5 3 3 5 4 4 8 4 4 3 3 3 3 2 3 3 8 9 
3954 670 NT NT         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 4 8 4 4 3 3 3 3 2 3 D D 9 
3047 823 NT NT         6 2 2 3 3 2 5 1 7 3 5 3 3 5 5 4 6 4 4 3 3 3 3 2 3 A D 3 
5610 985 NT NT         6 2 2 3 3 2 5 1 7 2 5 2 3 5 5 4 7 4 4 3 3 3 3 2 3 D C A 
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649 2 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
600 187 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 9 
1639 207 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2189 207 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 3 5 6 4 4 3 4 5 3 2 3 B D A 
4048 207 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
137 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
151 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
313 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
439 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
638 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
650 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
714 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 6 
717 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
764 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
767 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
768 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
815 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B C A 
823 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
993 208 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1042 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1058 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1130 208 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1232 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1293 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1376 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1382 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B N/A N/A 
1411 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1432 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1524 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1537 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 5 4 3 4 5 3 2 3 B D A 
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1609 208 NT NT         7 2 2 2 3 2 5 1 3 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1620 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 8 
1763 208 S S         7 2 2 2 3 2 5 1 7 4 4 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1779 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 2 
1818 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2011 208 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2112 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2229 208 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2256 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 2 D A 
2377 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B C A 
2890 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3222 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
3259 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3305 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3327 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3339 208 R S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D B 
3496 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 1 D A 
3641 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3646 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3688 208 S S         7 2 2 2 3 2 5 1 8 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3835 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4146 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4153 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4174 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4225 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 9 
4290 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4329 208 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4424 208 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4449 208 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4551 208 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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5016 208 S S         7 2 2 2 3 2 5 1 7 3 5 3 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5187 208 S S         7 2 2 2 3 2 5 1 9 3 5 3 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5357 208 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
212 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
215 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
284 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
469 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
495 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
599 209 R R         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 4 D A 
605 209 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
618 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
634 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
687 209 R R         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
715 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
735 209 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
759 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
795 209 R R         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
972 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 2 4 5 3 2 3 B D A 
1151 209 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1158 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1170 209 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B C 9 
1182 209 R S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1259 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1267 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1279 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1326 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1360 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1383 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1421 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1427 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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1547 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 9 
1555 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1575 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1588 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1736 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1777 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1780 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 3 D 2 
1852 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1871 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1924 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1948 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1949 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D 8 
2076 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2087 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 1 3 2 3 B D A 
2206 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2221 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
2307 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 A D A 
2330 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2391 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2412 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
2413 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2463 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2598 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2891 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
2903 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
3005 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3033 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3039 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3052 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3188 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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3207 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3314 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 2 2 3 B D A 
3324 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3369 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3414 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3416 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3506 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 3 D 7 
3582 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 3 D 8 
3589 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3594 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 4 D A 
3687 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3752 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3847 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3885 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 3 4 3 4 5 3 2 3 B D A 
3973 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4002 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4004 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4122 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4151 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B F A 
4186 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4187 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4195 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 3 7 2 
4220 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4221 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4235 209 S S         7 2 2 2 3 2 5 1 7 3 4 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4271 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4276 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4292 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4376 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4395 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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4430 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4436 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4447 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4459 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4463 209 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4464 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4477 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4574 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4942 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5218 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 3 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5240 209 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5460 209 S NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5527 209 NT NT         7 2 2 2 3 2 5 1 5 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5569 209 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3189 211 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4059 211 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4896 211 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3941 212 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
191 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
230 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 3 3 B D A 
590 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
791 215 R R         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 2 5 3 
1081 215 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1390 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1396 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1652 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1708 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3030 215 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3114 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3555 215 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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4023 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4166 215 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4200 215 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4256 215 NT NT         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2115 216 NT NT         7 2 2 4 3 2 5 1 5 3 3 2 3 4 5 3 7 4 2 3 1 5 3 2 3 3 6 2 
2274 216 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2542 216 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3915 216 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4097 216 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1389 217 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1492 217 R R         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1821 217 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3289 217 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1428 255 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1504 255 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 E D A 
1522 255 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1994 255 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2958 255 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4012 308 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1515 310 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2315 396 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
3050 411 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2888 412 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2895 426 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3066 502 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3181 502 R R         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2675 516 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 3 3 2 3 B D A 
2057 537 S S         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2338 537 NT NT         7 2 2 2 3 2 5 1 7 3 3 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1015 548 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
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1463 548 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
793 595 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1813 596 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
1518 598 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4204 656 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3815 657 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3457 661 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
4352 661 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
3584 662 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4006 664 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 4 5 5 6 4 4 3 4 5 3 2 3 B D A 
3393 665 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3486 665 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5189 698 S S         7 2 2 2 3 2 5 1 7 4 5 4 3 5 5 4 6 4 4 3 4 5 3 2 3 B D A 
4013 743 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4047 750 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
2383 773 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
3809 785 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
571 851 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
4437 871 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5144 871 NT NT         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5080 878 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 2 4 3 4 5 3 2 3 B D A 
4457 879 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
5629 938 S S         7 2 2 2 3 2 5 1 7 3 5 4 3 5 5 5 6 4 4 3 4 5 3 2 3 B D A 
 
R = Resistant 
S = Susceptible 
NT = Not Tested 
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Programming 
concordance.pl 
# This script accepts input from 'input.txt' in the form of one isolate per row with genotypes 
# using two markers. The first row contains the column headers which are the marker names. 
# e.g. IS MIRU_12 
#      208 9 
#      213 1 
#      215 7 
#      208 7 
#      319 17 
#      209 7 
#      209 7 
#      209 4 
#      213 1 
# 
# The output is a number of pairwise concordance measures between the markers. 
# Matching concordance is the proportion of isolate pairs having identical marker1 genotypes 
which also have identical marker2 genotypes 
# Mismatching concordance is the proportion of isolate pairs having non-identical marker marker1 
# genotypes which also have non-identical marker2 genotypes 
# Total concordance is the combination of of both matching and mismatching concordances. 
# 
open INPUT,"<input.txt" or die "Can't open file: input.txt"; 
 
$count = 0; 
$labels = <INPUT>; 
chomp $labels; 
($marker1,$marker2) = split /\t/, $labels; # Column labels in 1st line 
while (<INPUT>) { 
 chomp; 
 ($is,$miru)=split /\t/; 
 $rec={}; 
 $rec->{IS} = $is; 
 $rec->{MIRU} = $miru; 
 push @dataset, $rec; 
} 
 
# Set up comparison matrix 
for $isolate1 ( 0 .. $#dataset){ # Iterate through list 
 for $isolate2 ( $isolate1 .. $#dataset){ # Iterate through rest of list 
  if ($isolate1 == $isolate2) { # Don't match with self 
   $matrix[$isolate1][$isolate2] = 0; 
   next; # Skip self-match 
  } 
  # Match IS strains -> upper-right matrix sector 
  if ($dataset[$isolate1]{IS} == $dataset[$isolate2]{IS}){ 
   $matrix[$isolate1][$isolate2] = 1; 
  } else { 
   $matrix[$isolate1][$isolate2] = 0; 
  } 
  # Match MIRU strains -> lower-left matrix sector 
  if ($dataset[$isolate1]{MIRU} == $dataset[$isolate2]{MIRU}){ 
   $matrix[$isolate2][$isolate1] = 1; 
  } else { 
   $matrix[$isolate2][$isolate1] = 0; 
  } 
 } 
} 
 
$isolates = $matches = 0; 
 
for $isolate1 ( 0 .. $#matrix){ # Iterate through list 
 $isolates++; 
 for $isolate2 ( $isolate1 .. $#matrix){ # Iterate through rest of list 
  if ($isolate1 == $isolate2) { # Don't match with self 
   next; 
  } 
  if($matrix[$isolate1][$isolate2] == $matrix[$isolate2][$isolate1]){ 
   $matches++; 
  } 
  if ($matrix[$isolate1][$isolate2] == 1){ #IS matching pairs with matching MIRU 
   $CountIScluster++; 
   if ($matrix[$isolate2][$isolate1] == 1){ 
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    $IS_MIRUclusterMatch++; 
   } 
  } else { # Non matching IS with non-matching MIRU 
   $CountISnoncluster++; 
   if ($matrix[$isolate2][$isolate1] == 0){ 
    $CountNonClusterMatch++; 
   } 
  } 
  if ($matrix[$isolate2][$isolate1] == 1){ # MIRU matching pairs with matching IS 
   $CountMIRUcluster++; 
   if ($matrix[$isolate1][$isolate2] == 1){ 
    $MIRU_ISclusterMatch++; 
   } 
  } 
 } 
} 
open OUTFILE,">>result.txt"; 
print OUTFILE "$marker1 vs $marker2\n"; 
print OUTFILE "Isolates: $isolates\n"; 
$pairs = ($isolates**2-$isolates)/2; 
print OUTFILE "Pairs: $pairs\n"; 
print OUTFILE "$marker1 matching pairs with matching $marker2 pairs: $IS_MIRUclusterMatch\n"; 
print OUTFILE "$marker2 matching pairs: $CountMIRUcluster\n"; 
print OUTFILE "$marker1 matching pairs: $CountIScluster\n"; 
printf OUTFILE "%s%.2f%s","$marker2 on $marker1 matching concordance: ", 
$IS_MIRUclusterMatch/$CountIScluster, "\n"; 
printf OUTFILE "%s%.2f%s","$marker1 on $marker2 matching concordance: ", 
$MIRU_ISclusterMatch/$CountMIRUcluster, "\n"; 
printf OUTFILE "%s%.2f%s","Mismatching concordance: ", $CountNonClusterMatch/$CountISnoncluster, 
"\n"; 
print OUTFILE "Total Matches: $matches\n"; 
printf OUTFILE "%s%.2f%s", "Total Concordance: ", $matches/$pairs, "\n"; 
print OUTFILE "\n"; 
close INPUT; 
close OUTFILE; 
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Molecular epidemiology has established itself as a powerful weapon in the arsenal arrayed against 
infectious diseases in general and tuberculosis (TB) in particular. It has provided novel insights into 
the structure and dynamics of the TB epidemic at both local and global levels and continues to do so 
as the organism evolves under the evolutionary pressures to which it is subjected such as drug 
intervention, novel host populations and changing host behavioural patterns. 
Although numerous genetic markers have been developed for use in this field (as discussed in Chapter 
1), the most widely used is still the RFLP pattern provided by the insertion element, IS6110. We have 
shown, using serial isolates from chronically secreting patients, that this marker evolves over time with 
a half-life in the order of 8.74 years, which is in the range which makes it useable for distinguishing 
between epidemiologically unrelated cases of disease while linking together those which are linked by 
chains of ongoing transmission (Chapter 2). This rate was split into two components: a fast rate of 
change (t½ = 0.57 years), observed to be occurring in the early phase of disease, soon after diagnosis, 
and a later, slow rate (t½ = 10.69). We interpreted these vastly different evolutionary rates to reflect 
two independent evolutionary phenomena. We speculated that the fast rate is likely to have been due 
to the presence of both pre- and post-evolved variants where the evolutionary event had occurred at 
some time prior to diagnosis. Such evolutionary change may be influenced by active growth or 
adaptation to a new host environment. The slow rate could either reflect evolution as a consequence of 
exposure to anti-tuberculosis drugs or liquefaction of a lesion in which a subset of strains had 
undergone an evolutionary event. However, in either case, a direct link between IS6110 transposition 
and strain fitness remains to be demonstrated. It also became clear from our observations that both 
the original and evolved strains of M. tuberculosis may be present simultaneously within the host and 
that either or both may appear in sputum culture at any time, thus complicating the interpretation of 
molecular epidemiological data. 
In further investigating the nature of IS6110 evolution in the context of the transmission of M. 
tuberculosis within households, we found that variant strains emerged at a rate of 0.14 per source case 
per year (Chapter 3). The manifestation of evolution was usually closely associated with transmission 
of disease. This supports the notion that the environmental pressures of a new host environment may 
select for an evolved strain, in which IS6110 transposition was one of a number of events, of which 
only it was documented. Alternatively, such altered strains may be observed simply because they 
evolved early in the disease phase when their relative numbers are sufficient for them to form a 
significant proportion of the population. It is quite possible that many more evolutionary events occur 
within the bacterial population which are never observed as a result of their low representation. The 
rate of variant strain production implies that the overall strain population will change at a rate of 
2.9% per annum. Conventional understanding of epidemiological linkage as being defined by clusters 
of identical strains will, therefore, underestimate the level of transmission as variant strains appear in 
the population without the loss of their progenitor genotypes. 
The implications of these findings led us to consider the possibility of incorporating evolution of the 
molecular marker into the concept of a chain of transmission. We found that, by allowing for up to 
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two changes in the IS6110 RFLP fingerprint, it was possible to link strains together into 
‘superclusters’ on the basis of Nearest Genetic Neighbour. As we anticipated, this significantly 
increased the estimate of disease attributable to ongoing transmission in the study community to 
between 73 and 88% (Chapter 4). The implications of this finding are twofold. Firstly. this 
demonstrates that the current TB control programme is unable to diagnose and treat cases before they 
have infected both their close and community contacts. Secondly, an intervention strategy which 
targets transmission has the potential to dramatically reduce the level of tuberculosis in the 
community. However, such a strategy will need to be vigorously maintained for decades, given that 
the high level of transmission has created a substantial pool of latent infection which may sporadically 
reactivate. 
A secondary observation of note that emerged from the previous study was the substantial impact of 
the degree to which the estimation of clustering is affected by the temporal boundaries of the data 
under investigation. This suggested that the length of a study may have a substantial impact on such 
calculations, a phenomenon which has previously been largely ignored. The reason for this is that 
transmission chains which overlap the edges of the study window appear to be smaller than they in 
fact are. Our analysis of sub-windows of longer datasets (both real and simulated) confirmed this 
hypothesis, revealing that studies conducted over shorter time periods will significantly under-estimate 
the extent of clustering (Chapter 5). We also noted that this effect is highly correlated with the size of 
a cluster so that epidemics consisting predominantly of smaller clusters will be more severely affected. 
Accordingly, we proposed that molecular epidemiological studies be conducted over a minimum of 
four years. Where this is not possible, calculations of ongoing transmission should be viewed under the 
caveat that they will under-estimate the true value, particularly in epidemics dominated by small 
clusters. 
While numerous studies have described the characteristics of epidemics in various settings as a static 
overview, not many that have addressed the dynamics of an epidemic in terms of a changing strain 
population structure, particularly in a high-incidence context. Having access to twelve years of 
molecular, demographic and clinical data from a study site in Cape Town, South Africa, enabled us to 
conduct such an analysis (Chapter 6). We found that, while the incidence of tuberculosis cases infected 
with four of the predominant strain clades remained relatively stable over this period, cases with 
Beijing clade strains increased exponentially. It was also apparent that, while this phenomenal growth 
was due to drug-sensitive strains, both drug-sensitive and –resistant strains enjoyed a selective 
advantage over their non-Beijing counterparts. Comparison of the clinical and demographic data of 
cases with Beijing and non-Beijing clade strains failed to identify major factors which could explain 
our observations with the exception that the Beijing clade strains had a greater proportion of smear 
positive sputa and were less likely to be successfully treated than other strains. Thus we suggested that 
the genetic make-up of strains within the Beijing clade may encode a higher level of fitness than those 
of other strains. This would also allow Beijing clade strains to more easily overcome the fitness cost 
imposed by the acquisition of mutations conferring resistance, thereby resulting in their more frequent 
transmission. However, we cannot exclude the possibility that host-pathogen compatibility allowed 
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the Beijing clade to expand exponentially. It was in such a context that we used another genotyping 
marker (spoligotyping) to investigate the relationship between the success of different Beijing 
sublineages within the Beijing clade and their host population (Chapter 7). We found a significant 
correlation between prevalence of certain sublineages and the regions in which they are found (East 
Asia vs. South Africa) which could not be explained by founder effects. Our theory, therefore, is either, 
that different host populations have selected for different Beijing sublineages, or that specific 
sublineages have adapted to be more successful in particular human populations. 
While IS6110 remains a useful molecular epidemiological tool, it has certain limitations in that it 
requires time-consuming culturing of the sputum sample and is only applicable to strains of M. 
tuberculosis which possess more than five copies of the insertion element. For these reasons, alternative 
molecular markers have been sought and one which has gained favourable consideration is 
Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat (MIRU-VNTR) which 
is based on a PCR amplification of a combination of minisatellite-like variable-number repeat regions 
scattered around the bacterial genome. Any molecular epidemiological marker which is to replace 
IS6110 as the standard must be able to perform at least as well as it in a variety of contexts. Variations 
of MIRU-VNTR genotyping, using different combinations of loci, have compared favourably with 
IS6110 in studies done in low-incidence settings, however, it was not clear that this would be the case 
in a high-incidence community with high levels of transmission. We therefore set out to compare a 
number of MIRU-VNTR loci combinations with IS6110 (Chapter 8). We used a variety of methods to 
evaluate the performance of the MIRU-VNTR markers with respect to that of IS6110 within the 
context of a subset of strains found in the study population which belonged to the Beijing clade and 
which had a robust phylogeny. We also compared the ability of both marker types to correctly 
describe M. tuberculosis isolates from a Beijing sub-lineage which was well-characterised by four drug-
resistance markers. We found that while MIRU-VNTR yielded clustering estimates that were similar 
to that of IS6110, this was merely coincidental. The independent evolution of the two types of marker 
resulted in discordance between both the predicted transmission chains and strains with unique 
genotypes. The analysis of the Beijing sublineage suggested that IS6110 was more accurate marker in 
terms of discriminating between epidemiologically unrelated cases although it tended to split related 
cases into a number of subgroups. Allowing for limited evolution overcame this problem to a large 
degree in the case of IS6110, but was generally not useful when applied to MIRU-VNTR. Our 
findings differ from previous studies which have demonstrated a close correlation between IS6110-
RFLP and MIRU-VNTR genotyping. However, these studies were conducted in low incidence, 
Western European settings where the TB epidemic is primarily driven by reactivation and 
immigration. In this context, efficient TB control programs would largely prevent recent and ongoing 
transmission with the subsequent generation of closely related clonal variants. In most instances, this 
would imply that strains cultured from TB cases would be genetically distantly related and would thus 
not share either IS6110-RFLP or MIRU-VNTR genotypes. In this situation, MIRU-VNTR and 
IS6110-RFLP genotyping would discriminate strains equally well. In contrast, our high incidence 
setting has promoted the evolution of a large number of genetically, closely related strains which are 
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maintained within the host population. The evolutionary distance between them of such a nature that 
strains often differ in terms of only one of the two markers. Accordingly, we hypothesised that the 
degree of discordance between IS6110-RFLP and MIRU-VNTR genotyping is dependent on the 
genetic distance between isolates. This is supported by the observation that distantly related isolates 
from different Beijing sublineages have evolved distinct IS6110-RFLP and MIRU-VNTR genotypes. 
Therefore, in spite of its limitations, particularly when using fewer loci, MIRU-VNTR remains a 
valuable technique and is just as robust as IS6110 in the elucidation of higher level phylogenetic 
relationships. 
We have, in the course of these studies and those listed in Appendix B, accumulated a substantial, 
longitudinal dataset comprising both clinical and molecular strain data. This continuously growing 
database constitutes a valuable resource for both epidemiological and other TB-related studies. Much 
still remains to be done in the field of molecular epidemiology of tuberculosis. Although the value of 
such investigations have been well established, the tools and our understanding of what they tell us 
are still maturing. The need for a better marker for tracking transmission chains is accepted, but there 
is as yet, no obvious candidate which meets all the criteria. It may well be that there exists no single 
solution and that different markers will continue to be used for specific applications. Whatever marker 
is used, however, the data it provides require careful interpretation. Many factors besides those 
presented here, influence estimates of clustering. These would include: the proportion of TB cases that 
are sampled and are able to be genotyped, the level of drug-resistance, the types of cases included in 
the sample and whether or not they were infectious and the mobility of the community which leads to 
both influx and efflux of bacterial strains. The relatively recent phenomenon of HIV and its 
interaction with tuberculosis adds a new dimension to the epidemic, further complicating 
interpretation. In addition, M. tuberculosis continues to evolve. 
Phthisis, Consumption, Scrofula, King’s evil, Pott’s disease – tuberculosis has been with us in its 
various guises for millennia. This ancient and resourceful enemy will not be easily defeated. 
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Chapter 1 Molecular biology of tuberculosis 
 Primary author 
Chapter 2 Calculation of the stability of the IS6110 banding pattern in patients with persistent M. 
tuberculosis disease 
 Equal contribution with first author 
 Conceptualisation and Planning of study 
 Construction of database 
 Analysis and interpretation of data 
 Writing of manuscript 
Chapter 3 Evolution of the IS6110 based RFLP pattern during the transmission of Mycobacterium 
tuberculosis 
 Equal contribution with first author 
 Planning of study 
 Construction of database 
 Analysis and interpretation of data 
 Writing of manuscript 
Chapter 4 Genetic Distance: A measure of ongoing transmission of Mycobacterium tuberculosis 
 Conceptualisation and planning of study 
 Construction of database 
 Development of analytical tools, analysis and interpretation of data 
 Writing of manuscript 
Chapter 5 The implications of study-duration in the molecular epidemiology of tuberculosis 
 Conceptualisation and planning of study 
 Construction of database 
 Development of analytical tools, analysis and interpretation of data 
 Writing of manuscript 
Chapter 6 Population dynamics of Mycobacterium tuberculosis genotype families: A 12-year 
perspective of an epidemic 
 Conceptualisation and planning of study 
 Construction of database 
 Analysis and interpretation of data 
 Writing of manuscript 
Chapter 7 Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is 
human population dependent 
 Analysis and interpretation of data 
 Writing of manuscript 
Candidate’s contributions  173 
 
 
Chapter 8 Discordance between MIRU-VNTR genotyping and IS6110 RFLP fingerprinting of 
Beijing genotype Mycobacterium tuberculosis strains 
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 Construction of database 
 Development of analytical tools, analysis and interpretation of data 
 Writing of manuscript 
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In addition to the papers which form part of this thesis, I have also contributed to the publications 
listed below in various ways. Besides playing a part in the planning of these studies and the writing 
and editing of manuscripts, a major contribution I have made has been in the generation, 
management and classification of molecular data such as IS6110 RFLP, spoligotype, PGRS and 
MIRU-VNTR. A substantial part of this has been the establishment of interconnected databases for 
the storage and retrieval of this data. A second important aspect has been in the analysis of molecular 
and clinical/demographic data. This has often involved the development of analytical techniques and 
software. 
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